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ABSTRACT
Chapter 1 of this Dissertation presents a brief introduction to the basic properties of porphyrins
and their derivatives (hydroporphyrins), their abundance and functions in the nature, and their
applications in photodynamic therapy.
Chapter 2 reports the synthesis, characterization, conformational analysis and cellular studies of
novel mono conjugated regioisomers of chlorin e6 derivatives that are promising photosensitizers for
photodynamic therapy. All three regioisomers were synthesized from pheophytin a, which was
extracted from the alga Spirulina pacifica. In vitro investigations using human carcinoma HEp2 cells show
that the 152-lysyl regioisomers accumulate the most within cells, and the most phototoxic are the 131
regioisomers. Cellular studies revealed that the 131-aspartylchlorin e6 conjugate could be a more
efficient photosensitizer for PDT than the currently used commercial 152 derivative.
Chapter 3 describes the synthesis, characterization and cellular investigation of water soluble
regioisomers of di-conjugated chlorin e6 derivatives for photodynamic therapy. New synthetic routes
were developed to synthesize all three regioisomes. Both the 152,173-diamino and 131,173-diamino
derivatives were synthesized starting from chlorin e6 and the 131,152-diamino derivatives were
synthesized from pheophytin a. The effects of position and number of amino acid substituents on their
In vitro photodynamic properties are described.
Chapter 4 discussed the design, synthesis and characterization of electron deficient symmetric
porphyrin for incorporation into a synthetic cytochrome to mimic the activity of native cytochrome. It
also presents a brief introduction of basic synthetic routes to obtain porphyrin macrocycles. The
importance of the construction of artificial hemoproteins to understand the cytochromes activity is also
discussed. Various synthetic routes and strategies to obtain the symmetric porphyrin are reported in
detail.
viii

CHAPTER 1: INTRODUCTION
1.1 Porphyrins
Porphyrin is a macrocycle which consists of four pyrrole units, and each of these pyrrole units is
connected with each other by methine (=CH-) bridges. The macrocycle is fully conjugated and has 22π
electrons but only 18π electrons participate in the delocalized aromatic system according to Hückel’s
4n+2 rule.1-3 As a result of the extended conjugation, porphyrins absorb light in the visible region and are
highly colored. Porphyrins obeys Hückel’s rule of aromaticity (n=4) and they are usually planar according
to their crystal structures. Their aromaticity has been confirmed using heat of combustion
measurements, bond distances (X-ray crystal structures),4,5 and chemical shifts in
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H NMR

spectroscopy.1,6
The classical nomenclature for porphyrin was first introduced by H. Fischer.7 The four methine
positions between the pyrrole units were assigned as α, β, ϒ and δ: in general, they are named the meso
positions. The peripheral β pyrrolic positions were numbered from 1 to 8. Later the four pyrrole rings in
the pophyrin were labeled as A, B, C and D and all the carbons and nitrogens in the macrocycle were
numbered from 1 to 24 (Figure 1.1). This nomenclature was accepted by IUPAC and is currently also
used to designate porphyrinoid derivatives such as isoporphyrin, chlorin, etc.8

Figure 1.1: Porphyrin nomenclature
Unsubstituted porphyrin (porphin) can exist in two different tautermeric forms (Figure 1.2).
Spectroscopic and computational calculations proved tautomer 1 which holds two hydrogens on two
1

opposite pyrrole rings; this is more stable than the tautomer 2 with two hydrogens at adjacent pyrrole
rings.9

Figure 1.2: Tautermerization of porphyrin
Porphyrin acts as a tetradentate ligand while binding with metal ions. The macrocyclic cavity of
the porphyrin can coordinate with metal ions having a maximum radius of 2 Å.10 The geometry of these
complexes and number of additional ligands is a property of the metal ion.11 Depending on the metal,
they can form square planar (Cu2+, Ni2+), square-pyramidal (Mg2+, Zn2+) or octahedral (Fe2+, Mn2+)
complexes. Almost all metal ions form a 1:1 complex with porphyrin. Upon coordination of metal, two
protons on the inner nitrogens will leave and form neutral complexes with divalent metals. Central
metal ions can coordinate with porphyrins through σ-coordination with nitrogen lone pairs and πinteraction of metal pπ or dπ orbitals with other nitrogens π orbitals. σ-Coordination of the inner
nitrogens always acts as an electron donor to the metal ion but π-coordination can act as either a πdonor or acceptor depending on the metal and the substituents on the porphyrin. These
metalloporphyrins play vital roles in biological systems associating with globular proteins. Hemoglobin,
myoglobin, chlorophyll, cytochromes, catalases and peroxidases are well known examples. They play a
very important role not only in biological systems but also in chemical, industrial and technological fields
as biosensors, semiconductors and catalysts.12
1.2 Spectroscopic Character of Porphyrins
Due to their highly conjugated π system, porphyrins show very characteristic absorption spectra.
They show intense absorption around 380 to 420 nm, called the Soret band or B-band, and a few weaker
absorption bands in the longer wavelength region (500 to 750 nm) of visible light, called Q bands or β –
2

α bands.13 According to Gouterman’s four orbital model (Figure 1.3), the Soret band corresponds to
excitation of the porphyrin from its ground state to its second excited state (S0 to S2) and Q bands
correspond to excitation from the ground state to the first excited state (S0 to S1). Because of x and y
polarization of free base porphyrin the HOMO (egx) and HOMO-1 energy levels are not degenerate;
hence the Q band is further split in to four bands.14,15 Upon formation of a metalloporphyrin, the
symmetry of the porphyrin changes from D2V to D4h (4-fold symmetry) as it removes the protons on the
inner nitrogens. As a result of higher symmetry the HOMO and HOMO-1 energy levels are degenerate
and the absorption spectrum of metalloporphyrins shows only two Q bands in the visible region.
Protonation of the macrocycle also results in an effective 4-fold symmetry and gives rise to spectra
displaying only two Q-bands (Figure1.4).

Figure 1.3: Simplified Gouterman four-orbital model for D2h symmetry free-base porphyrins (top) and
transition-metal D4h symmetry porphyrins (bottom).14
The characteristic changes in the absorption spectrum during chemical reactions provide
evidence about the possible alteration of the structure. While variations of the peripheral substituents
3

on the porphyrin ring often cause minor changes to the intensity and wavelength of the absorption
features, protonation of two of the inner nitrogen atoms or the insertion/change of metal atoms into
the macrocycle usually strongly changes the visible absorption spectrum.16

Figure 1.4: Typical UV–Vis spectra for a free-base porphyrin (top) and a porphyrin-metal complex
(bottom). [Adapted with permission from reference 12. Copyright (2010) American Chemical Society.]
As in benzene, the chemical shifts of the proton signals of porphyrins are strongly affected by
the aromatic ring current. 1H NMR signals for meso protons (5, 10, 15, 20) appear far down field (around
10 ppm) in the 1H NMR spectrum compared with normal sp2 hybridized CH protons. Protons at beta
positions are also shifted further downfield than normal sp2 hybridized CH protons and are slightly
shifted upfield compared to the meso protons. All these peripheral protons are positioned in the
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deshielded region of the porphyrin spectrum. As a consequence of the induced diamagnetic ring
current, the inner NH protons are shifted to the negative region of the 1H NMR spectrum as they are in
the shielded region. Also, substituents on the porphyrin show the same behavior. The closer the
substituent to the ring, the more downfield the protons appear relative to its normal position.
1.3 Hydroporphyrins
Hydroporphyrins are partially reduced derivatives of porphyrins (Figure 1.5). Saturation of one
or more of the porphyrin double bonds by hydrogen atoms or alkyl groups will form the various
hydroporphyrins. Generally, oxidation of the hydroporphyrin macrocycle back to porphyrin is easier
than further reduction. The most common hydroporphyrins in nature are chlorins (dihydroporphyrins),
bacteriochlorins and isobacteriochlorins (tetrahydroporphyrins) which all retain their macrocyclic
conjugation. Reduction of one pyrrole double bond in the porphyrin ring leads to a dihydroporphyrin
(chlorin). Further reduction of the dihydroporphyrin will result in the tetrahydroporphyrin in which the
reduced pyrrole double bonds occur either in opposite pyrrole units (called bacteriochlorins) or in
adjacent pyrroles (called isobacteriochlorins). As reported in the recent literature, all these porphyrins,
chlorins and bacteriochlorins show aromatic character17 as they have conjugated 18π electron systems
and further reduction of pyrrole double bonds in bacteriochlorins is energetically unfavored.18
Saturation of the bridging methine positions of porphyrin will lead to loss of their macrocyclic
conjugation and results in non-aromatic meso-hydrogenated systems like porphodimethene and
porphyrinogen.
The

class of dihydroporphyrins or chlorins includes

chlorophyll, pheophytin and

bacteriochlorophylls c, d, e and f which regulate the photosynthesis of green plants and phototrophic
bacteria. Bacteriochlorophylls a, b, and g belong to the class of bacteriochlorins. Due to their
photophysical properties, some members of the chlorin and bacteriochlorin families are of great interest
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in the medicinal field for photodynamic therapy (PDT). Siroheme is a heme-like prosthetic group found
in sulfite and nitrite reductase enzymes; it belongs to the class of isobacteriochlorins.

Figure 1.5: Structures of hydroporphyrins
1.4 Naturally Occurring Porphyrins
Porphyrin derivatives, especially metal complexes, play a vital role in several life processes. Their
functions vary and depend on the protein environment and the central metal ion. For example
hemeproteins, which contain a porphyrin prosthetic group, are responsible for oxygen transport in
hemoglobin, oxygen storage in myoglobin, electron transport in cytochromes and oxygen reduction in
cytochrome oxidase. The variations in the function of hemeproteins mainly come from the interaction
between the protein and heme prosthetic group. Chlorophyll is another very important porphyrin-based
natural system, which is a catalyst in the process of converting light energy to chemical energy in plants,
photosynthesis.
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1.4.1 Hemoglobin and Myoglobin
Hemoglobin and myoglobin are two of the most important proteins in the body. They are high
molecular weight protein systems containing an iron(II) protoporphyrin IX prosthetic group (heme
group, Figure 1.6a). Their function is to facilitate transport and storage of molecular oxygen in higher
animals. Hemoglobin binds with O2 and transports it from the lungs to the muscle cells. Then it transfer
O2 to myoglobin which has higher affinity for O2 than does hemoglobin. By itself, heme is not a good
oxygen carrier. It must be part of a larger protein to prevent oxidation of the Fe2+ to Fe3+ in the
porphyrin core.
a)

b)

c)

Figure 1.6: a) Heme prosthetic group, the iron(II) protoporphyrin-IX complex; b) Structure of human
hemoglobin.19 The protein α and β subunits are in red and blue, and the iron-containing heme groups in
green; c) Structure of oxymyoglobin.20 Modified from references 19 and 20.
Hemoglobin consists of four subunits (two α and two β) and each holds one heme group (Figure
1.6b). In the lungs the partial pressure of O2 is high and the pH is low due to low CO2 concentration.
These factors favor the formation of a hemoglobin-O2 complex. Once the first O2 molecule binds with
the heme group, that changes the shape of the protein in a way favorable for binding (relaxed state) of
the second O2 molecule. This special property, called the cooperative effect, is mainly caused by the
decrease in the size of Fe2+ after binding with O2. It is due to a change in the spin state of Fe2+
(Figure1.7).
7

Figure 1.7: Iron(II) slight orientation changes from deoxyhemoglobin to oxyhemoglobin.21
As shown in Figure 1.6, four of the six coordination sites of Fe2+ are occupied by nitrogen atoms
from a planar porphyrin ring. The fifth coordination site is occupied by a nitrogen atom of an imidazole
ring of the histidine amino acid. In deoxyhemoglobin (Hb) the sixth coordination site is available for
coordination with dioxygen. Because of lower crystal field splitting, the iron(II) in deoxyheamoglobin is
in a high spin state and has a radius of 92 pm. Therefore the ferrous ion is positioned slightly out of the
porphyrin plane. When dioxygen, which is a weak ligand, binds to the ferrous of the hemoglobin (HbO2)
it increases the crystal field slightly, increasing the splitting just enough tip the iron into a low spin state its radius contracts to 75 pm and the ion moves into the plane of the porphyrin along with the histidine
residue.22 That changes the conformation of the protein and increases the binding affinity for dioxygen
(cooperative effect) to the other units, probably by breaking some salt bridges in the protein. Inside the
cells, the partial pressure of O2 is low and the pH is high due to higher concentration of CO2. These
conditions favor the tense state which has low affinity for O2 and leads to release of dioxygen.
Myoglobin is a single-chain globular protein containing an iron(II) protoporphyrin IX prosthetic
group in the center (Figure 1.6c). Myoglobin has a higher affinity for O2 than hemoglobin, even at lower
O2 concentration. The active site of myoglobin is very similar to that of hemoglobin. A proximal histidine
group is attached directly to the iron center and there is a histidine group on the opposite face, not
8

bonded to the iron. This is called the distal histidine, and influences the affinity for O2 by increasing the
O2 binding constant by hydrogen bonding to dioxygen (Figure 1.8). This histidine residue serves two very
important functions in the polypeptide; 1) It prevents oxidation of the Fe2+ to Fe3+ by any number of
possible oxidizing agents. If it is oxidized to ferric, the O2 affinity will be lost; 2) the position of this
histidine side chain makes it difficult to bind carbon monoxide (CO) to the iron in a linear fashion, while
allowing oxygen to bind easily as it binds to iron in a bent fashion. Formally, free heme has a much
higher (23,000 times) affinity for CO than O2, but in hemoglobin and myoglobin, CO has a lower binding
constant compared to free heme.

Figure 1.8: The distal histidine amino acid from the hemoglobin protein molecule further stabilizes the
O2 molecule by hydrogen-bonding interactions.23
1.4.2 Chlorophyll
Chlorophyll is vital for photosynthesis, which allows plants and cyanobacteria to absorb energy
from light and convert it into chemical energy. Chlorophylls are mainly found in chloroplasts of plants
and cyanobacteria. Most of the chlorophylls (a, b, d, and f) are chlorin pigments containing a magnesium
as a central metal ion, but few of them (chlorophyll c1 and c2) remain as unreduced porphyrin
derivatives. Slight changes in peripheral substituents in chlorin and porphyrin macrocycles result in
different classes of chlorophylls as shown in Figure 1.9.
9

Chlorophyll a

Chlorophyll b

Chlorophyll d

Chlorophyll f

R1

-CH3

-CH3

-CH3

-CHO

R2

-CH=CH2

-CH=CH2

-CHO

-CH=CH2

R3

-CH2CH3

-CHO

-CH2CH3

-CH2CH3

Figure 1.9: Structures of different chlorophylls
As shown in Figure 1.9, chlorophyll derivatives consist of a porphyrinoid macrocycle with a
central magnesium ion. All chlorophylls contain the isocyclic β-keto ester ring that is biosynthetically
derived from the C13 propionic acid side chain of protoporphyrin IX. Peripheral substituents in
chlorophylls vary widely. There are more than 50 derivatives that have been isolated and identified from
photosynthetic organisms. The chlorophyll c structure deviates from other chlorophylls; it has an
unreduced porphyrin macrocycle compared to the dihydroporphyrin in other chlorophylls and a free
unsaturated propionic acid chain at C17 compared to the phytol esterified propionic acid.
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Chlorophylls absorb strongly in the blue (mostly at 430 nm) and red (mostly at 660 nm) regions
of the electromagnetic spectrum (Figure 1.10). Thus, their absorption bands significantly overlap with
the emission spectrum of the solar radiation reaching the biosphere, resulting in efficient tools for
conversion of radiation into chemical energy.

Figure 1.10: Absorption spectrum of chlorophyll a.24
Bacteriochlorophylls which are related to chlorophylls, are photosynthetic pigments that are
found in various phototropic bacteria. Bacteriochlorophylls c, d, and e are dihydroporphyrin (chlorin)
structures like chlorophylls, being reduced in ring D only. Bacteriochlorophylls a (Figure 1.11), b, and g
are tetrahydroporphyrin (bacteriochlorins), which have two reduced pyrrole rings (ring B and D). In
general, bacteriochlorophylls absorb light of a longer wavelength than do the chlorophylls. The position
of the absorption maximum is observed in the red or infra-red region and depends on the conjugation of
the macrocycle and its protein environment.
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Figure 1.11: Structure of bacteriochlorophyll a
All of these chlorophyll derivatives (chlorophylls and bacterochlorophylls) share a number of
modifications in the macrocycle to achieve their main function; light harvesting. These common
structural modifications include 1) usage of Mg2+ as the central metal ion; 2) addition of an extra ring
(five membered isocyclic ring) to the tetrapyrrole structure; 3) loss of one or more double bonds from
the conjugated system, but while still maintaining their aromaticity; and 4) with an elongated nonpolar
phytol group. These modifications impart unique properties to chlorophylls, such as longer wavelength
light absorption compared with heme groups, and increased lipophilicity and electron transfer ability.
1.4.2.1 Chemical Degradation of Chlorophylls
Chlorophyll a and b are the most common and predominant pigments in all oxygen-evolving
photosynthetic organisms such as higher plants, red and green algae. The ratio of chlorophyll a to b in
the chloroplast is normally 3:1. It is known that the ratio of chlorophyll a to b varies with the amount of
light received by the plant, for example, the ratio is higher in high-light growth conditions than in lowlight growth conditions. These pigments can be extracted from plant leaves and from alga in large
quantities. Chlorophyll a and b can be separated by classical and high performance liquid
chromatography. Also more convenient large scale separation methods by solvent partition have been
reported.4 The reagent Girard ‘T’ (carboxymethyltrimethylammonium chloride hydrazide) readily reacts
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with the 3-formyl group of chlorophyll b to form the water soluble derivative and makes the separation
easier.
Pheophytin a (5) and b (a chlorophyll molecule lacking a central Mg2+ ion) can be obtained from
chlorophyll a (4) and b respectively by treating with a mild acid. Effective hydrolysis of the phytol ester
group of pheophytin 5 to achieve pheoporbide 6 has been reported under acidic, alkaline and enzymatic
conditions. In addition both the phytyl residue and the magnesium atom of chlorophyll 4 (in ether) can
be removed under acidic conditions (30% HCl) to form pheophorbide 6 (Scheme 1.1).

Scheme 1.1: Pathways for hydrolysis and transesterification of phytol ester group of pheophytin a
As reported, hydrolysis of the phytyl propionate group of chlorophyll b requires a higher
concentration of HCl than does the hydrolysis of the phytyl propionate group of chlorophyll a (4) and
this fact has been used successfully to separate chlorophyll a (4) from b.9 But with HCl-ether conditions,
the hydrolysis of both phytol residue and 132-CO2Me group of chlorophyll 4 to its acid and subsequent
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decarboxylation of the 132-COOH group with formation of the corresponding pyropheophorbide 7 was
reported.9 Then the regioselective hydrolysis of the phytyl propionate residue of chlorophyll 4 was
performed using 80% aqueous trifluoroacetic acid at 0 0C by Wasielewski and Svec.25 Transesterification
of pheophytin 5 by the action of methanol in the presence of sulfuric acid produced methyl
pheophorbide 8 in quantitative yield.8 Also esterification of pheophorbide 6 with diazomethane
produced

methyl

pheophorbide

8

in

high

yield.

Oxidation

of

any

chlorin

with

dichlorodicyanobenzoquinone (DDQ) gives the corresponding porphyrin. For example, methyl
pheophorbide a (8) gives 2-vinylpheoporphyrin a5 dimethyl ester (9) where in the subscript number
indicates the number of oxygen atoms in the molecule. If methyl pheophorbide 8 is refluxed in collidine
it gives the corresponding ‘pyro’ derivative 7.
Air oxidation of pheophorbide a (6) under alkaline conditions initially forms the hydroperoxide
intermediate 10 and subsequent fragmentation of the hydroperoxide and loss of the phytol residue
results in Fisher’s so-called “unstable chlorin” 11 (Scheme 1.2).8

Scheme 1.2: Pathways for modification of the isocyclic ring of pheophorbide a (6)
14

On evaporation of the solvent this chlorin 11 is converted into purpurin-18 (12) and subsequent
esterification with diazomethane gives the purpurin 7 trimethyl ester (13). Further refluxing of purpurin
7 trimethyl ester (13) in collidine produces rhodoporphyrin-XV dimethyl ester (14) in 81% yield. Base
catalyzed nucleophilic addition to the β-keto ester group of pheophorbide-a (6) under an inert
atmosphere (without involvement of oxygen) leads to the isocyclic ring-opened chlorin derivative 15
through intermediate formation of a 152 enol.
Under alkaline conditions pheophorbide a (6) is converted into chlorin e6 (16) by cleaving the
isocyclic ring. Chlorin e6 features prominently in this Dissertation. Opening of the isocyclic ring of
pheophorbide a (6) by methoxide followed by esterification with diazomethane affords the chlorin e6
trimethyl ester (17, Scheme 1.3).

Scheme 1.3: Modifications of chlorin e6
Methanolysis of methyl pheophorbide a (8) affords chlorin e6 trimethyl ester (17) in quantitative
yield. Decarboxylation of the free acid groups of chlorin e6 (16) sequentially forms chlorin 18 and 19.
Upon further heating of chlorin 19 the stable phylloporphyrin XV (20) is formed.
15

Treatment of chlorin e6 (16) with potassium permanganate and subsequent esterification of the
resulting diacid 21 leads to formation of the formyl derivative 22. When heated with hydroxylamine
hydrochloride in aqueous pyridine, the formyl derivative 22 leads to deformylation to afford
rhodochlorin 23. Intramolecular aldol condensation of the formyl derivative 22 results in introduction an
extra six membered ring to the chlorin core. The formyl derivative 22 can be treated with hydrogen
cyanide to afford cyanolactone 25 and subsequent reduction with a zinc/acetic acid system followed by
esterification gives the nitrile derivative 26. Hydrolysis of the nitrile derivative 26 followed by
esterification can afford chlorine e6 trimethyl ester (17).

Scheme 1.4: Further modifications of the carboxyl groups on the chlorin e6 (16)
1.4.3 Cytochromes
Cytochromes are proteins with heme prosthetic groups that take part in oxidation/reduction
reactions by carrying electrons. They can be found in the inner mitochondrial membrane or in the
endoplasmic reticulum in cells.
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In the past these pigments were classified into groups based on the position of the lowest
energy absorption band in the reduced state. For example cytochrome-a (605 nm), cytochrome-b (565
nm) and cytochrome-c (550 nm). But nowadays cytochromes are subdivided into four classes depending
on the nature and the mode of binding of the heme prosthetic groups to protein. At least 30 different
cytochromes have been identified.
There are four major established subclasses (Figure 1.12):
(1) Cytochromes-a contain heme-a as the prosthetic group.
(2) Cytochromes-b contain heme-b (protoheme) as the prosthetic group, not covalently bound to the
protein.
(3) Cytochromes-c contain a prosthetic group very similar to heme-b but there are covalent thioether
linkages between the heme side-chains and the protein.
(4) Cytochromes-d contain a tetrapyrrolic chelate of iron as the prosthetic group, in which the degree of
conjugation of double bonds is less than is found in porphyrin.26
Both heme-a and heme-c are biosynthetically derived from heme-b. Conversion of the vinyl
group at position 2 in heme-b to a hydroxylethylfarnesyl side chain followed by oxidation of the methyl
group at position 8 to a formyl group will result in heme-a. The porphyrin macrocycle of cytochrome c,
which is very similar to the porphyrin macrocycle of cytochrome-b, linked to the protein via two cysteine
residues of the protein with the two vinyl groups of the porphyrin. All other cytochrome heme groups
are covalently bound to the protein. Unlike in hemoglobin and myoglobin, in cytochromes all six
coordination sites of iron are occupied by specific amino acid residues of the protein and the nitrogens
in the porphyrin. Therefore cytochromes cannot bind to ligands such as O2 and CO. Their function
involves transfer of a single-electron, in a reversible equilibrium between the Fe2+ and Fe3+ states of the
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central iron atom. Even though they have very similar prosthetic groups, their reduction midpoint
potentials span an 800 mV range, from cytochrome-c3 (-400 mV) to cytochrome-b559 (+400 mV); this
gives the electron chain its “directionality” so that electrons move from one carrier to another in the
chain. These changes in redox potentials are mainly influenced by the protein environment. Other
factors such as nature of axial ligation with iron, peripheral substituents of the porphyrin, solvent
accessibility to the metal site, electrostatic interactions with amino acid side chains of proteins and
protonation state of neighboring amino acids also influence the redox potential of the cytochrome.

Figure 1.12: Structures of commonly occurring natural hemes -a, -b, -c, and -d.
1.5 Photodynamic Therapy (PDT)
PDT is a binary cancer therapy, which relies on selective uptake of a photosensitizer into the
cancer cells which upon irradiation with light of an appropriate wavelength produce highly toxic singlet
oxygen and other cytotoxic species.27,28 Singlet oxygen can readily react with electron rich biomolecules
such as unsaturated lipids, amino acids and DNA.29 Its limited diffusion prevents damage to the normal
cells next to the tumor. The selectivity of the PDT treatment depends upon both the tumor-targeting
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ability of the photosensitizer and the light used to activate it. The most coherent light sources are lasers
and since the maximum of skin permeability occurs in the range of approximately 620-850 nm called the
“therapeutic window”, light of this spectral range is predominantly used in PDT.30 Hence,
photosensitizers with a strong absorption band in this region can be activated to gather light that
penetrates deeper into the tissues.
The photophysical processes of PDT are illustrated in the simplified Jablonski diagram shown in
Figure 1.13. In the presence of laser radiation, a photosensitizer (P0) which is in the ground state, is
excited to a singlet excited state. Relaxation of the singlet exited state yields the short-lived lowest
excited singlet state (1P*). There is little opportunity for it to react with another molecule via either
electron or energy transfers because the excited singlet state has a very short life-time. Most of the
singlets will return to the ground state by emitting energy in the form of fluorescence, which helps to
visualize the tumor. A few of the singlet excited photosensitizers will undergo intersystem crossing to
the triplet state (3P*) which has a longer life time (10-3 s) than the singlet state (10-8 s).31 Normally these
triplet state molecules will return to the ground state by emitting their energy via phosphorescence. But
in the cell the excited triplet state can undergo two types of reactions; defined as types I and II
mechanisms. 1) It can transfer electrons to a biological substrate to form radicals. Ultimately these
electrons can interact with molecular oxygen to form superoxide (type I mechanism). 2) In the presence
of ground state oxygen, which is in the triplet state, the energy will transfer from the excited triplet
state of photosensitizer to ground state triplet oxygen (3O2). This will produce a short lived and highly
reactive excited singlet oxygen (1O2) which can readily react destructively with any nearby biomolecules
(type II mechanism). Each photosensitizer molecule can typically generate 103-105 molecules of singlet
state oxygens before being degraded through photobleaching by excited singlet oxygen or by some
other process.31 In water, lifetimes of singlet oxygen are much shorter than in organic solvents and their
lifetime gets even shorter in the cells due to rapid reactions with subcellular substrates. Therefore the
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diffusion of singlet state oxygen from the site of generation is very limited (0.01-0.02 μm).32 Such limited
diffusion of singlet state oxygen provides a huge advantage in PDT.33 Ultimately, these destructive
reactions lead to cell death through apoptosis or necrosis.
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Figure 1.13: Production of singlet oxygen by PDT
In the first step of PDT (Figure 1.14), the photosensitizer or the drug is administered into the
blood stream through a vein or else placed directly on the skin. Then the photosensitizer will be
absorbed by the cells all over the body. But it will accumulate in cancer cells more than normal cells and
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also the photosensitizer stays longer in cancer cells than normal cells. Within 72 – 96 hours after
injection much of the photosensitizers accumulate in the cancer cells. Then the tumor is exposed to light
of an appropriate wavelength to activate the photosensitizer. After absorbing light the photosensitizer
will excite and generate singlet oxygen and eventually shrink or destroy the tumor. The major
mechanism of tumor destruction is damaging the blood vessels in the tumor that prevent the tumor
from receiving its essential oxygen and nutrients.

Injection of
photosensitizing agent

Photosensitizing agent
concentrate at the tumor site

Figure 1.14: The stages of photodynamic therapy
Studies are now being performed to test the use of PDT for several types of cancer and precancerous conditions, including cancers of the: skin, cervix, bladder, prostate, bile duct, pancreas,
stomach, brain, mouth, and larynx (voice box). The main advantages of PDT are:
1) It is less invasive than surgery.
2) It has few long-term side effects.
3) It is a tumor targeted therapy that causes less damage to normal cells.
4) It is cost-effective compared to other cancer treatment methods.
5) It can be combined with other cancer treatments.
The usage of an external light source makes PDT limited to areas where light can reach. Therefore
PDT is limited to treat cancers on or just under the skin, or in the lining of organs that can be reached
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with the light source as the light can be directed through fiber optic cables to internal organs. PDT is less
effective in treating larger and widely spread cancers. The poor selectivity of current photosensitizers for
tumor tissue remains another main drawback in photodynamic therapy.
The selectivity toward cancer cells over normal cells in the PDT treatment depends upon both the
tumor-targeting ability of the photosensitizer and the light used to activate it. Extensive research is
underway to develop modern photosensitizers that meet the following criteria for an ideal
photosensitizer.34,35 It should have;
1) Minimal dark toxicity and only be cytotoxic in the presence of light
2) High quantum yield of singlet oxygen production in vivo
3) High selectivity for tumor cells over normal cells
4) Fast elimination from the skin and epithelium
5)

Strong absorption peaks in the therapeutic window (the far-red and near-infrared regions)

6) Available manufacturing and synthesis
7) Homogeneous composition
8) Storage and application light stability.
The effective destruction of tumor cells requires a high concentration of singlet state oxygen in the
tumor. To achieve this, the photosensitizer should have a high quantum yield of singlet oxygen
production and also should have high accumulation of the photosensitizer in the tumor site.
It is well known that the 650-800 nm region is the optimal wavelength absorption for an efficient
photosensitizer. Lower and upper limits are set by the absorption and scattering of tissue and the
minimum energy required to excite the ground state oxygen. Lower wavelengths will increase the
absorption by tissue and reduce the penetration of light. Heme proteins in the tissue absorb more light
at the lower region and are maximal around 400 nm. Therefore light penetration through tissue
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increases with longer wavelengths, but above 1000 nm water in the biological tissue starts to absorb
light heavily (Figure 1.15).

Figure 1.15: The absorption spectrum for arteries (SaO2 ≈ 98%)36
As shown in Figure 1.16, molecular oxygen has two low-lying singlet excited states, 1Δg and 1Σg+.
Where, transition from excited state 1Δg to ground state (1Σg-) is spin forbidden, therefore excited state
1

Δg Oxygen has relatively longer lifetime. Energy difference between ground state (1Σg-) and excited

states, 1Δg and 1Σg+ are 95 kJ mol-1 (22.5 kcal mol-1) and 158 kJ mol-1 (31.5 kcal mol-1), respectively.
However, porphyrins which absorb light in the longer wavelength region emit low energy when it comes
to the ground state. The energy level often mentioned for photosensitizer is that for the excitation of it
to singlet state. Therefore the energy of the triplet state is even lower than that of the singlet state. If
the triplet state energy is lower than the energy required to excite ground state oxygen to the singlet
state (95 kJ mol-1), it is not possible for it to act as an effective photosensitizer.
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Figure 1.16: Potential energy curves for the three low-lying electronic states of molecular oxygen.
[Adapted with permission from reference 31. Copyright (2002) Elsevier.]
Tumor-selectivity of photosensitizers can be increased by targeting the distinctive features of tumor
tissue over normal tissue, such as increased low-density lipoprotein receptors, macrophages, acidic
environment and tumor stroma with large interstitial space, leaky vasculature, increased lipids and
newly-synthesized collagen. The mechanism for selectivity of porphyrin towards cancer cells is still
unclear. According to our research (see later) amphiphilic character, overall charge, and spatial
conformation of the molecule play a vital role in tumor selectivity.
Maintaining the proper balance between hydrophilicity and hydrophobicity is the most
important factor when designing an optimal-porphyrin based photosensitizer. Previous studies revealed
that hydrophobic photosensitizers readily accumulate in tumors more than hydrophilic photosensitizers,
as they bind with LDL, enter into the cytoplasm via endocytosis, or binding with lipoprotein receptors,
and subsequently redistribute in the membrane domain, mitochondria, Golgi apparatus, and lysosomes.
However, poor solubility of these compounds in aqueous media prevents their circulation in the blood
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stream and also hydrophobic drugs are retained in the body for a longer time and result in adverse skin
photosensitivity reactions in the body. Conversely hydrophilic photosensitizers excrete easily from the
body after the therapy. They can bind with serum albumin and accumulate in the stroma of the tumor
cells.4
The following attributes of the porphyrin derivatives make them powerful and versatile
chromophores for PDT studies:
1) The presence of main absorption bands in the therapeutic window, the Q bands, around 600700 nm. It is advantageous to use red-shifted chromophores in order to get better penetration of
exciting laser source;
2) Intense extinction coefficients. Singlet oxygen production depends on the extinction
coefficient of the chromophore; and
3) Ease of modification of substituent groups. Porphyrins have several distinct functionalization
sites, i.e., the meso position, β-position. The solubility of porphyrin derivatives in nonpolar or polar
solvents can be modified by varying the porphyrin substituents.
1.5.1 Clinical Photosensitizers
Photofrin (porfimer sodium, hematoporphyrin, HpD, Figure 1.17) has been commercially
developed and approved in a number of countries as a first generation photosensitizer. But it is far from
an ideal photosensitizer. It is not a single compound; it consists of a mixture of monomers and oligomers
of porphyrins linked by ether and ester linkages.7 Its long wavelength absorption (Q band) is not situated
within the therapeutic window. The longest wavelength absorption maximum is at 630 nm, typical for
porphyrin. Therefore it has limited use due to poor light penetration. It also has longer retention times
in the body and causes skin photosensitivity.
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Figure 1.17: Structure of Photofrin
Levulan (5-aminolevulinic acid or ALA, Figure 1.18), which is the first unique compound in the
porphyrin biosynthesis pathway, is a naturally occurring prodrug which converts enzymatically in to
protoporphyrin (active photosensitizer) after administration37,38 and it has received approval for the
treatment of cancerous lesions in 1999. The active drug belongs to the porphyrin category like Photofrin
and therefore suffers from weak absorption in the therapeutic window. The drug is applied superficially
on the tumor because of lack of selectivity when it is administered systemically.39 The use of ALA in PDT
has several advantages over Photofrin: there is a more rapid clearance (limiting skin photosensitivity to
1–2 days), it can be applied topically for the treatment of skin cancer and orally for cancer in the oral
cavity or digestive tract.

Figure 1.18: Conversion of 5-aminolevulinic acid to protoporphyrin IX
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Verteporfin (Visudyne, BPD, 1.19) is a benzoporphyrin derivative. It absorbs at 690 nm; this
longer wavelength allows deeper penetration due to extended conjugation of the macrocycle. The free
carboxylic acid groups and ester groups provide the necessary amphiphilicity, allowing rapid
accumulation and excretion from tumors. Difficulty of its synthesis is one of the major drawbacks.

Figure 1.19: Structure of one isomer Verteporfin
To overcome the major drawbacks in porphyrin based photosensitizers, low excitation
coefficient in the therapeutic window and persistence in skin, so called second generation chlorin based
photosensitizers (Figure 1.20), such as Foscan (Temoporfin) NPe6 (LS11, mono-aspartylchlorin e6) and
HPPH [Photochlor, 2-(1-hexyloxyethyl)-2-devinyl-pyropheophorbide a] have been developed.35 Chlorins
are particularly promising photosensitizers for PDT because of their distinctive ability to accumulate in
tumorous tissues,40 intense absorptions at 664 nm, high stability, low dark toxicity and ability to
generate singlet oxygen in the light.41-43 Amphiphilicity, another favorable trait, has been shown to
improve the effectiveness of photosentizers. Chlorophyll a derivatives of the chlorin e6 series possess
three carboxylic side chains, making them an ideal substrate for synthesis of novel amphiphilic
photosensitizers.
As mentioned earlier, chlorins are reduced porphyrins; hydrogenation of one of the pyrrole
double bonds provides its characteristic absorption spectrum. Their strong absorption in the long
wavelength region (around 650 nm, inside the therapeutic window) and high molar extinction
coefficient make them more promising photosensitizers than Photofrin.44,45 For an example Talaporfin
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shows absorption peaks at 400 and 654 nm with molar absorption coefficients of 180 000 and 40 000
M−1 cm−1 respectively.45 These properties of chlorins allow for deeper photodamage of tissue and a
better therapeutic effect compared with porphyrins.46 As reported in the literature, chlorin derivatives
have higher quantum yields for singlet oxygen production and long triplet lifetimes, which may help to
increase singlet oxygen production.47 The measured lifetime of the triplet state in buffer solution is 760
μS for chlorin e644 and 300 μS for Talaporfin.45 But the quantum yield of singlet oxygen production of
Talaporfin (0.77) is similar to the reported value of chlorin e6 (0.7).45

Figure 1.20: Second generation chlorin photosensitizers
Aizawa and coworkers reported that Talaporfin has 10 times greater uptake in malignant tissue
cells than in normal organs.48 It transports through the body by binding to the plasma proteins and
lipoproteins. The previous studies revealed that Talaporfin bound more strongly to plasma proteins than
to lipoproteins.49 They are also rapidly cleared from the body; this would be of great advantage in
clinical studies. Because of that, the therapeutic dosage of Talaporfin causes very little skin sensitization
compared to most porphyrin-based photosensitizers, and it clears quickly from tissue.11,21,50 However
the future of photodynamic therapy highly depends on the development of more tumor selective and
more efficient photosensitizers. Development of improved derivatives of Talaporfin is a major objective
of the research work reported in this Dissertation.
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CHAPTER 2: SYNTHESIS AND CHARACTERIZATION OF CHLORIN e6 DERIVATIVES FOR
PHOTODYNAMIC THERAPY1
2.1 Introduction
Mono-L-aspartyl chlorin e6 (1, Talaporfin, also known as, NPe6, or LS11) is a photosensitizer used
in photodynamic therapy (PDT). It was approved in Japan (in 2004) but not yet in the USA, for PDT of
lung cancer and marketed as Laserphyrin.1 It is trademarked as Aptocine by Light Sciences Oncology and
is a second generation photosensitizer in advanced-stage clinical trials. Light Sciences Oncology (LSO)
has completed treatment of patients in a phase III trial of NPe6 in hepatocellular carcinoma (HCC), a
phase III trial for metastatic colorectal cancer (MCRC) and in phase I and Phase II clinical trials in benign
prostatic hyperplasia (BPH), or enlargement of the prostate.2
As shown in Scheme 2.1, NPe6 (1) is synthesized starting from pheophytin a (4) which is
extracted from alga. Transesterification of the phytyl group of the pheophytin a (4) with methanol in
acidic conditions afforded methyl pheophorbide a (3). Subsequent isocyclic ring opening of methyl
pheophorbide a (3) with methoxide produced chlorine e6 trimethyl ester. Hydrolysis of all three methyl
esters then yielded chlorin e6 (2). The final product NPe6 (1) can be obtained after carboxylic acid
activation of chlorin e6 (2) and then coupling with aspartic acid.3

Scheme 2.1: Synthesis of NPe6 from Spirulina pacifica

1

This chapter reprinted with permission from Jinadasa, R. G. W.; Hu, X.; Vicente, M. G. H.; Smith, K. M. J.
Med. Chem. 2011, 54, 7464. Copyright (2011) American Chemical Society.
32

Chlorin e6 (2) possesses three carboxylic acid side chains. Of the three carboxylic acids, the
propionic acid chain seems more accessible for activation and for nucleophilic attack than the acetic or
formic acid chains under classical coupling reaction conditions. Therefore academic papers published
since 1997 assumed NPe6 (1) was the propionic acid regioisomer of chlorin e6 (5). But in 1998, Gomi and
coworkers claimed NPe6 (1) is actually the acetic acid regioisomer not the propionic acid regioisomer,
according to 2D NMR studies.4 But this discovery was not accepted by the porphyrin community
because it was against chemical logic, and the NMR work was done in D2O which is known to cause
aggregation. In this synthesis, protecting groups or any other strategies were not used to do a selective
coupling reaction. All three carbocyclic acid side chains in chlorin e6 (2) are susceptible to activation
followed by conjugation with amino acid. The classical coupling reagent, DCC and DMAP were used to
activate the carboxylic acid and then nucleophilic addition of the free amine group of aspartic acid
followed by elimination of activator as urea produced the final product (Scheme 2.2).

Scheme 2.2: Mechanism of DCC/ DMAP coupling reaction
According to the mechanism in Scheme 2.2, it is reasonable to assume that the propionic side
chain, which is located far away from the macrocycle and is more accessible than the other acidic side
chains, will activate first to give the conjugated product. Additionally, the propionic side chain is located
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perpendicular to the macrocycle and this makes it less stericaly hindered. The acetic acid and formic acid
chains are more sterically hindered by both substituents and by the macrocycle compared to the
propionic side chain. Apart from that, the formic acid is deactivated during esterification under acidic
conditions because it is directly attached to the macrocycle and conjugated with it. Under acidic
conditions, the inner nitrogens of the macrocycle are protonated and this makes it electron deficient.
That prevents the activation of the conjugated carboxylic acid to undergo nucleophilic attack. It seems
that neither the formic nor the acetic side chains were considered serious competition to the propionic
carboxyl chain.
With the intention to establish the true isomeric identity of NPe6, all three regioisomers 5, 6 and
7 were prepared by total synthesis from chlorin e6 (2) or methyl pheophorbide a (3), and the acetic
regioisomer 6 was shown to be identical with NPe6.5 In 2007, our group was also able to obtain the X-ray
structure of this ambiguous compound 6 which was prepared using the same method with DCC as a
coupling agent.5 Surprisingly, the crystal structure confirmed that the aspartyl group is attached to the
acetic acid position in chlorin e6. It was really a surprise to see highly regioselective coupling at the acetic
acid position without any carboxylic protecting groups. It seems this coupling follows a different path
than classical coupling reactions. This highly regioselective coupling provides an easy, short and high
yielding route to synthesize acetic acid derivative without any protecting groups. It was possible to
synthesis all three regio-isomers (Figure 2.1) of chlorin e6 starting from pheophytin a (4) in reasonable
yield.
Our particular interest is to synthesize various regioisomers (Figure 2.1) of chlorin e6, since such
molecules could selectively accumulate in specific organelles within cancer cells and cause effective
photodamage. Their biological efficacy could be modulated based on the position and the type of amino
acids (nature of the side chain). Furthermore, introducing spacer groups such as ethylene diamine, to
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the formic acid chain should significantly influence the chemical and biological properties of the
photosensitizer,6 as they alter the aggregation behavior and hydrophilic character of the conjugates.7,8

Figure 2.1: Synthesis of NPe6 regioisomers
It was recently reported that the photosensitizing properties of the conjugate can be improved
by introduction of metal ions into the coordination sphere of chlorins.9,10 Heavy metal atoms in
tetrapyrroles will enhance the intersystem crossing rates and consequently the singlet oxygen quantum
yields.10 Unfortunately, metal coordination with chlorophylls also results in a blue shift of the Q band in
the absorption spectrum.11
2.2 Mechanistic Studies
The synthetic, X-ray5 and spectroscopic4 work mentioned above confirmed the formation of the
acetic acid derivative from reaction between DCC activated chlorin e6 and carboxyl protected aspartic
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acid. To discover the path of this coupling reaction, several reactions were designed and 1H NMR and
mass spectroscopy were used to characterize the intermediates.
In this reaction one equivalent of chlorin e6, one equivalent of DCC and one equivalent of DMAP
were suspended in DCM under argon for two hours at room temperature. After 30 minutes TLC with
10% acetone/CH2Cl2 showed two newly formed spots. Chlorin e6 does not move on TLC with less polar
solvent systems such as 10% acetone/CH2Cl2. These observations confirmed the formation of a less polar
highly reactive intermediate of chorin e6 in the reaction with DCC. Isolation of these fractions failed due
to the high reactivity of the product. The colors of the fractions changed from purple to green during
column chromatography. Once the color had changed to green, the material refused to elute from the
column, even with high polar solvent systems. Mass spectroscopy of the reaction mixture showed two
main peaks at m/z 785 and 578.
Based on the mass spectrum and TLC, it was hypothesized12 that the intermediate could be a
seven-membered anhydride intermediate 8 which has high reactivity and can easily undergo a ringopening reaction with nucleophiles to produce acetic acid derivatives 10. The other possible
intermediate is the nine-membered anhydride intermediate 8’ which has the same mass as the sevenmembered intermediate, but was not seriously considered because of lower stability compared to the
seven membered ring and the color change to purple during formation of anhydride (Scheme 2.3).
Formation of the seven membered anhydride ring can clearly change a part of the conjugation of the
compound and that can result in the color change. The ring opening of the isocyclic ring of methyl
pheophorbide a also had resulted in a blue shift in CH2Cl2. Contrasting to ring-opening of pheophorbide
a, the red shift in this case is attributable to the formation of an anhydride ring between the formic and
acetic acid chains.
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Scheme 2.3: Proposed intermediate during DCC/DMAP coupling with chlorin e6
Due to the high reactivity and polarity associated with the presence of the free acid chain in
anhydride 8, isolation was very challenging. In order to reduce its polarity, esterification was performed
using diazomethane under argon, to obtain methyl protected anhydride 9. Esterification was done
without any purification directly following the coupling reaction due to the high sensitivity of the
anhydride towards moisture. Excess amounts of diazomethane gas were bubbled through the reaction
mixture for 3-5 minutes. TLC indicated the formation of the methyl protected anhydride 9. After the
reaction, column chromatography was performed in order to purify the intermediate. But during the
column chromatography the color of the mixture changed to green and the material became stuck to
the column. Upon applying to a silica gel chromatography, the anhydride ring could be opened easily
and this changed the color from purple to green, forming the very polar molecule 11 bearing two free
acids. Although attempts were made using different column supports such as Sephadex or alumina, still
no practical way was found to isolate the pure compound 9.
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Then it was decided to prove the regioselectivity of the coupling reaction using NMR
spectroscopy. A small nucleophile like ethoxide was selected to open the anhydride to minimize the
complications in the 1H NMR spectrum (Scheme 2.4). So once we obtained the intermediate seven
membered anhydride 8 using DCC and DMAP as was discussed before, it was reacted with one
equivalent of freshly prepared sodium ethoxide to obtain chlorin e6 ethyl ester (12). Then the remaining
free acids were protected with diazomethane gas and purified via column chromatography. Mass
spectroscopy confirmed the the product chlorin e6 dimethyl ethyl ester (13). Then the 1H NMR spectrum
of chlorin e6 dimethyl ethyl ester (13) was compared with 1H NMR spectrum of chlorine e6 trimethyl
ester to confirm the regioisomer.

Scheme 2.4: Synthesis of 152 ethyl ester chlorin e6 dimethyl ester
As shown in Figure 2.2, the 1H NMR spectrum of chlorin e6 trimethyl ester shows six singlets
between 3 to 4.5 ppm for six methyl groups. Of these six singlets, three belong to the methyl ester
groups and the other three peaks belong to the methyl groups directly connected to the macrocycle. All
of these methyl groups are found in the deshielded region of the macrocycle due to its ring current.
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Hence all the peaks are downfield from their normal position in the NMR spectrum. The first three peaks
(a,b,c) belong to three methyl esters and the one most downfield is the that closest to the macrocycle,
the 131 ester. Likewise, the 152 ester is more downfield compared to the 173 ester. These peaks had
been assigned in previous studies using 2D NMR. Upon comparison of the two NMR spectra of chlorin e 6
trimethyl ester and chlorin e6 dimethyl ethyl ester (13), it was possible to verify the ethyl ester had been
definitely added at the 152 (acetic acid) position, because of disappearance of the 152 methyl ester peak
(b) and the appearance of two new peaks (d & e) for the ethyl group in the chlorin e6 dimethyl ethyl
ester. This also provides evidence that the ring opening reaction of the anhydride 8 was occurring at the
152 position instead of 131 position, regardless of the size or nucleophilicity of the molecule.
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Figure 2.2: 1H NMR spectral Comparison of 152 ethyl ester chlorin e6 (13) and chlorin e6 trimethyl ester
It is worth noticing that the amount of DCC plays an important role in the mechanism of the
reaction. When we increase the amount of DCC in the coupling reaction, the appearance of new spot in
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the TLC was apparent. This new spot is less polar compared to the anhydride 8. The reaction with one
equvelent of aspartic acid tert-butyl ester hydrochloride followed by esterification with diazomethane
formed the expected mono aspartyl chorin e6 dimethyl ester (14). Hence it was decided to add 2.5
equivalents of aspartic acid tert-butyl ester hydrochloride with DIEA to the activated chlorin e6. After
three hours diazomethane gas was bubbled through the mixture to esterify any remaining free acid
groups. TLC indicated the formation of two new spots. Both fractions were isolated and characterized by
1

H NMR spectroscopy. Based on NMR and mass spectra, the major fraction is the expected

monoaspartylchorin e6 dimethyl ester (14) and the second fraction is the diaspartylchlorine e6 methyl
ester (16). Existence of a peak for the 131 methyl group (peak c, Figure 2.2) confirmed that the two
aspartyl groups were inserted at the 173 and 152 positions. Increasing the amount of DCC helped to
increase the yield of diaspartyl derivative 16 but the monoaspartyl derivative 14 was always the major
product. This observation also supports the conclution that the two free acids 131 and 152 had been
fused to form the anhydride seven membered ring, keeping the 173 free for DCC activation (Scheme
2.5). The activation with DCC forms a seven-membered anhydride intermediate 8 between the formic
and acetic acid chains, and if there is excess DCC, it will activate the remaining propionic acid to form
intermediate 15. This structure corresponds with the mass spectrum peak at m/z 785. Then, the free
amine group of the aspartic acid can attack both of the activated positions of intermediate 15 to form
diaspartylchlorin e6 methyl ester (16). Formation of monoaspartylchorin e6 dimethyl ester (14) as the
major product even with excess aspartic acid provides the evidence that the acetic acid activation
follows a different path and forms a more active functional group than does the propionic acid
activation with DCC. This supports the suggested intermediate 8; the somewhat strained sevenmembered ring anhydride is more reactive towards nucleophilic attack than the activated propionic side
chain.
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Scheme 2.5: Formation of mono and diaspartic acid chlorin e6 derivatives with DCC/DMAP

Figure 2.3: UV-Vis spectra of chlorin e6 (2, black) and anhydride intermediate 8 (red) in CH2Cl2
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After confirming the mechanism for the unique regioselective coupling reaction, the yield of the
reaction was improved. In this synthetic route, formation of the seven-membered anhydride
intermediate can be monitored through TLC and UV-Visible spectroscopy (Figure 2.3). Once it formed,
an amino acid or other nucleophile was added and the reaction was monitored by TLC, following the
disappearance of the intermediate or by the visible color change from purple to green.
2.3 Structural Elucidation and Synthesis of Chlorin e6 Derivatives
2.3.1 Synthesis of 173 Chlorin e6 Conjugates
The synthetic route to 173 monolysinechlorin e6 trimethyl ester (20) is shown in Scheme 2.6. It
was possible to obtain monolysinechlorin e6 trimethyl ester (20) in 33% overall yield from pheophorbide
a (17). Pheophytin a (4) was obtained by extraction from S. pacifica alga, an ideal source for chlorophyll
a that greatly simplifies the purification of the algal extract because of the absence of chlorophyll b in
the alga.13 Pheophorbide a (17) was obtained by selective hydrolysis of the phytyl ester group of
pheophytin a (4) using the Wasielewski and Svec procedure, without affecting the β-keto-ester of the
isocyclic ring.14 This ring serves as a natural protecting group during the coupling reactions. In the
literature an effective hydrolysis of the phytyl ester group under acidic,15 basic,16 and under the
influence of enzymes can be found.17 There are some drawbacks to the reaction done under alkaline
hydrolysis. It tends to eliminate the phytyl group with retention of the magnesium ion in the macrocycle,
to hydrolyze the 132 methyl ester to carboxyl with formation of chlorophyllins, and also tends to open
the isocyclic ring to give chlorin derivatives.18 But under acidic hydrolysis both the phytyl group and the
magnesium ion can be removed in a single step without affecting the isocyclic ring. After acid hydrolysis,
the structure of compound 17 was confirmed by 1H NMR and mass spectroscopy. The presence of peaks
for the central NH protons of macrocycle in the 1H NMR confirmed the elimination of central magnesium
atom. These central NH protons resonate around δ -2 to -3 ppm due to significant shielding from the
induced ring current of the large π system of the macrocycle. Likewise the meso protons appear
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considerably downfield because they are situated outside the ring in the deshielded region. In addition
to the characteristic chlorin peaks, the most significant peak in the structure elucidation of
pheophorbides are the peak that confirms the presence of isocyclic ring. The only proton in the isocyclic
ring appears as a sharp singlet at δ 6.26. It is much more deshielded than is a normal β-keto-ester
proton, due to the induced macrocycle ring current.

Scheme 2.6: Synthesis of propionic acid derivative of chlorin e6
Selective hydrolysis of the phytyl ester produced the free 173 carboxylic acid group which was
used to couple pheophorbide a (17) with H-lysine(boc) methyl ester. Numerous coupling conditions
were tested to form the amide bond between lysine and 173 carboxyl group of pheophorbide 17 and it
was found that the DCC/DMAP combination provided the best yield. Coupling with modern coupling
reagents like HOBt and TBTU did not change the yield and formed unwanted side products from opening
of the isocyclic ring. In the literature an alternate path has been reported for the production of the 172
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amide derivative 23 (Scheme 2.7). Treatment of natural chorin derivative 21 with 2,3-dichloro-5,6dicyano-1,4-benzoquinone (DDQ) leads to the formation of the lactone 22 by oxidizing the chlorin ring.19
Then, opening of the lactone with nucleophiles formed the desired ester 23 in good yield.20 But it seems
to be challenging to get rid of extra hydroxyl formed after ring opening of the lactone group while
keeping the dihydrochlorin ring; dehydration may lead to the more stable porphyrin system. The
optimum strategy for the coupling of pheophobide 17 with lysine is activation of the free acid with DCC
and DMAP in dichloromethane. DIEA was used to neutralize the H-Lysine(Boc).HCl salt.

Scheme 2.7: Alternate method to obtain propionic acid derivative of chlorin e6
Coupling of H-Lysine(Boc)-OH with pheophorbide 17 provided lysine(boc) methyl ester
pheophorbide a (18) in 52% yield. 1H NMR spectroscopy demonstrated the existence of the isocyclic ring
and new peaks are apparent for the lysine moiety.
Next it was necessary to open the isocyclic ring to obtain the desired chlorin e6 derivative 19
(Scheme 2.8). The isocyclic ring in phephorbide 17 is easily opened with cleavage of the β-keto-ester by
the action of various nucleophiles. The ease of opening of the isocyclic ring is due to the release of ring
strain and the formation of a resonance stabilized carbanion as an intermediate. In the literature, both
O- and N-nucleophiles have been use to open the ring successfully. Methanolysis of the isocyclic ring of
pheophorbide has been reported under several sets of reaction conditions. Chlorin e6 trimethyl ester
(24) was formed when the pheophorbide is treated with methanol and diazomethane in the presence of
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pyridine under nitrogen for 24 hours.21 Treatment with 0.5% KOH in methanol in the presence of
pyridine also leads to the expected product 24.22 Methanolysis with sodium methoxide in THF provided
an excellent yield compared to the other two conditions.

Scheme 2.8: Opening of the isocyclic ring
Apart from nucleophilic attack, this ring is susceptible to various reactions like allomerization
and decarboxymethylation (Figure 2.3). In the presence of a base, the acidification of the 132 proton by
the two neighboring carbonyl groups initiates easy enolization. This leads to a rapid irreversible
oxidation of the isocyclic ring by atmospheric oxygen, this is called allomerization, or autoxidation.23 At
higher temperatures, the ester group (COOMe) of the β-keto-ester can undergo decarboxymethylation
and form the corresponding stable pyro derivative.24

Figure 2.3: Reactions of isocyclic ring
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Due to the high yield and short reaction times, it was decided to use sodium methoxide to open
up the isocyclic ring to obtain the chorin e6 derivative 19. This reaction was carried out under argon to
prevent allomerization and in an ice bath to prevent the racemization of the lysine. Previous literature
has reported that under strong basic conditions amino acids can undergo racemization.25 A dilute
solution of sodium methoxide (0.5 M) was freshly prepared each time, by reacting dry methanol with
sodium metal. The ring opening step was easy to follow by using its UV-Vis spectrum. Chorin e6
compounds have a much sharper Soret band compared to the pheophorbides. Once the ring opens, the
Soret band is blue shifted from 413 to 404 nm and reaction mixture quickly turns from brown to green
upon addition of the sodium methoxide mixture. Subsequent isocyclic ring opening with sodium
methoxide26 in THF produced 173-monolysine(boc)chlorin e6 trimethyl ester (19) in high yield (89%). The
identity of the molecule 19 was confirmed using 1H NMR, mass spectrometry and UV-Vis spectrometry.
Disappearance of characteristic sharp singlet at δ 6.33 for the single proton in the isocyclic ring and the
appearance of a multiplet for two protons a δ 5.38 confirmed the formation of chlorine e6 derivative.
Deprotection of the amine27 of the lysine side chain with TFA: CH2Cl2 yielded the desired
molecule 173-monolysinechlorin e6 trimethyl ester (21) in 33% overall yield from pheophorbide a (17)
(Scheme 1).

2.3.2 Synthesis of Chlorin e6
Previously discussed mechanistic studies revealed that selective coupling at the acetic acid side
chain of chlorin e6 (2) yielded the 152 chlorin e6 derivatives. The target is to synthesize all three isomers
starting from a natural inexpensive source: S. pacifica alga. To achieve the target it is nesassary to
synthesize chlorin e6 (2) from pheophytin a (4). The synthetic route to chlorin e6 (2) from pheophytin a
(4) is shown in Scheme 2.8. Transesterification of the phytyl ester group of pheophytin a (4) was
accomplished with 5% sulfuric acid in methanol at room temperature. In spite of the convenient
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hydrolysis of the phytyl ester to carboxylic acid, it was decided to do a transesterification to simplify the
purification process. Methyl pheophorbide a (3) was obtained in quantitative yield and its identity was
confirmed using NMR and mass spectroscopy.

Scheme 2.8: Synthesis of chlorin e6 (2) from pheophytin a (4)
The ring opening of the isocyclic ring of methyl pheophorbide a (3) with methoxide produced
chlorin e6 trimethyl ester (24). The first few attempts of the Isocyclic ring opening reaction failed with
sodium methoxide in CH2Cl2. An optimized yield of 98% of chlorin e6 trimethyl ester (24) was obtained
with 1.1 equivalents of freshly prepared sodium methoxide in THF. The 1H NMR spectrum and mass
spectrum confirmed the existence of the extra methyl group for the methylated formic group.
Chlorin e6 (2) can be obtained by hydrolysis of all three methyl esters of chlorin e6 trimethyl
ester (24). Methyl ester hydrolysis has been attempted with numerous reagents and conditions.
Hydrolysis with stronger bases such as NaOH, LiOH and KOH under different conditions yields an
inseparable mixture of compounds. Esters can be hydrolyzed with various protic or Lewis acids, e.g.,
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CH3SO3H, p-TSA, BCl3,28 or BBr3.29 Hydrolysis with BBr3 in CH2Cl2 formed a mixture of partially hydrolyzed
products and various by products. These reagents are highly reactive and are not tolerated by many
functional groups, which seriously limits their utility. Apart from numerous methods based on
saponification/hydrolysis reaction pathways, this conversion can be carried out with various strong
nucleophilic reagents capable of cleaveing the esters by dealkylation (SN2 -type) reactions.30 Among
them, LiCl, LiBr and LiI have been described as effective reagents for conversion of esters derived from
primary and secondary alcohols. Little success was achieved using a large excess of LiI in ethyl acetate
under reflux conditions for 24 hours.15 The main problem is partial hydrolysis of these which results in a
mixture of mono, di and tri acids which is hard to purify using normal column chromatography. Only
21% maximum yield of chlorin e6 (2) was obtained after purification via Sephadex LH 20 column
chromatography (100% MeOH) on a small scale.
2.3.3 Synthesis of 152-Chlorin e6 Conjugates
The final steps in the synthesis of 152-amino acid derivatives 27c and 27d of chlorin e6 require
the coupling of chlorin e6 with a protected amino acid followed by deprotection. According to previous
studies5 with three free carboxylic acids, the 152-carboxylic acid is activated regardless of the coupling
reagent employed. A detailed mechanism was discussed at the beginning of this Chapter. As was
proposed, the reaction goes through a seven-membered anhydride intermediate 8 which forms
between the acetic and formic acid chains. The free amine of the amino acid selectively attacked the
more accessible carbonyl group of the anhydride 8. DIEA was used to activate the amino acid by
neutralizing the salt. To minimize the loss of the product during the chromatography and to simplify the
characterization of the product, both the 173- and 131- acids were converted into methyl esters with
diazomethane. Classical esterification with methanol under acidic conditions only reacts with the
propionic side chain and leaves the formic side chain unchanged. Not only that, all these acid labile
protecting groups can be cleaved during esterification under acidic conditions. Freshly prepared
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diazomethane was bubbled through the reaction mixture and the reaction was monitored by TLC. Both
products 26a and 26b were characterized by 1H NMR and mass spectroscopy. An optimum yield of 45%
of the 152-monoaspartylchlorin e6 di(tert)butyl dimethyl ester (26a) and 77% of of 152-monolysine(boc)
chlorin e6 trimethyl ester (26b) were obtained with 1.2 equivalents of DCC and DMAP in CH2Cl2 at room
temperature for 12 hours (Scheme 2.9).

Scheme 2.9: Synthesis of acetic acid derivatives of chlorin e6 (2)
Yields are extremely variable for the aspartyl derivative compared to the lysine derivative,
possiblly due to steric bulkiness of the tert-butyl protecting group of the aspartic acid. Excess DCC and
aspartic acid reduced the yield significantly by forming the diaspartic acid conjugate as a side product.
Deprotection of the amine of the lysine conjugate 26b and both acids of the aspartyl conjugate 26a have
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been achieved under acidic conditions. Deprotection using TFA in CH2Cl2 afforded 152monoaspartylchlorin e6 dimethyl ester (27c) and 152-monolysinechlorin e6 trimethyl ester (28b) in 79%
and 73% yields, respectively.
Insertion of palladium into the chlorin ring was done before the deprotection step to simplify
the purification, but a good 1H NMR spectrum of deprotected palladium chlorin derivative could not be
obtained. Several deprotection methods were tested. tert-Butyl deprotection with TFA/CH2Cl2,31 ZnBr/
CH2Cl232 and with HCl gas in CH2Cl2, but all were unsuccessful. Product was difficult to identify using 1H
NMR due to peak broadening. This may be due to a paramagnetic species which is produced during the
deprotection step. To solve this problem, palladium insertion was done after deprotection. Both
palladium acetate and palladium chloride worked well in the insertion reaction. An optimized yield of
98% of palladium inserted chlorin derivatives 28a and 28b was consistently obtained with 1.2
equivalents of palladium acetate in THF at 40 oC (Scheme 2.10). A significant blue shift in the UV-Vis
spectrum was observed (Figure 2.4). 1H NMR and mass spectroscopy also confirmed the insertion of
palladium.

Scheme 2.10: Palladium insertion reaction
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Figure 2.4: UV-Vis spectroscopic progression of the palladium insertion reaction in THF. 152Monoaspartylchlorin e6 dimethyl ester (27a, green) and palladium inserted 152-Monoaspartylchlorin e6
dimethyl ester (28a, blue)

2.3.4 Synthesis of 131 Chlorin e6 Conjugates
There are two possible ways to synthesize 131 conjugates. These are: (1) selective esterification
of 173 and 152 carboxylic acids of chlorin e6 (2) followed by coupling,33 and (2) isocyclic ring-opening of
methyl pheophorbide a (3) with a nucleophile. By using the second method we will be able to avoid the
low yielding chlorin e6 (2) synthesis and enhance the yield of the overall reaction. Unfortunately, the ring
opening-reaction was only successful with ethylene diamine. Coupling with any other linker or direct
coupling of amino acids has to follow the first route.
Under acidic conditions, the inner nitrogen atoms of the chlorin ring are fully protonated and
the 131-carboxylic acid becomes severely deactivated. The protonated chlorin core is inductively
electron-withdrawing from the 131-carbonyl, making the carbonyl double bond stronger. This prevents
the formation of protonated 131-carbonyl intermediate during the esterification. This permits selective
esterification of the 152- and 173- carboxylic acids. These carboxylic acids were selectively methylated
with 5% H2SO4/MeOH to give chlorin e6 dimethyl ester (29) in quantitative yield. The remaining 13151

carboxylic acid was activated using HOBt/TBTU under basic conditions and coupled directly with Laspartic di(tert)butyl ester to give (30) in 66% yield. With DCC/DMAP a lower yield was obtained
compared to HOBt/TBTU. Product 30 was isolated using silica gel column chromatography and
characterized by 1H NMR and mass spectroscopy. Subsequent deprotection of both carboxylic acid
groups in the aspartic chain provided compound 7 in 57% overall yield from chlorin e6 (Scheme 2.11).

Scheme 2.11: Synthesis of 131 aspartic acid derivative of chlorin e6 7
Nucleophilic opening of the isocyclic ring in pheophorbide a (17) with ethylenediamine and
ethanolamine has been reported.34 The same reaction was carried out with β-alanine(tert)butyl ester to
produce a link to couple aspartic acid to the chlorin e6 dimethyl ester 29. Isocyclic ring-opening with βalanine(tert)butyl ester was unsuccessful, presumably because of its lower nucleophilcity and its
bulkiness compared to ethylenediamine. oupling β-alanine(tert)butyl ester with the remaining 131carboxylic acid of the chlorin e6 dimethyl ester (29) followed by deprotection of the tert-butyl group
provided 131-mono-β-alanylchlorin e6 dimethyl ester (32) in 64% yield over two steps. Aspartic
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di(tert)butyl ester was coupled through the linker to the chlorin e6 to produced 131-mono-βalanylaspartylchlorin e6 dimethyl ester 33; subsequent deprotection of the tert-bytyl group provided 34
in 54% overall yield (Scheme 2.12).

Scheme 2.12: Synthesis of 131-β-alanylaspartylchlorin e6 34
The high yielding isocyclic ring-opening reaction with ethylenediamine was used to develop a
potentially high yielding way to synthesize novel chlorin e6 photosensitizers directly from pheophytin a
(2) in four steps. Nucleophilic opening of the isocyclic ring of methyl pheoporbide 3 with
ethylenediamine led to molecule 35 which was isolated in 91% yield. The reaction was monitored using
TLC and UV-Vis spectroscopy. Due to the change in conjugation of the molecule, the color changed from
dark green to bright green during ring-opening. Recently it was found possible to reduce the reaction
time by half at 40 oC using toluene as a solvent. 1H NMR, UV-Vis and mass spectroscopy confirmed the
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presence of the product 35. Subsequent coupling of protected lysine followed by deprotection provided
the desired product 37 in four steps and in 55% yield from pheophytin a (2) (Scheme 2.13).

Scheme 2.13: Synthesis of 131-ethylenediaminylchlorin e6 37
2.4 Molecular Modeling
Conformation analysis calculations for all three regioisomers (173, 152 and 131) of lysine
derivatives of chlorin e6 20, 27b and 37 was achieved in the gas phase at the HF/6-31G level and the
minimum energy conformations were obtained (Figure 2.5). In addition, the minimum energy
conformation of a mono-cationic 131-lysinyl chlorin e6 derivative without a linker (Figure 2.5d) was also
examined for direct comparison with the propionic acid derivative 20 and the acetic acid derivative 27b.
These calculations were done using atom coordinates from the X-ray structure of 152-aspartylchlorin e6
tetramethyl ester.12 As shown in Figure 2.5, the lysine attached propionic side chain in the 17 3-lysinyl
derivative 20 is nearly perpendicular to the macrocyclic plane (Figure 2.5a). The lysine residue in the 152-
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lysinyl derivative 27b forms approximately a 120o angle (Figure 2.5b). On the other hand, as shown in
Figure 2.5c and 2.5d, the lysine-attached formic acid side chain extends away from the macrocycle in the
131-lysinyl derivatives, with and without the short spacer. Subsequently, in the L-shape conformation of
the 173-lysinylchlorin e6 derivative 20 the amino acid covers one face of the chlorin ring, while in the
case of the 152- and 131-lysinyl derivatives, it extends away from the macrocycle resulting in nearly a
linear conformation for the 131 derivatives. According to the minimum energy conformations in the gas
phase, the use of a short linker and the presence of two (rather than one) positive charges, as a result of
conjugation to the C-terminus rather than the N-terminus of the amino acid, do not appear to have a
substantial effect on the preferred conformation; the main factor affecting the molecule conformation is
the site of substitution. Water effects were also evaluated for the 131-lysinylchlorin e6 derivative 37.
There was no significant difference in the minimum energy conformation for the aquous phase
compared with the conformation in the gaseous phase.

Figure 2.5: Energy minimized conformations in gas phase for chlorin e6 derivatives (a) 20, (b) 27b, (c) 37
and (d) [131 LysCe6TME]+. Optimization by energy was carried out at HF/6-31G level.
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2.5 Cell Culture Studies
2.5.1 Time-dependent Cellular Uptake
The results obtained for the time-dependent uptake of chlorin e6 and its derivatives at a
concentration of 10 μM in human HEp2 cells are shown in Figure 2.6. All amino acid conjugates of
chlorin e6 were readily taken up by cells and showed similar uptake kinetics to unconjugated chlorin e6.
Interestingly, the 152-lysinylchlorin e6 derivatives 27b and its palladium complex 28b accumulated to a
much higher extent than all other compounds, at all time points studied. In comparison with chlorin e6
(2), the lysinyl derivatives 27b and 28b showed 18-fold and 4-fold higher cellular uptake, respectively,
after 24 hours. The observed high uptake for derivatives 27b and 28b is probably due to the lysine
residue in position 152 since the corresponding aspartyl derivatives 27a and 28a accumulated to a
significantly lower extent within cells. Presumably, the stronger interactions between the positively
charged lysine derivatives, (compared with the corresponding aspartyl derivatives), with the negatively
charged plasma membrane leads to enhanced cellular uptake. On the other hand a lysine residue in
position 173, as in derivative 20, showed a dramatic decrease in cellular uptake compared with the same
residue in position 152, suggesting that the molecular conformation plays an important role on the
mechanism of cellular uptake. Indeed the extended conformation of the 152-lysinylchlorin e6 derivative
27b (Figure 2.5b) might be the most favored for penetration across the plasma membrane, compared
with the L-shape and linear conformations of the 173- and 131-lysinyl derivatives (Figures 2.5a,c),
respectively. The presence of a chelated palladium ion, as well as the more linear structure of the 13 1lysinyl side chain might lead to enhanced π-π stacking of the macrocycles, decreasing cellular uptake.
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Figure 2.6: Time-dependent uptake of chlorin e6 (2, black line) and its derivatives 173-LysCe6TME (20,
brown line), 152-AspCe6DME (27a, light blue line), 152-LysCe6TME (27b, red line), 152-AspPdCe6DME
(28a, green line), 152-LysPdCe6TME (28b, blue line), 131-AspCe6DME (7, maroon line), 131-βAlaAspCe6DME (34, purple line) and 131-EDLysCe6DME (37, pink line) at 10 M by HEp2 cells.

2.5.2 Cytotoxicity
The dark cytotoxicity and phototoxicity of chlorin e6 and its derivatives was evaluated in HEp2
cells exposed to increasing concentrations of each compound up to 400 μM; the results are shown in
Figures 2.8 and 2.7, respectively, and summarized in Table 2.1. Chlorin e 6 and its lysinyl derivatives 20,
27b and 28b were found to be non-toxic in the dark up to the highest concentration of 400 μM
investigated. All other amino acid derivatives showed very low dark cytotoxicities (Figure 2.7), with IC50 >
320 μM except for the 131-chlorin e6 derivatives 7 and 37, which showed IC50 of 285 and 268 μM,
respectively. However, upon exposure to low light dose (1 J/cm), all chlorin e6 derivatives were found to
be highly toxic to HEp2 cells (Figure 2.8). The most phototoxic were the 131-chlorin e6 derivatives 7, 34
and 37, with estimated IC50 values of 0.61, 0.82 and 1.34 μM, respectively. Among these, the most
promising aspartyl derivatives for PDT applications are compounds 7 and 34, because they have the
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highest dark cytotoxicity/phototoxicity ratio, > 466:1. The presence of the β-alanine spacer between the
131 carbonyl group and the aspartic acid residue seems to have only a small effect, slightly decreasing
compound cytotoxicity. On the other hand the 152-aspartylchlorin e6 derivative 27a was less phototoxic
than its 131 regioisomer 7 by approximately 7-fold, and the introduction of palladium further reduced its
phototoxicity. The positively charged 173- and 152-lysinylchlorin e6 derivatives 20 and 27b were the least
phototoxic, and the introduction of palladium increased the phototoxicity of the 152 derivative by about
10-fold. These results show for the first time that the phototoxicity of amphiphilic conjugates of chlorin
e6 depends mainly on the site of conjugation, probably as a result of molecule conformation; the nature
of the amino acid, the molecule overall charge, and the presence of palladium(II) also affect
phototoxicity, but apparently to a smaller extent. Our results suggest that the most extended, nearly
linear conformation of the 131 regioisomers facilitates binding to biological substrates, enhancing their
toxic effect.
Table 2.1: Cytotoxicity (HEp2 cells) for chlorin e6 and its derivatives using the MTT assay
Compound

Dark toxicity (IC50, μM)

Phototoxicity (IC50, μM)

Ratio

Chlorin e6 (2)

>400

20.8

>19.2

173-LysCe6TME (20)

>400

26.2

>15.3

152-AspCe6DME (27a)

373.1

4.0

93.4

152-LysCe6TME (27b)

>400

28.8

>13.9

152-AspPdCe6DME (28a)

324.8

16.7

19.4

152-LysPdCe6TME (28b)

>400

3.3

>121.2

131-AspCe6DME (7)

284.6

0.61

466.6

131-βAlaAspCe6DME (34)

383.9

0.82

468.2

131-EDLysCe6DME (37)

268.4

1.34

200.3
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Figure 2.7: Dark toxicity of chlorin e6 (2, black line) and its derivatives 173-LysChlorin e6TME (20, brown
line), 152-AspChlorin e6DME (27a, light blue line), 152-LysChlorin e6TME (27b, red line), 152-AspPdChlorin
e6DME (28a, green line), 152-LysPdChlorin e6TME (28b, blue line), 131-AspChlorin e6DME (7, maroon
line), 131-βAlaAsp hlorin e6DME (34, purple line), and 131-EDLysChlorin e6DME (37, pink line) toward
HEp2 cells using 1 J/cm2 light dose and the Cell Titer Blue assay.
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Figure 2.8: Phototoxicity of chlorin e6 (2, black line) and its derivatives 173-LysChlorin e6TME (20, brown
line), 152-AspChlorin e6DME (27a, light-blue line), 152-LysChlorin e6TME (27b, red line), 152-AspPdChlorin
e6DME (28a, green line), 152-LysPdChlorin e6TME (28b, blue line), 131-AspChlorin e6DME (7, maroon
line), 131-βAlaAsp hlorin e6DME (34, purple line), and 131-EDLysChlorin e6DME (37, pink line) toward
HEp2 cells using 1 J/cm2 light dose and the Cell Titer Blue assay.
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2.5.3 Intracellular Localization
The preferential sites of subcellular localization of this series of chlorin e6 derivatives were
evaluated by fluorescence microscopy, upon exposure of HEp2 cells to 10 μM compound concentrations
for six hours. Figure 2.9 to 2.17 in supporting information shows the fluorescence pattern observed for
all compounds and Table 2.2 summarizes their main sites of subcellular localization.
Table 2.2: Main subcellular sites of localization for chlorin e6 and its derivatives in HEp2 cells
Compound

Lysosomes

ER

Golgi

Mitochondria

Chlorin e6 (2)

+

++

-

-

173-LysCe6TME (20)

+

++

+

-

152-AspCe6DME (27a)

++

++

-

+

152-LysCe6TME (27b)

++

++

+

-

152-AspPdCe6DME (28a)

++

+

++

-

152-LysPdCe6TME (28b)

+

++

-

-

131-AspCe6DME (7)

+

++

++

++

131-βAlaAspCe6DME (34)

++

++

++

-

131-EDLysCe6DME (37)

++

++

++

-

Overlay experiments using the organelle specific fluorescence probes BoDIPY Ceramide (Golgi),
LysoSensor Green (Lysosomes), MitoTracker Green (mitochondria), and ER tracker Blue/White
fluorescence (ER) were conducted to evaluate the preferential sites of compound localization. All the
chlorin e6 derivatives were found to localize in the lysosomes and the ER. This is not surprising, since the
structurally-related LS-11 (1, 152-aspartyl chlorin e6) is a known lysosomal localizer, and HPPH (2-[1hexyloxyethyl]-2-devinyl-pyropheophorbide a) localizes preferentially in the ER.35 Photodamage to ER
and/or lysosomes has been shown to lead to activation of apoptotic pathways.35,36 In addition, the most
phototoxic 131 chlorin e6 regioisomers were also found in Golgi and mitochondria; presumably, the
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photodamage effect to multiple organelles caused by the 131 derivatives can trigger various apoptotic
pathways, leading to effective cell destruction. The multiple sites of intracellular localization observed
for the 131 chlorin e6 derivatives might again be due to their linear conformations that may facilitate
their binding to various intracellular sites.
2.6 Conclusion
A series of chlorin e6 derivatives, conjugated directly or with a spacer group with either an
aspartic or a lysine residue at the propionic (173), acetic (152) or formic (131) side chains of the chlorin
macrocycle, have been synthesized in good yields from pheophytin a (4) extracted from S. pacifica. In
comparison with chlorin e6 (2), all amino acid derivatives readily accumulated in human HEp2 cells.
Cytotoxicity results revealed that none of these compounds is toxic in the absence of light in the range
of therapeutic dose. However after exposure to light all of these derivatives showed high phototoxicity.
According to the phototoxicity results, the most phototoxic compounds were found to be the formic
acid regioisomers, bearing either an aspartic acid or a lysine residue directly conjugated to position-13 of
the chlorin macrocycle, or connected via a short spacer group. 131-Aspartylchlorin e6 (7) showed the
lowest IC50 value of 0.61 μM. Computational conformational analysis revealed that the 131 regioisomer
has an extended, nearly linear, conformation in comparison with the 152 and 173 regioisomers. This
linear conformation might facilitate the binding to multiple intracellular and internal components and
subsequent photodamage to multiple cellular sites. These results show that the site of amino acid
conjugation in the chlorin e6 macrocycle is the major determinant of its phototoxicity. Therefore, we
conclude that the 131 regioisomer of mono-L-aspartylchlorin e6 (7) is a more efficient photosensitizer for
PDT than is the commercially available 152 regioisomer (LS-11, 1)
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2.7 Experimental
Isolation of pheophytin a (4) from Spirulina pacifica:

Approximately 300 g of dried Spirulina pacifica algae was wetted with acetone and subsequently slurried
with 2 L of liquid nitrogen in a resistant 2 gallon bucket to form a frozen slush. The algae were then
transferred to a 3 L reaction vessel and 2 L of acetone was added. The vessel was fitted with a Fisher
jumbo mechanical stirrer with a 46 cm impeller shaft and a 3-neck lid was clamped to the vessel. The
reaction mixture was heated at reflux under argon with mechanical stirring for 3 h. The supernatant was
then filtered through Whatman 1 paper on a Buchner funnel and more acetone was added to the solid.
This slurry was allowed to sit overnight protected from light. Then the extraction and filtration processes
were repeated twice. The green filtrates were combined and evaporated and then purified by flash
column chromatography on silica gel. Elution first with CH2Cl2 removed the fast-running yellow
carotenoid band. Then elution with 95:5 CH2Cl2/acetone eluted the major blue-grey pheophytin a band
(4, C55H74N4O5, 1.5g); UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 668 nm (44,600) , 611 (8,600 ), 538 (9,700), 507
(10,800), 414 (106,000); 1H NMR (chloroform-d, 400 MHz): δ 9.50 (s, 1H), 9.35 (s, 1H), 8.57 (s, 1H), 8.0
(m, 1H), 6.28 (m, 1H), 6.26 (s, 1H), 6.18 (s, 1H), 4.48 (m, 1H), 4.21 (m, 1H), 3.88 (s, 3H), 3.64 (s, 3H), 3.60
(q, J = 7.5 Hz, 2H), 3.40 (s, 3H), 3.20 (s, 3H), 2.63 (m, 2H), 2.34 (m, 2H), 1.74(d, J = 7.5 Hz, 3H), 1.61 (t, J =
7.5 Hz, 3H) Phytyl: 5.13 (m, 1H), 4.50 (m, 1H), 1.90 (m, 2H), 1.56 (m, 3H), 1.0-1.3 (m, 2H), 0.85 (m, 6H)
0.71 (m, 6H). MS (MALDI-TOF) m/z 872 [M+H]+, calcd. for C55H75N4O5 872.256.
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Pheophorbide a (17):

Pheophytin a (4, 250 mg, 0.29 mmol) was selectively hydrolyzed to give the 17 3-carboxylic acid without
affecting the 131-carbomethoxy group via the Wasielewski and Svec procedure which requires stirring
pheophytin a in 25 ml of degassed TFA/H2O 80:20 at 0 °C overnight. The reaction mixture was poured
into 150 ml of H2O and extracted with CHCl3. The extract was washed three times with H2O and once
with 10% NaHCO3 to remove TFA. This formed a precipitate in the organic layer. Then it was washed
with 10% citric acid until the precipitate was dissolved. The organic layer was dried over anhydrous
Na2SO4. Evaporation of solvent provided a brown residue that was purified via silica gel column
chromatography with 50% ethyl acetate in CH2Cl2. After evaporation of solvent pheophorbide a (17,
C35H36N4O5, 155 mg, 0.26 mmol, 90%) was obtained. UV-Vis (D M): λmax (ε/M-1cm-1) 667 nm (55,200),
609 (7,900), 535 (9,500), 505(12, 100), 413 (119, 200); 1H NMR (acetone-d6, 400 MHz): δ 9.53 (s, 1H),
9.20 (s, 1H), 8.85 (s, 1H), 7.99 (dd, J = 17.86, 11.61 Hz, 1H), 6.34 (s, 1H), 6.26 (d, J = 16.82 Hz, 1H), 6.26
(dd, J = 11.61, 1.13 Hz, 1H), 4.66 (m, 1H), 4.23 (m, 1H), 3.88 (s, 3H), 3.59 (s, 3H), 3.47 (q, J = 7.5 Hz, 2H),
3.38 (s, 3H), 3.01 (s, 3H), 2.59 (m, 2H), 2.35 (m, 2H), 1.85 (d, J = 7.5 Hz, 3H), 1.55 (t, J = 7.5 Hz, 3H), -1.3
(s, 1H), -1.5 (s, 1H). MS (MALDI-TOF) m/z 593 [M+H]+, calcd. for C35H37N4O5 593.276.
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Lysine(boc) methyl ester pheophorbide a (18):

Pheophorbide a (17, 100 mg; 0.169 mmol) was dissolved in 10 ml of CH2Cl2. Then DCC (42 mg) and
DMAP (10 mg) were added and the mixture was left for 15 min. H-Lysine (boc) methyl ester.HCl (60 mg,
0.20 mmol) and DIEA (0.07 ml, 0.40 mmol) were dissolved in 5 ml of CH2Cl2, added to the reaction
mixture and it was stirred for 4 h. [Note: this reaction is favored by dilute conditions. Concentrated
conditions favor the formation of the anhydride (bispheophorbide), and will slow the reaction.] The
reaction mixture was washed with 10% citric acid, water and brine, dried over anhydrous Na2SO4 and
purified on a silica gel column (eluted with 10% acetone in CH2Cl2). After the major brown band was
eluted from the column, the solvent was evaporated and the solid was dissolved in ethyl acetate and
filtered. (DCC precipitates in ethyl acetate.) Evaporation of the ethyl acetate gave lysine (boc) methyl
ester pheophorbide a (18, C47H58N6O8, 74 mg, 0.085 mmol, 51%); UV-Vis (D M): λmax (rel. inten.) 667 nm
(0.463), 609 (0.066), 535 (0.080), 505(0.100), 413 (1.000); 1H NMR (acetone-d6, 400 MHz ): δ 9.12 (s, 1H),
8.71 (s, 1H), 8.70 (s, 1H), 7.64 (dd, J = 17.8, 11.63 Hz, 1H), 7.20 (d, J = 7.2 Hz, 1H), 6.33 (s, 1H), 6.02 (d, J =
17.85 Hz, 1H), 5.93 (d, J = 11.61 Hz, 1H), 5.77 (s, 1H), 4.65 (m, 1H), 4.41 (m, 1H), 4.21 (m, 1H), 3.91 (s,
3H), 3.59 (s, 3H), 3.47 (s, 3H), 3.19 (s, 3H) 3.09 (q, J = 7.5 Hz, 2H), 2.92 (3H, s), 2.83 (m, 2H), 2.66 (m, 1H),
2.48 (m, 1H), 2.25 (m, 1H), 1.85-1.62 (br , 4H), 1.86 (d, J = 7.24, 3H), 1.37 (t, J = 7.58, 3H), 1.43 (m, 2H),
1.26 (s, 9H), - 1.95 (s, 1H), -2.23 (s, 1H) MS (MALDI-TOF) m/z 835 [M+H]+, calcd. for C47H59N6O8 835.439.
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173-Monolysine(boc)chlorin e6 trimethyl ester (19):

Lysine(boc) methyl ester pheophorbide a (18, 74 mg, 0.085 mmol) was dissolved in a dry 2:1 THF/MeOH
solvent system and stirred under argon for 10 min. Sodium methoxide (0.17 mL of a 0.5 M solution,
0.085 mmol) was added and the reaction mixture was allowed to stir at 0 °C for 1 h. The reaction was
followed by UV-Vis spectroscopy. The solution turns from brown to green as the isocyclic ring opens.
The reaction mixture was then poured into water. The mixture was extracted with CH2Cl2 and the
organic layer was washed with water and 5% citric acid, dried over anhydrous Na2SO4 and then
evaporated. The residue was dissolved in 2% methanol/CH2Cl2 and purified on a silica gel plug with the
same mobile phase. The solvent was evaporated and 173-monolysine(boc)chlorin e6 trimethyl ester (19,
C48H62N6O9, 68 mg, 0.078 mmol, 89%) was obtained. 1H NMR (acetone-d6, 400 MHz ): δ 9.80 (s, 1H), 9.65
(s, 1H), 9.03 (s, 1H), 8.19 (dd, J = 17.87, 11.58 Hz, 1H), 7.44 ( d, J = 7.6 Hz, 1H), 6.40 (d, J = 17.87, 1.33 Hz,
1H), 6.13 (d, J = 11.61, 1.36 Hz, 1H), 5.89 (s, 1H), 5.38 (m, 2H), 4.63 (q, J = 7.22 Hz, 1H), 4.55 (dd, J =
10.34, 1.95 Hz, 1H), 4.44 (m, 1H), 4.25 (s, 3H), 3.78 (q, J =7.67, 2H) 3.75 (s, 3H), 3.69 (s, 3H), 3.56 (s, 3H)
3.49 (s, 3H), 3.27 (3H, s), 3.00 (m, 2H), 2.66 (m, 1H), 2.33 (m, 1H), 2.20 (m, 1H), 1.85-1.62 (br , 4H), 1.78
(d, J = 7.24, 3H), 1.69 (t, J = 7.58, 3H), 1.43 (m, 2H), 1.32 (s, 9H), - 1.32 (s, 1H), -1.52 (s, 1H). MS (MALDITOF) m/z 867 [M+H]+, calcd. for C48H63N6O9 867.466.
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173-Monolysinechlorin e6 trimethyl ester (20):

Monolysine(boc) chlorin e6 trimethyl ester (19, 68mg, 0.078 mmol) was dissolved in 2 ml of dry CH2Cl2 in
an ice bath under argon. Thioanisole (0.057 mmol) and 1 ml of TFA were added and the reaction mixture
was allowed to stir overnight. The reaction mixture was rotavaped several times with diethyl ether to
remove TFA. The resulting precipitate was washed several times with diethyl ether to remove
thioanisole. Then the precipitate was dissolved in CH2Cl2 which was washed three times with H2O and
once with 10% NaHCO3 to remove TFA. The organic layer was dried over anhydrous Na2SO4. Solvent was
evaporated to give 173-monolysinechlorin e6 trimethyl ester (20, C43H54N6O7, 43 mg, 0.056 mmol; 72%)
was obtained. UV-Vis (acetone): λmax (ε/M-1cm-1) 664 (65,000), 608 (4,900), 528 (4,500), 500 (16,100),
400 (213,000); 1H NMR (acetone-d6, 400 MHz ): δ 9.79 (s, 1H), 9.63 (s, 1H), 9.03 (s, 1H), 8.17 (dd, J =
17.87, 11.58 Hz, 1H), 7.59 ( d, J = 7.6 Hz, 1H), 6.38 (d, J = 17.87, 1.33 Hz, 1H), 6.12 (d, J = 11.61, 1.36 Hz,
1H), 5.37 (m, 2H), 4.63 (q, J = 7.22 Hz, 1H), 4.55 (dd, J = 10.34, 1.95 Hz, 1H), 4.44 (m, 1H), 4.25 (s, 3H),
3.76 (m, 2H) 3.75 (s, 3H), 3.69 (s, 3H), 3.55 (s, 3H) 3.48 (s, 3H), 3.25 (3H, s), 3.09 (m, 2H), 2.67 (m, 1H),
2.30 (m, 1H), 2.20 (m, 1H), 1.85-1.62 (br , 3H), 1.78 (d, J = 7.24, 3H), 1.68 (t, J = 7.58, 3H), 1.51 (m, 2H),
1.39 (m, 2H), - 1.33 (s, 1H), -1.53 (s, 1H). 13C NMR (dichloromethane-d2, 400 MHz) δ 173.8, 173.3, 172.6,
170.9, 169.9, 167.9, 155.3, 149.4, 145.6, 140.0, 136.8, 136.6, 135.9, 135.7, 135.2, 131.4, 129.7, 129.6,
124.1, 122.1, 103.1, 102.6, 99.0, 94.2, 53.5, 53.4, 52.5, 50.0, 41.7, 38.9, 34.4, 32.8, 32.2, 31.1, 30.8, 23.4,
22.9, 20.0, 18.0, 12.6, 12.4, 11.5. MS (MALDI-TOF) m/z 767 [M+H]+, calcd. for C43H55N6O7 767.414.
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Methyl pheophorbide a (3):

Pheophytin a (4, 250 mg, 0.29 mmol) was treated with 5% sulfuric acid in methanol (degassed by
bubbling with argon) overnight at room temperature under argon and protected from light. It was
diluted with CH2Cl2, washed with water and then with 10% saturated aqueous sodium bicarbonate. The
organic layer was dried over anhydrous Na2SO4, filtered and then evaporated. Purification was achieved
via silica gel chromatography with 5% acetone in CH2Cl2 to obtain methyl pheophorbide a (3, C36H38N4O5,
170 mg, 0.28 mmol, 96%) was obtained. UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 668 nm (40,700), 610 (8,100),
560 (3,200), 538 (9400), 506 (10,400), 412 (93,400); 1H NMR (acetone-d6, 400 MHz): δ 9.33 (s, 1H), 9.11
(s, 1H), 8.61 (s, 1H), 7.83 (dd, J = 17.86, 11.61 Hz, 1H), 6.21 (s, 1H), 6.19 (dd, J = 17.85, 1.26 Hz, 1H), 6.09
(dd, J = 11.57, 1.37 Hz, 1H), 4.50 (q, J = 7.32 Hz, 1H), 4.19 (m, 1H), 3.90 (s, 3H), 3.62 (s, 3H), 3.58 (s, 3H),
3.44 (q, J = 7.5 Hz, 2H), 3.61 (s, 3H), 3.59 (s, 3H), 2.66 (m, 1H), 2.56 (m, 1H), 2.32 (m, 2H), 1.85 (d, J = 7.5
Hz, 3H), 1.59 (t, J = 7.5 Hz, 3H), -1.8 (br, 2H). MS (MALDI-TOF) m/z 607 [M+H]+, calcd. for C36H39N4O5
607.292.
Chlorin e6 trimethyl ester (24):

Methyl pheophorbide a (3, 921 mg, 1.52 mmol) was dissolved in dry THF and stirred under argon for 10
min. Then 1.65 ml of a 1 M sodium methoxide solution (1.65 mmol) was added to the solution which
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was allowed to stir for 2 h at 0 °C (the reaction was monitored using UV-Vis spectroscopy). The solution
was diluted with H2O and extracted with CH2Cl2. The organic layer was dried over anhydrous Na2SO4,
filtered and then evaporated. The solid obtained was dissolved in CH2Cl2 and chromatographed on a
short silica gel column eluted with the 5% acetone/CH2Cl2. After evaporation of solvent, chlorin e6
trimethyl ester (24, C37H42N4O6, 948 mg, 1.48 mmol, 98% of) was obtained. UV-Vis (CH2Cl2): λmax (ε/M1

cm-1) 666 nm (43,700), 608 (4,500), 558 (1,800), 530 (4,700), 500 (11,200), 404 (123,400); 1H NMR

(acetone-d6, 400 MHz): δ 9.72 (s, 1H), 9.53 (s, 1H), 9.03(s, 1H), 7.08 (dd, J = 17.86, 11.61 Hz, 1H), 6.31
(dd, J = 17.85, 1.26 Hz, 1H), 6.06 (dd, J = 11.57, 1.37 Hz, 1H), 5.36 (s, 2H), 4.63 (q, J = 7.32 Hz, 1H), 4.52
(dd, J = 10.50, 2.21 Hz, 1H), 4.25 (s, 3H), 3.77 (s, 3H), 3.67 (q, J = 7.5 Hz, 2H), 3.61 (s, 3H), 3.54 (s, 3H),
3.44 (s, 3H), 3.17 (s, 3H), 2.72 (m, 1H), 2.35 (m, 1H), 2.26 (m, 1H), 2.06 (m, 1H), 1.75 (d, J = 7.5 Hz, 3H),
1.64 (t, J = 7.5 Hz, 3H), -1.34 (s, 1H), -1.52 (s, 1H); MS (MALDI-TOF) m/z 639 [M+H]+, calcd. for C37H43N4O6
639.318.
Chlorin e6 (2):

Chlorin e6 trimethyl ester (24, 50 mg, 0.078 mmol) was dissolved in anhydrous ethyl acetate under
argon. Lithium iodide (124 mg, 0.94 mmol) was added. The reaction mixture was refluxed for 48 h under
argon. The reaction mixture was diluted with water and adjusted to pH 3 with aqueous citric acid and
then washed with CH2Cl2. The solution was evaporated and redissolved in acetone and evaporated
several times. The solid was washed with water and then dried under vacuum. The residue was
dissolved in methanol and purified on a Sephadex LH20 column to yield chlorin e6 (2, C34H36N4O6, 10 mg,
0.017 mmol, 21%); UV-Vis (MeOH): λmax (ε/M-1cm-1) 666 nm (45,300), 610 (8,700), 558 (7,800), 530
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(9,700), 502 (15,500), 402 (145,100); 1H NMR (acetone-d6, 400 MHz): δ 9.73 (s, 1H), 9.51 (s, 1H), 9.04(s,
1H), 8.05 (dd, J = 17.86, 11.61 Hz, 1H), 6.28 (dd, J = 17.85, 1.26 Hz, 1H), 6.02 (dd, J = 11.57, 1.37 Hz, 1H),
5.60 (d, J = 18.94 Hz, 1H), 5.40 (d, J = 18.94 Hz, 1H), 4.65 (m, 1H), 4.55 (m, 1H), 3.64 (m, 2H), 3.63 (s, 3H),
3.42 (s, 3H), 3.15 (s, 3H), 2.72 (m, 1H), 2.35 (m, 1H), 2.26 (m, 1H), 2.06 (m, 1H), 1.75 (d, J = 7.5 Hz, 3H),
1.64 (t, J = 7.5 Hz, 3H), -1.6 (s, 2H); MS (MALDI-TOF) m/z 597 [M+H]+, calcd. for C34H37N4O6 597.271.
152-Monoaspartylchlorin e6 di(tert)butyl dimethyl ester (26a):

Chlorin e6 (2, 100 mg, 0.168 mmol) was dissolved in dry CH2Cl2. DCC (35 mg, 0.168 mmol) and DMAP (9
mg, 0.074) were added and the mixture was allowed to stir until reagents were completely dissolved.
After 3 h, aspartic acid di(tert)butyl ester hydrochloride (47.2 mg, 0.168 mmol) and DIEA (0.03 ml, 0.18
mmol) were mixed in CH2Cl2 and added to the reaction mixture which was allowed to stir overnight. The
mixture was diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a wash with
brine and water. It was dried over anhydrous Na2SO4 and then evaporated. Then it was dissolved in
CH2Cl2 and treated with excess ethereal diazomethane. The residue was dissolved in 2% methanol/
CH2Cl2 and purified via silica gel column chromatography with the same mobile phase to afford 152monoaspartylchlorin e6 di(tert)butyl dimethyl ester(26a, C48H61N5O9, 65 mg, 0.076 mmol, 45%); 1H NMR
(aceton-d6, 400 MHz ) δ 9.64 (s, 1H), 9.32 (s, 1H), 9.02 (s, 1H), 7.81 (dd, J = 11.58, 17.85 Hz, 1H), 7.00 (s,
1H), 6.09 (dd, J = 17.87, 1.26 Hz, 1H), 5.85 (dd, J = 11.60, 1.29 Hz, 1H), 5.38 (s, 2H), 4.6 (br, 3H), 4.32 (s,
3H), 3.62 (s, 3H), 3.54 (s, 3H), 3.52 (q, J = 7.3 Hz, 2H), 3.30 (s, 3H), 3.02 (s, 3H), 2.78 (m, 3H), 2.44 (m, 2H),
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1.87 (m, 1H), 1.65 (d, J = 7.3 Hz, 3H), 1.58 (t, J = 7.7 Hz, 3H), 1.26 (s, 9H), 1.16 (s, 9H), -1.42 (s, 1H), -1.53
(s, 1H); MS (MALDI-TOF) m/z 852 [M+H]+, calcd. for C48H62N5O9 852.454.
152-Monoaspartylchlorin e6 dimethyl ester (27a):

152-Monoaspartylchlorin e6 di(tert)butyl dimethyl ester (26a, 65 mg, 0.076 mmol) was dissolved in 2 ml
of dry CH2Cl2 in a ice bath under argon. Thioanisole (0.006 ml) and 2 ml of TFA were added and the
reaction mixture was allowed to stir overnight. The reaction mixture was rotavaporated several times
with diethyl ether to remove TFA. The resulting precipitate was washed several times with diethyl ether
to remove thioanisole. Then the precipitate was dissolved in CH2Cl2 which was washed three times with
H2O and once with 10% NaHCO3 to remove TFA. (This may form a precipitate. If so, the organic layer is
washed with citric acid until the precipitate dissolves in the organic layer). The organic layer was dried
over anhydrous Na2SO4. The solvent was evaporated to obtain 152-monoaspartylchlorin e6 dimethyl
ester (27a, C40H45N5O9, 44 mg, 0.06 mmol, 79%); UV-Vis (acetone) λmax (ε/M-1cm-1) 664 (48,400), 609
(6,000), 560 (2,000), 529 (6,300), 500 (14,200), 402 (151,800); 1H NMR (acetone-d6, 400 MHz ) δ 9.76 (s,
1H), 9.58 (s, 1H), 9.04 (s, 1H), 8.10 (dd, J = 17.85, 11.59 Hz, 1H), 6.33 (dd, J = 17.87, 0.98 Hz, 1H), 6.07
(dd, J = 11.61, 1.09 Hz, 1H), 5.32 (m, 2H), 4.84 (m, 1H), 4.60 (m, 2H), 4.26 (s, 3H), 3.72 (q, J = 7.3 Hz, 2H),
3.57 (s, 3H), 3.54 (s, 3H), 3.45 (s, 3H), 3.21 (m, 3H), 2.95 (dd, J = 16.85, 5.53 Hz, 1H), 2.88 (dd, J = 16.85,
5.09 Hz, 1H) 2.68 (m, 1H) 2.32 (m, 2H), 1.78 (m, 1H), 1.74 (d, J = 7.3 Hz, 3H), 1.66 (t, J = 7.7 Hz, 3H), -1.39
(s, 1H), -1.58 (s, 1H); 13C NMR (acetone-d6, 100 MHz) δ 174.5, 173.5, 173.2, 172.6, 171.7, 170.4, 169.4,
155.8, 150.3, 146.3, 140.4, 137.4, 136.6, 136.3, 135.8, 132.0, 130.6, 126.0, 122.6, 104.2, 103.1, 99.7,
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95.4, 54.2, 54.0, 52.2, 50.4, 41.2, 37.8, 32.1, 31.0, 26.1, 23.8, 20.3, 18.4, 12.6, 11.6; MS (MALDI-TOF) m/z
740 [M+H]+, calcd. for C40H46N5O9 740.3296.
Palladium 152-monoaspartylchlorin e6 dimethyl ester (28a):

152-Monoaspartylchlorin e6 dimethyl ester (27a, 44 mg, 0.06 mmol) was dissolved in 2 ml of dry THF.
Palladium acetate (14.2 mg, 0.063 mmol) was dissolved in THF and added to the reaction vessel and it
was allowed to stir at 40 °C for 3 h. The reaction was followed by UV-Vis spectroscopy. The solution
turned from green to bluish green as the complex formed. After evaporation of solvent, the residue was
dissolved in methanol and purified via sephedex LH-20 chromatography with the same mobile phase to
afford palladium 152-monolysine chlorin e6 trimethyl ester (28a, C40H43N5O9Pd, 50 mg, 0.059 mmol,
98%); UV-Vis (acetone-d6): λmax (ε/M-1cm-1) 619 (31,200), 579 (6,200), 489 (4,000), 393 (44,200); 1H
NMR (acetone-d6, 400 MHz ) δ 9.53 (s, 1H), 9.54 (s, 1H), 8.93 (s, 1H), 8.03 (dd, J = 17.82, 11.54 Hz, 1H),
6.17 (d, J = 17.79 Hz, 1H), 6.00 (dd, J = 11.61, 1H), 5.19 (d, J = 18.77 Hz, 1H), 5.04 (d, J = 18.59 Hz, 1H),
4.92 (m, 1H), 4.63 (m, 2H), 4.20 (s, 3H), 3.62 (s, 3H), 3.57 (m, 2H), 3.57 (s, 3H), 3.37 (s, 3H), 3.07 (m, 3H),
2.68 (m, 2H) 2.38 (m, 1H) 2.12 (m, 1H), 1.78 (m, 2H), 1.74 (d, J = 7.3 Hz, 3H), 1.50 (t, J = 7.7 Hz, 3H). MS
(MALDI-TOF) m/z 845 [M+H]+, calcd. for C40H44N5O9Pd 845.217.
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152-Monolysine(boc)chlorin e6 trimethyl ester (26b):

Chlorin e6 (2, 75 mg, 0.12 mmol) was dissolved in dry CH2Cl2 (10 ml). DCC (31.3 mg, 0.15 mmol) and
DMAP (11 mg, 0.09 mmol) were added and the mixture was allowed to stir until completely dissolved.
After 3 h, H-lysine(boc)-OMe hydrochloride (45 mg, 0.15 mmol) and DIEA (0.03 ml, 0.17 mmol) were
mixed in CH2Cl2 (2 ml) and added to the reaction mixture. The reaction was allowed to stir overnight.
The mixture was diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a wash
with brine and water. It was dried over anhydrous Na2SO4 and then evaporated. Then it was dissolved in
CH2Cl2 and treated with excess ethereal diazomethane. The residue was dissolved in 12%
acetone/CH2Cl2 and purified via silica gel column chromatography with the same mobile phase to afford
152-monolysine(boc)chlorin e6 trimethyl ester (26b, C48H62N6O9, 84 mg, 0.097 mmol, 77%); 1H NMR
(acetone-d6, 400 MHz ) δ 9.77 (s, 1H), 9.55 (s, 1H), 9.04 (s, 1H), 8.08 (dd, J = 17.87, 11.58 Hz, 1H), 7.07
(m, 1H), 6.31 (dd, J = 17.87, 1.33 Hz, 1H), 6.06 (dd, J = 11.61, 1.36 Hz, 1H), 5.87 (s, 1H), 5.32 (s, 2H), 4.65
(q, J = 7.22 Hz, 1H), 4.60 (dd, J = 10.34, 1.95 Hz, 1H), 4.49 (m, 1H), 4.26 (s, 3H), 3.71 (q, J =7.67, 2H) 3.57
(s, 3H), 3.54 (s, 3H), 3.47 (s, 3H) 3.44 (s, 3H), 3.19 (3H, s), 2.97 (m, 2H), 2.71 (m, 1H), 2.37 (m, 2H), 1.80
(m, 3H), 1.77 (d, J = 7.24, 3H), 1.66 (t, J = 7.58, 3H), 1.39 (s, 9H), 1.27 (m, 2H), - 1.35 (s, 1H), -1.56 (s, 1H);
MS (MALDI-TOF) m/z 867 [M+H]+, calcd. for C48H63N6O9 867.450.
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152-Monolysinechlorin e6 trimethyl ester (27b):

152-Monolysine(boc)chlorin e6 trimethyl ester (26b, 84 mg 0.097 mmol) was dissolved in dry CH2Cl2 (3
ml) in an ice bath under argon. Thioanisole (0.01 ml) and TFA (1 ml) were added and the reaction
mixture was allowed to stir overnight. The reaction mixture was rotavaporated several times with
diethyl ether to remove TFA. The resulting precipitate was washed several times with diethyl ether to
remove thioanisole. Then the precipitate was dissolved in CH2Cl2 and washed three times with H2O and
once with 10% NaHCO3 to remove TFA. The organic layer was dried over anhydrous Na2SO4. Solvent was
evaporated to obtain 152-monolysinechlorin e6 trimethyl ester (27b, C43H54N6O7, 56 mg, 0.071 mmol,
73%); UV-Vis (acetone) λmax (ε/M-1cm-1) 664 (57,800), 608 (4,600), 529 (4,900), 500 (14,800), 400
(187,200); 1H NMR (acetone d6, 400 MHz ) δ 9.68 (s, 1H), 9.42 (s, 1H), 9.02 (s, 1H), 7.95 (dd, J = 17.87,
11.58 Hz, 1H), 7.12 (d, J = 6.8 Hz, 1H), 6.20 (dd, J = 17.87, 1.33 Hz, 1H), 5.95 (dd, J = 11.61, 1.36 Hz, 1H),
5.35 (s, 2H), 4.65 (q, J = 7.22 Hz, 1H), 4.61 (dd, J = 10.34, 1.95 Hz, 1H), 4.53 (m, 1H), 4.27 (s, 3H), 3.59 (m,
2H) 3.55 (s, 6H), 3.48 (s, 3H) 3.37 (s, 3H), 3.09 (3H, s), 2.99 (m, 3H), 2.73 (m, 1H), 2.38 (m, 2H), 1.80 (m,
3H), 1.78 (d, J = 7.24, 3H), 1.61 (t, J = 7.58, 3H), 1.43 (m, 2H), - 1.40 (s, 1H), -1.57 (s, 1H); 13C NMR
(dichloromethane-d2, 100 MHz) δ 173.0, 172.7, 170.7, 170.0, 168.2, 167.8, 155.5, 149.5, 145.7, 140.2,
136.9, 136.8, 136.0, 135.5, 135.4, 131.5, 129.7, 129.6, 124.3, 122.2, 102.8, 102.5, 99.2, 94.4, 53.3, 52.4,
52.3, 52.0, 49.7, 40.8, 40.2, 34.4, 32.5, 31.4, 29.8, 28.2, 23.3, 22.5, 20.0, 18.0, 12.5, 12.4, 11.5; MS
(MALDI-TOF) m/z 767 [M+H]+, calcd. for C43H55N6O7 767.413.
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Palladium 152-monolysinechlorin e6 trimethyl ester (28b):

152-Monoysinechlorin e6 trimethyl ester (27b, 56 mg, 0.071 mmol) was dissolved in 5 ml of dry THF.
Palladium acetate (16.13 mg, 0.072 mmol) was dissolved in THF and added to the reaction vessel and
allowed to stir at 60 °C for 3 h. The reaction was followed by UV-Vis spectroscopy. The solution turned
from green to bluish green as the complex formed. After evaporation of solvent, the residue was
dissolved in methanol and purified via Sephadex LH-20 chromatography with the same mobile phase to
afford palladium 152-monolysinechlorin e6 trimethyl ester (28b, C43H52N6O7Pd, 61 mg, 0.07 mmol, 99%);
UV-Vis (acetone): λmax (ε/M-1cm-1) 620 (97,520), 581 (14,500), 490 (7,600), 394 (140,900); 1H NMR
(acetone d6, 400 MHz) all the peaks were broad due to the paramagnetic nature of the compound. MS
(MALDI-TOF) m/z 871 [M+H]+, calcd. for C43H53N6O7Pd 871.301.
131-Aspartylchlorin e6 di(tert)butyl dimethyl ester (30):

Chlorin e6 dimethyl ester (29, 55 mg, 0.088 mmol) was dissolved in dry CH2Cl2. A mixture of HOBt (12
mg, 0.089 mmol), TBTU (29 mg, 0.089 mmol) and DIEA (0.017 ml, 0.1 mmol) in DMF (3 ml) was added
and the mixture was allowed to stir for 30 min. H-Asp(tBu)2.HCl (60 mg, 0.21 mmol) and DIEA (0.037 ml,
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0.21 mmol) were mixed in CH2Cl2 and added to this reaction mixture. The mixture was stirred overnight.
It was diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a wash with brine
and water. It was dried over anhydrous Na2SO4 and then evaporated. The residue was dissolved in 5%
acetone/CH2Cl2 and purified via silica gel column chromatography using the same mobile phase to afford
131-aspartylchlorin e6 di(tert)butyl dimethyl ester (30, C48H61N5O9, 50 mg, 0.058 mmol, 66%); UV-Vis
(acetone): λmax (ε/M-1cm-1) 663 nm (0.330), 607 (0.025), 528 (0.020), 500 (0.081), 399 (1.000); 1H NMR
(acetone-d6, 400 MHz) δ 9.79 (s, 1H), 9.70 (s, 1H), 9.10 (s, 1H), 8.39 (d, J = 7.93 Hz, 1H), 8.19 (dd, J =
11.58, 17.85 Hz, 1H), 6.37 (dd, J = 17.85, 1.23 Hz, 1H), 6.10 (dd, J = 11.87, 1.26 Hz, 1H), 5.71 (d, J = 18.95
Hz, 1H), 5.30 (m, 2H), 4.67 (q, J = 7.22 Hz, 1H), 4.49 (dd, J = 10.34, 1.95 Hz, 1H), 3.76 (q, J = 7.3 Hz, 2H),
3.74 (s, 3H), 3.64 (s, 3H), 3.61 (s, 3H), 3.50 (s, 3H), 3.27 (s, 3H), 3.16 (dd, J = 5.8, 0.78 Hz, 2H), 2.73 (m,
1H), 2.32 (m, 2H), 1.79 (m, 1H), 1.69 (m, 6H), 1.64 (s, 9H), 1.53 (s, 9H), -1.57 (s, 1H), -1.85 (s, 1H); MS
(MALDI-TOF) m/z 852 [M+H]+, calcd. for C48H62N5O9 852.454.
131-Aspartylchlorin e6 dimethyl ester (7):

The 131-aspartylchlorin e6 di(tert)butyl dimethyl ester (30, 50 mg, 0.058 mmol) was dissolved in 2 ml of
dry CH2Cl2 in an ice bath under argon. Thioanisole (0.005 ml) and 2 ml of TFA were added and the
reaction mixture was stirred overnight. The reaction mixture was evaporated several times with diethyl
ether to remove residual TFA. The resulting precipitate was washed several times with diethyl ether to
remove thioanisole. Then the precipitate was dissolved in CH2Cl2 and washed three times with H2O and
once with 10% NaHCO3 to remove TFA. The organic layer was dried over anhydrous Na2SO4 and then
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evaporated to afford 131-aspartylchlorin e6 dimethyl ester (7, C40H45N5O9, 38 mg, 0.051 mmol, 88%); UVVis (acetone): λmax (ε/M-1cm-1) 663 nm (126,800), 607 (9,000), 528 (7,450), 500 (31,500), 399 (385,800);
1

H NMR (acetone-d6, 400 MHz) δ 9.79 (s, 1H), 9.70 (s, 1H), 9.12 (s, 1H), 8.50 (d, J = 7.93 Hz, 1H), 8.19 (dd,

J = 11.58, 17.85 Hz, 1H), 6.37 (d, J = 18.85 Hz, 1H), 6.10 (d, J = 11.87 Hz, 1H), 5.71 (d, J = 18.95 Hz, 1H),
5.45 (dd, J = 13.76, 5.80 Hz, 1H), 5.30 (d, J = 18.93 Hz, 1H), 4.67 (q, J = 7.22 Hz, 1H), 4.50 (dd, J = 10.34,
1.95 Hz, 1H), 3.76 (q, J = 7.3 Hz, 2H), 3.71 (s, 3H), 3.63 (s, 3H), 3.60 (s, 3H), 3.51 (s, 3H), 3.31 (dd, J = 5.76,
3.47 Hz, 2H), 3.26 (s, 3H), 2.70 (m, 2H), 2.31 (m, 2H), 1.79 (m, 1H), 1.71 (d, J = 7.24, 3H), 1.67 (t, J = 7.58,
3H), -1.57 (br s, 1H), -1.87 (s, 1H). 13C NMR (acetone-d6, 100 MHz) δ 174.0, 173.8, 172.6, 170.3, 169.1,
168.9, 154.5, 149.9, 145.4, 139.2, 137.0, 136.6, 136.4, 135.1, 131.0, 130.7, 130.3, 129.7, 122.0, 104.2,
101.8, 99.4, 95.0, 54.1, 52.3, 51.8, 50.4, 49.7, 43.2, 38.4, 36.6, 31.7, 30.7, 23.5, 20.0, 18.1, 12.3, 12.0,
11.3; HRMS (MALDI-TOF) m/z 740.344 [M+H]+, Calcd. for C40H46N5O9 740.330.
Chlorin e6 dimethyl ester (29):

Chlorin e6 (2, 50 mg, 0.083 mmol) was dissolved in 5% sulfuric acid and methanol (10 ml) and allowed to
stir overnight protected from light, under argon. The reaction mixture was dilute with CH2Cl2 and poured
into cold 5% aqueous NaHCO3 (This may form a precipitate. If so, the organic layer is washed with citric
acid until the precipitate dissolves in the organic layer). The organic layer was washed with water and
brine, dried over anhydrous Na2SO4 and filtered. Solvent was removed to afford chlorin e6 dimethyl
ester (C36H40N4O6, 51 mg, 0.082 mmol, 99%); UV-Vis (chloroform): λmax (ε/M-1cm-1) 666 nm (49,700), 610
(5,900), 562 (2,700), 523 (5,900), 502 (13,200) 402 (143,400); 1H NMR (acetone-d6, 400 MHz): δ 9.56 (s,
1H), 9.23 (s, 1H), 8.96(s, 1H), 7.75 (dd, J = 17.86, 11.61 Hz, 1H), 6.03 (dd, J = 17.85, 1.26 Hz, 1H), 5.80 (dd,
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J = 11.57, 1.37 Hz, 1H), 5.64 (d, J = 18.91 Hz, 1H), 5.45 (d, J = 18.91 Hz, 1H), 4.62 (q, J = 7.32 Hz, 1H), 4.52
(dd, J = 10.50, 2.21 Hz, 1H), 3.81 (s, 3H), 3.61 (s, 6H), 3.40 (q, J = 7.5 Hz, 2H), 3.26 (s, 3H), 2.93 (s, 3H),
2.72 (m, 1H), 2.35 (m, 1H), 2.26 (m, 1H), 2.06 (m, 1H), 1.75 (d, J = 7.5 Hz, 3H), 1.53 (t, J = 7.5 Hz, 3H), -1.6
(s, 2H); MS (MALDI-TOF) m/z 625 [M+H]+, calcd. for C36H41N4O6 625.302.
131- β-Alanylchlorin e6 (tert)butyl dimethyl ester (31):

Chlorin e6 dimethyl ester (29, 55 mg, 0.088 mmol) was dissolved in dry CH2Cl2. A mixture of HOBt (12
mg, 0.088 mmol), TBTU (29 mg, 0.089 mmol) and DIEA (0.017 ml, 0.10 mmol) in DMF (2 ml) was added
and the mixture was stirred for 30 min. β-Alanine(tBu).HCl (18 mg, 0.1 mmol) and DIEA (0.017 ml, 0.1
mmol) were mixed in CH2Cl2 and added to the reaction mixture. The mixture was then allowed to stir
overnight before being diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a
wash with brine and water. It was dried over anhydrous Na2SO4 and then evaporated to dryness. The
residue was dissolved in 5% acetone/CH2Cl2 and purified via silica gel column chromatography using the
same mobile phase to afford 131-β-alanylchlorin e6 (tert)butyl dimethyl ester (31, C43H53N5O7, 45 mg,
0.06 mmol, 68%); 1H NMR (acetone-d6, 400 MHz) δ 9.70 (s, 1H), 9.63 (s, 1H), 9.01 (s, 1H), 8.17 (t, J = 5.71
Hz, 1H), 8.11 (dd, J = 11.58, 17.85 Hz, 1H), 6.31 (d, J = 18.85 Hz, 1H), 6.04 (d, J = 11.87 Hz, 1H), 5.65 (d, J
= 18.95 Hz, 1H), 5.38 (d, J = 19.06 Hz, 1H), 4.66 (q, J = 7.22 Hz, 1H), 4.52 (dd, J = 10.34, 1.95 Hz, 1H), 4.02
(m, 1H), 3.09 (m, 1H), 3.77 (s, 3H), 3.68 (q, J = 7.3 Hz, 2H), 3.61 (s, 3H), 3.51 (s, 3H), 3.46 (s, 3H), 3.21 (s,
3H), 2.71 (m, 2H), 2.31 (m, 2H), 1.79 (m, 1H), 1.72 (d, J = 7.24, 3H), 1.65 (t, J = 7.58, 3H), 1.54 (s, 9H), 1.62 (s, 1H), -1.91 (s, 1H); MS (MALDI-TOF) m/z 752 [M+H]+, calcd. for C43H54N5O7 752.402.
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131-β-Alanylchlorin e6 dimethyl ester (32):

The 131- β-alanylchlorin e6 (tert)butyl dimethyl ester (31, 45 mg, 0.059 mmol) was dissolved in 1.5 ml of
dry CH2Cl2 in a ice bath under argon. Thioanisole (0.005 ml) and 1.5 ml of TFA were added and the
reaction mixture was stirred overnight before being diluted with CH2Cl2 and washed three times with
H2O and once with 10% NaHCO3. The organic layer was dried over anhydrous Na2SO4 and the solvent
was evaporated to obtain 131-β-alanylchlorin e6 dimethyl ester (32, C39H45N5O7, 39 mg, 0.056 mmol,
95%); 1H NMR (acetone-d6, 400 MHz) δ 9.74 (s, 1H), 9.72 (s, 1H), 9.10 (s, 1H), 8.22 (dd, J = 11.58, 17.85
Hz, 1H), 8.15 (t, J = 5.71 Hz, 1H), 6.39 (d, J = 18.85 Hz, 1H), 6.12 (d, J = 11.87 Hz, 1H), 5.65 (d, J = 18.95
Hz, 1H), 5.37 (d, J = 19.06 Hz, 1H), 4.66 (q, J = 7.22 Hz, 1H), 4.52 (dd, J = 10.34, 1.95 Hz, 1H), 4.07 (m, 1H),
3.95 (m, 1H), 3.77 (s, 3H), 3.68 (q, J = 7.3 Hz, 2H), 3.61 (s, 3H), 3.53 (s, 3H), 3.52 (s, 3H), 3.28 (s, 3H), 2.69
(m, 2H), 2.31 (m, 2H), 1.79 (m, 1H), 1.72 (d, J = 7.24, 3H), 1.65 (t, J = 7.58, 3H), -1.62 (s, 1H), -1.91 (s, 1H);
MS (MALDI-TOF) m/z 696 [M+H]+, calcd. for C39H46N5O7 696.811.
131- β-Alanyl-aspartylchlorin e6 di(tert)butyl dimethyl ester (33):

131-β-Alanylchlorin e6 dimethyl ester (32, 39 mg, 0.056 mmol) was dissolved in dry CH2Cl2. A mixture of
HOBt (8 mg, 0.06 mmol), TBTU (18 mg, 0.06 mmol) and DIEA (0.017 ml, 0.1 mmol) in DMF (2 ml) was
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added and the mixture was stirred for 30 min. H-Asp(tBu)2.HCl (40 mg, 0.14 mmol) and DIEA (0.025 ml,
0.14 mmol) were mixed in CH2Cl2 and added to the reaction mixture. The mixture was stirred overnight
before being diluted with CH2Cl2 (10 ml) and then washed with 5% aqueous citric acid, followed by a
wash with brine and water. It was dried over anhydrous Na2SO4 and then evaporated. The residue was
dissolved in 10% acetone/CH2Cl2 and purified via silica gel column chromatography using the same
mobile phase to afford 131- β-alanyl-aspartylchlorin e6 di(tert)butyl dimethyl ester(33, C51H66N6O10, 45
mg, 0.048 mmol, 87%); 1H NMR (acetone-d6, 400 MHz) δ 9.74 (s, 1H), 9.70 (s, 1H), 9.10 (s, 1H), 8.19 (dd, J
= 11.58, 17.85 Hz, 1H), 8.11 (t, J = 5.66 Hz, 1H), 7.64 (d, J = 8.11 Hz, 1H), 6.37 (d, J = 19.18 Hz, 1H), 6.10
(d, J = 12.94 Hz, 1H), 5.66 (d, J = 19.03 Hz, 1H), 5.38 (d, J = 19.09 Hz, 1H), 4.77 (dt, J = 8.14, 5.74 Hz, 1H),
4.66 (q, J = 7.22 Hz, 1H), 4.52 (dd, J = 10.34, 1.95 Hz, 1H), 4.07 (m, 1H), 3.95 (m, 1H), 3.75 (s, 3H), 3.76 (q,
J = 7.3 Hz, 2H), 3.60 (s, 3H), 3.53 (s, 3H), 3.50 (s, 3H), 3.27 (s, 3H), 2.80 (d, J = 2.57 Hz, 1H), 2.79 (d, J =
3.06 Hz, 1H), 2.31 (m, 2H), 1.79 (m, 1H), 1.71 (d, J = 7.24, 3H), 1.68 (t, J = 7.58, 3H), 1.43 (s, 9H), 1.42 (s,
9H), -1.61 (s, 1H), -1.91 (s, 1H). MS (MALDI-TOF) m/z 923 [M+H]+, calcd. for C51H67N6O10 923.491.
131- β-Alanyl-aspartylchlorin e6 dimethyl ester (34):

The 131- β-alanyl-aspartylchlorin e6 di(tert)butyl dimethyl ester (33, 45 mg, 0.048 mmol) was dissolved in
2 ml of dry CH2Cl2 in an ice bath under argon. Thioanisole (0.004 ml) and 2 ml of TFA were added and the
reaction mixture was stirred overnight before being evaporated several times with diethyl ether to
remove residual TFA. The resulting precipitate was washed several times with diethyl ether to remove
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more residual thioanisole. The precipitate was dissolved in CH2Cl2 and washed three times with H2O and
once with 10% NaHCO3 to remove TFA. The organic layer was dried over anhydrous Na2SO4 and the
solvent was evaporated to obtain 131- β-alanyl-aspartylchlorin e6 dimethyl ester (34, C43H50N6O10, 38 mg,
0.046 mmol, 97%); UV-Vis (acetone): λmax (ε/M-1cm-1) 663 (77,100), 607 (3,600), 528 (1,800), 500
(17,200), 399 (237,100); 1H NMR (acetone-d6, 400 MHz) δ 9.72 (s, 1H), 9.70 (s, 1H), 9.10 (s, 1H), 8.20 (dd,
J = 11.58, 17.85 Hz, 1H), 8.11 (br t, J = 5.66 Hz, 1H), 7.64 (br d, J = 8.11 Hz, 1H), 6.32 (d, J = 19.18 Hz, 1H),
6.10 (d, J = 12.94 Hz, 1H), 5.63 (d, J = 19.03 Hz, 1H), 5.37 (d, J = 19.09 Hz, 1H), 4.92 (dt, J = 8.14, 5.74 Hz,
1H), 4.66 (q, J = 7.22 Hz, 1H), 4.51 (dd, J = 10.34, 1.95 Hz, 1H), 4.07 (m, 1H), 3.95 (m, 1H), 3.74 (s, 3H),
3.75 (q, J = 7.3 Hz, 2H), 3.60 (s, 3H), 3.51 (s, 3H), 3.50 (s, 3H), 3.25 (s, 3H), 2.96 (d, J = 5.27 Hz, 1H), 2.69
(d, J = 3.06 Hz, 1H), 2.31 (m, 2H), 1.79 (m, 1H), 1.71 (d, J = 7.24, 3H), 1.66 (t, J = 7.58, 3H), -1.61 (s, 1H), 1.91 (s, 1H).

13

C NMR (acetone-d6, 100 MHz) δ 174.1, 173.9, 173.7, 173.4, 171.6, 170.5, 169.0, 168.4,

143.5, 139.8, 135.3, 134.8, 134.2, 130.7, 130.4, 129.5, 129.0, 128.7, 126.8, 125.2, 123.6, 122.3, 103.5,
100.5, 98.0, 95.0, 53.4, 52.5, 51.9, 49.4, 49.0, 38.8, 37.5, 36.6, 34.7, 31.2, 29.7, 23.3, 19.0, 17.0, 12.1,
11.5, 10.8; HRMS (MALDI-TOF) m/z 811.381 [M+H]+, calcd. for C43H51N6O10 811.367.
131-Ethylenediaminylchlorin e6 dimethyl ester (35):

Methyl pheophorbide a (3, 100 mg, 0.164 mmol) was dissolved in dry CHCl3 (5 ml) and stirred under
argon for 10 min. Then ethylenediamine (0.2 ml, 3.0 mmol) was added to the solution and the mixture
was stirred for 24 h. The reaction was monitored by spectrophotometry. The reaction mixture was
evaporated and the residue was dissolved in 2.5% MeOH/CH2Cl2 and then chromatographed on a short
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silica gel column using the same mobile phase to remove by-products, and then the product was eluted
using 50% MeOH/CH2Cl2 to afford 131-ethylenediaminylchlorin e6 dimethyl ester (35, C38H46N6O5, 100
mg, 0.150 mmol, 91%); 1H NMR (acetone d6, 400 MHz) δ 9.69 (s, 1H), 9.63 (s, 1H), 9.09 (s, 1H), 8.09 (dd, J
= 17.78, 11.58 Hz, 1H), 8.07 (br s, 1H), 6.29 (d, J = 18.85 Hz, 1H), 6.02 (d, J = 11.87 Hz, 1H), 5.67 (d, J =
19.08 Hz, 1H), 5.39 (d, J = 19.11 Hz, 1H), 4.66 (q, J = 7.22 Hz, 1H), 4.51 (dd, J = 10.34, 1.95 Hz, 1H), 4.01
(m, 1H), 3.87 (m, 1H), 3.75 (s, 3H), 3.66 (q, J = 7.3 Hz, 2H), 3.61 (s, 3H), 3.50 (s, 3H), 3.45 (s, 3H), 3.20 (s,
3H), 2.71 (m, 1H), 2.31 (m, 2H), 1.95 (br m, 1H), 1.80 (m, 1H), 1.72 (d, J = 7.24, 3H), 1.64 (t, J = 7.58, 3H),
-1.64 (s, 1H), -1.93 (s, 1H).

13

C NMR (acetone d6, 100 MHz) δ 173.1, 173.0, 169.2, 168.3, 167.7, 153.6,

149.1, 144.4, 138.1, 136.0, 135.3, 134.7, 133.9, 130.1, 129.8, 129.3, 120.9, 103.2, 100.7, 98.4, 93.9, 53.1,
51.4, 50.8, 50.2, 48.8, 41.2, 37.2, 30.7, 29.6, 22.6, 19.0, 17.2, 11.3, 11.0, 10.3. HRMS (MALDI-TOF) m/z
667.395 [M+H]+, calcd. for C38H47N6O5 667.361.
131-Ethylenediaminyl(boc)lysyl(boc)chlorin e6 dimethyl ester (36):

(boc)Lysine(boc)OH (55 mg, 0.082 mmol) was dissolved in dry CH2Cl2 (10 ml). A mixture of HOBt (15 mg,
0.11 mmol), TBTU (33 mg, 0.11 mmol) and DIEA (0.017 ml, 0.1 mmol) in DMF (3 ml) was added and then
the mixture was stirred for 1 h. 131-Ethylenediaminylchlorin e6 dimethyl ester (35, 50 mg, 0.075 mmol)
was added to the reaction mixture, which was stirred overnight. The mixture was diluted with CH2Cl2
and then washed with 5% aqueous citric acid, followed by a wash with brine and water. It was dried
over anhydrous Na2SO4 and then evaporated. The residue was dissolved in 2.5% MeOH/CH2Cl2 and

81

purified via silica gel column chromatography using the same mobile phase to afford 13 1ethylenediaminyl(boc)lysyl(boc)chlorin e6 dimethyl ester (36, C54H74N8O10, 65 mg, 0.065 mmol; 78%); 1H
NMR (acetone d6, 400 MHz) δ 9.54 (s, 1H), 9.53 (s, 1H), 9.07 (s, 1H), 8.14 (br s, 1H) 7.94 (dd, J = 17.78,
11.58 Hz, 1H), 7.78 (br s, 1H), 6.18 (d, J = 18.85 Hz, 1H), 6.16 (br s, 1H), 5.93 (d, J = 11.87 Hz, 1H), 5.89 (br
s, 1H), 5.63 (d, J = 19.08 Hz, 1H), 5.39 (d, J = 19.11 Hz, 1H), 4.67 (q, J = 7.22 Hz, 1H), 4.52 (dd, J = 10.34,
1.95 Hz, 1H), 4.17 (m, 1H), 3.85 (m, 1H), 3.75 (s, 3H), 3.66 (m, 3H), 3.61 (s, 3H), 3.52 (br q, J = 7.14 Hz,
2H), 3.41 (s, 3H), 3.39 (s, 3H), 3.11 (s, 3H), 3.00 (m, 2H), 2.71 (m, 1H), 2.32 (m, 2H), 1.95 (br m, 1H), 1.84
(m, 2H), 1.72 (d, J = 7.24, 3H), 1.67 (m, 1H), 1.59 (t, J = 7.58, 3H), 1.41 (m, 3H), 1.37 (s, 9H), 1.34 (s, 9H), 1.66 (s, 1H), -1.94 (s, 1H). MS (MALDI-TOF) m/z 995 [M+H]+, calcd. for C54H75N8O10 995.560.
131-Ethylenediaminyl-lysylchlorin e6 dimethyl ester (37):

The 131-ethylenediaminyl(boc)lysyl(boc)chlorin e6 dimethyl ester (36, 65 mg, 0.065 mmol) was dissolved
in of dry CH2Cl2 (3 ml) in a ice bath under argon. Thioanisole (0.003 ml) and of TFA (2 ml) were added
and the reaction mixture was stirred overnight. The reaction mixture was evaporated several times with
diethyl ether to remove TFA. The resulting precipitate was washed several times with diethyl ether to
remove thioanisole. Then the precipitate was dissolved in CH2Cl2 and washed three times with H2O and
once with 10% NaHCO3 to remove TFA. The organic layer was dried over anhydrous Na2SO4 and the
solvent was evaporated to afford 131-ethylenediaminyl-lysylchlorin e6 dimethyl ester (37, C44H58N8O6, 42
mg, 0.052 mmol, 81%); UV-Vis (acetone): λmax (ε/M-1cm-1) 663 nm (76,400), 607 (1,800), 527 (700), 500
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(14,600), 399 (242,100); 1H NMR (acetone d6, 400 MHz) δ 9.76 (s, 1H), 9.69 (s, 1H), 9.10 (s, 1H), 8.29 (br
s, 1H) 8.17 (dd, J = 17.78, 11.58 Hz, 1H), 7.86 (br s, 1H), 6.35 (d, J = 18.85 Hz, 1H), 6.07 (d, J = 11.87 Hz,
1H), 5.64 (d, J = 19.08 Hz, 1H), 5.40 (d, J = 19.11 Hz, 1H), 4.66 (q, J = 7.22 Hz, 1H), 4.52 (dd, J = 10.34, 1.95
Hz, 1H), 3.92 (m, 2H), 3.75 (br m, 5H), 3.74 (s, 3H), 3.60 (s, 3H), 3.53 (s, 3H), 3.49 (s, 3H), 3.26 (s, 3H),
2.96 (br t, 2H), 2.70 (m, 1H), 2.29 (m, 2H), 1.95 (br m, 1H), 1.84 (m, 2H), 1.72 (d, J = 7.24, 3H), 1.68 (t, J =
7.58, 3H), 1.45 (m, 2H), 1.31 (m, 2H) -1.60 (s, 1H), -1.89 (s, 1H). 13C NMR (dichloromethane d2, 100 MHz)
δ 176.6, 174.2, 174.0, 169.9, 169.7, 167.7, 154.5, 149.5, 145.3, 139.3, 136.8, 135.4, 135.2, 134.9, 130.9,
130.2, 129.8, 129.7, 129.0, 122.2, 102.9, 101.8, 99.2, 94.4, 55.4, 52.6, 52.0, 49.7, 41.4, 41.1, 39.6, 38.2,
35.0, 31.5, 31.1, 30.2, 23.3, 23.0, 20.0, 18.0, 12.4, 12.2, 11.6, 11.5. HRMS (MALDI-TOF) m/z 795.492
[M+H]+, calcd. for C44H59N8O6 795.456.
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2.8 Supporting information
1

H NMR spectrum of pheophorbide a (17) in acetone-d6 at 400 MHz
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1

H NMR spectrum of Lys(Boc)OMe pheophorbide a 18 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 173-Lys(Boc)Ce6 TME 19 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 173-LysCe6 TME 20 in acetone-d6 at 400 MHz
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1

H NMR spectrum of methyl pheophorbide a (3) in acetone-d6 at 400 Mhz
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1

H NMR spectrum of Ce6 TME (24) in acetone-d6 at 400 MHz
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1

H NMR spectrum of Ce6 (2) in dimethyl sulfoxide-d6 at 400 MHz
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1

H NMR spectrum of 152-Aspdi(tBu)Ce6 DME 26a in acetone-d6 at 400 MHz
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1

H NMR spectrum of 152-AspCe6 DME 27a in acetone-d6 at 400 MHz
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1

H NMR spectrum of 152-Lys(Boc)Ce6 TME 26b in acetone-d6 at 400MHz
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1

H NMR spectrum of 152-LysCe6TME 27b in acetone-d6 at 400 MHz
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1

H NMR spectrum of Ce6 DME (29) in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-Aspdi(tBu)Ce6 DME 30 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131 AspCe6 DME 7 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-β-Ala(tBu)Ce6 DME 31 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131 β-AlaCe6 DME 32 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-β-Ala-Aspdi(tBu)Ce6 DME 33 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-b-Ala-AspCe6 DME 34 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-ED-Ce6 DME 35 in acetone-d6 at 400 Mhz
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1

H NMR spectrum of 131-ED-(Boc)Lys(Boc)Ce6 DME 36 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-ED-LysCe6 DME 37 in acetone-d6 at 400 MHz
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13

C NMR spectrum of 173-LysCe6 TME 20 in dichloromethane-d2 at 100 MHz
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13

C NMR spectrum of Ce6 TME 24 in dichloromethane-d2 at 100 MHz
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13

C NMR spectrum of Ce6 2 in dimethyl sulfoxide-d6 at 100 MHz
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13

C NMR spectrum of 152-AspCe6 DME 27a in acetone-d6 at 100 MHz
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13

C NMR spectrum of 152-LysCe6 TME 27b in dichloromethane-d2 at 100 MHz
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13

C NMR spectrum of 131 AspCe6 DME 7 in acetone-d6 at 100 MHz
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13

C NMR spectrum of 131-β-Ala-AspCe6 DME 34 in chloroform-d at 100 MHz
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13

C NMR spectrum of 131-ED-Ce6 DME 35 in acetone-d6 at 100 MHz
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13

C NMR spectrum of 131-ED-LysCe6 DME 37 in dichloromethane-d2 at 100 MHz
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Figure 2.9: Subcellular localization of conjugate Ce6 in HEp2 cells at 10 µM for 18 h (a) phase contrast, (b)
overlay of compound Ce6 compound and phase contrast, (c) ER tracker Blue/White fluorescence (e)
MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green fluorescence, and (d, f, h, j)
overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.10: Subcellular localization of conjugate 152 AspCe6DME in HEp2 cells at 10 µM for 18 h (a)
phase contrast, (b) overlay of compound 152 AspCe6 compound and phase contrast, (c) ER tracker
Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.11: Subcellular localization of conjugate 152 PdAspCe6DME in HEp2 cells at 10 µM for 18 h (a)
phase contrast, (b) overlay of compound 152 PdAspCe6 compound and phase contrast, (c) ER tracker
Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.

116

Figure 2.12: Subcellular localization of conjugate 152 LysCe6TME in HEp2 cells at 10 µM for 18 h (a) phase
contrast, (b) overlay of compound 152 LysCe6 compound and phase contrast, (c) ER tracker Blue/White
fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.13: Subcellular localization of conjugate 152 PdLysCe6TME in HEp2 cells at 10 µM for 18 h (a)
phase contrast, (b) overlay of compound 152 PdLysCe6 compound and phase contrast, (c) ER tracker
Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.14: Subcellular localization of conjugate 173 LysCe6TME in HEp2 cells at 10 µM for 18 h (a) phase
contrast, (b) overlay of compound 173 LysCe6 compound and phase contrast, (c) ER tracker Blue/White
fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.15: Subcellular localization of conjugate 131 ED-lysCe6DME in HEp2 cells at 10 µM for 18 h (a)
phase contrast, (b) overlay of compound 131 ED-lysCe6 compound and phase contrast, (c) ER tracker
Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.16: Subcellular localization of conjugate 131 AspCe6DME in HEp2 cells at 10 µM for 18 h (a)
phase contrast, (b) overlay of compound 131 AspCe6 compound and phase contrast, (c) ER tracker
Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with compound fluorescence. Scale bar: 10 µm.
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Figure 2.17: Subcellular localization of conjugate 131 β-Ala-AspCe6DME in HEp2 cells at 10 µM for 18 h
(a) phase contrast, (b) overlay of compound 131 β-Ala-AspCe6 compound and phase contrast, (c) ER
tracker Blue/White fluorescence (e) MitoTracker Green fluorescence, (g) BoDIPY Ceramide, (i)
LysoSensor Green fluorescence, and (d, f, h, j) overlays of organelle tracers with compound
fluorescence. Scale bar: 10 µm.
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CHAPTER 3: SYNTHESIS AND CHARACTERIZATION OF WATER SOLUBLE CHLORIN e6 DERIVATIVES FOR
PHOTODYNAMIC THERAPY
3.1 Introduction
In the previous chapter the importance of chlorin e6 derivatives in photodynamic therapy was
discussed. The main goal was to increase the selectivity towards cancer cells over the normal cells. To
increase the selectivity, different amino acids such as aspartic acid, which has negatively charged side
chains, and lysine which has positively charged side chains at physiological pH were introduced to find
out how these positively and negatively charged photosensitizers accumulate in different organelles in
the cell. Also the positions of the amino acids were changed and a series of regioisomers was prepared
to find how this affects the cell penetration. Cell studies revealed that all amino acid derivatives readily
accumulated within human HEp2 cells in comparison with chlorin e6 (1). However, the most phototoxic
compounds were found to be the 131-regioisomers, bearing either an aspartic acid or a lysine residue
directly conjugated to position-13 of the chlorin macrocycle, or connected via a β-alanine or ethylene
diamine spacer. The most phototoxic compound of this series, and the most promising for PDT
applications, is 131-aspartylchlorin e6. But poor solubility of these molecules was one of the major
drawbacks in the cellular studies. Apart from that some of these molecules tend to self-aggregate easily
and result in lower cell uptake. To overcome these major shortcomings, a new series of chlorin e 6
derivatives which hold two amino acids in a single chlorin e6 molecule were synthesized (Figure 3.1). The
increase in the overall charge of the molecule and amphiphilicity, might increase the water solubility1,2
and decrease the self-aggregation in biological media.3
Recent literature reported that increasing water solubility of photosensitizers helps to increase
the cell uptake4,5 and hence increase the phototoxicity.6,7 Kimani and coworkers had synthesized mono-,
di- and tri-PEGylated chlorin e6 photosensitizers with tri(ethylene glycol) attached at three carboxylic
positions in chlorin e6.6 These were tested for solubility and hydrolytic stability and also phototoxicity,
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cell uptake and localization in ovarian OVCAR-5 cancer cells. Their results confirmed that the increasing
number of PEG groups increased the water solubility and uptake into the cancer cells. Computational
studies also indicated that PEG groups will increasingly resist formation of aggregates by π-π stacking.
These EG chains can wrap across the chlorin ring to prevent π-π stacking. Most significantly an
increased number of PEG groups increased the phototoxicity, and the increase was parallel to the cell
uptake.
Our hypothesis was that a higher number of charged substituents will increase the phototoxicity
by increasing cell uptake. As in the previous project, all possible regioisomers of diamino acid chlorin e 6
derivatives were synthesized (Figure 3.1). It was found from our previous study, that the position of the
amino acid plays a vital role in determining the conformation of the molecule.8 New synthetic routes
were developed to synthesize all three regioisomers. Both the 152,173-diamino and 131,173-diamino
derivatives were synthesized starting from chlorin e6 (1) and the 131,152-diamino derivatives were
synthesized from pheophytin a.

Figure 3.1: Di-amino acid regioisomers of chlorin e6
The aims of the present work were to determine: 1) the degree to which diaminochlorin e6
derivatives were taken up and localized in cancer cells, 2) the main site of accumulation (which cell
organelle), and 3) whether the position and charge of the amino acid substituents influenced the photo
and dark toxicity.
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3.2 Synthesis
3.2.1 Synthesis of 152,173-diaspartylchlorin e6 derivative
A major side product in the synthesis of 152-mono-aspartylchlorin e6 derivatives was the 152,173diaspartylchlorin e6 derivative 5.9 The yield of the byproduct 5 can be increased by changing the number
of equivalents of coupling reagent and amino acid. According to the proposed mechanism, DCC and
DMAP activated the acetic side chain and formed the anhydride intermediate 2. The excess coupling
reagent can activate the propionic acid side chain to form O-acylisourea anhydride intermediate 3
(Scheme 3.1).

Scheme 3.1: Proposed intermediates in the formation of 152-173 di-amino acid derivative 4.
Then, the free amine group of the amino acid can attack both carbonyl groups in intermediate 3,
one in the anhydride ring and the other one in the O-acylisourea group. Mechanistic studies revealed
the nucleophile first attacks the more reactive 152 position of the anhydride ring instead of the 131
position, regardless of the size or nucleophilicity of the molecule. Then the second equivalent can react
with the O-acylisourea group to form diaminochlorin e6 derivative 4.
The detailed synthetic route to 152,173-diaspartylchlorin e6 methyl ester (6) is shown in Scheme
3.2. It was possible to obtain diaspartyl methyl ester 6 in 33% overall yield from chlorin e6 (1). The
optimal yield of diaspartyl chlorin e6 6 (26%) was obtained with activation of chlorin e6 with three
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equivalents of DCC and DMAP in CH2Cl2 at room temperature for two hours followed by coupling with
2.5 equivalents of di-tert-butyl protected aspartic acid for 24 hours.

Scheme 3.2: Synthesis of 152,173-diaspartylchlorin e6 methyl ester (6)
Less than three equivalents of DCC and aspartic acid tend to form significant amounts of the 152monoaspartic acid conjugate as a side product. When the number of equivalents of either DCC or
aspartic acid was increased, the yield of diaspartyl chlorin e6 4 improved. But it was not possible to stop
the formation of the mono-aspartyl conjugate as a side product. Longer reaction times also helped to
increase the yield of diaspartyl derivative 4. After confirming the formation of tert-butyl protected
diaspartyl chorin e6 4 by mass spectrometry, freshly prepared diazomethane gas was bubbled through
the mixture for five minutes to convert remaining free acid groups into methyl esters. This reaction was
monitored by TLC. It was possible to see two new spots in the TLC plate. A brighter spot with lower RF
value belongs to the desired product 152,173-diaspartylchlorin e6 5 and the second spot, which has a
higher RF value similar to 152-monoaspartlychlorin e6. Purification was achieved via silica gel column
chromatography and the identity of the esterified product 5 was confirmed using 1H NMR and mass
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spectrometry. 1H NMR spectroscopy shows four singlets around 3.0 to 4.5 ppm which integrated to
three protons each. Out of four, three peaks belong to the methyl groups directly connected to the
macrocycle and the remaining peak belongs to the 132 methyl ester group. The most downfield singlet
at δ 4.25 confirmed the formation of the 131 methyl ester because this peak is unique to the methyl
group on the formic side chain of chlorin e6 (1). That observation confirmed that aspartic acid coupled
with the acetic and propionic side chains of the molecule.
In the final step, all four tert-butyl ester protections in molecule 5 were removed in a TFA/CH2Cl2
mixture for six hours at room temperature. The solvent was evaporated and aqueous work-up was
performed to neutralize the remaining TFA. But basic aqueous work-up was unsuccessful due to the
higher water solubility of these compounds. To avoid the aqueous work-up, TFA and CH2Cl2 was first
removed by blowing nitrogen over the solution and the sample was placed in a high vacuum for four
hours. Finally the product was freeze-dried by dissolving it in water/acetonitrile mixture. Once the
sample was neutralized the color changed from purple to dark green. The identity of product 6 was
confirmed by 1H NMR, 13C NMR and mass spectrometry.
3.2.2 Synthesis of 131,173-diaspartylchlorin e6 derivative
There are two possible routes to synthesize the 131,173 chlorin e6 conjugate 10: 1) coupling of
the first amino acid to the propionic acid chain of pheophorbide 8 and subsequent isocyclic ring opening
of pheophorbide 8 with ethylenediamine followed by coupling of the second amino acid to the free
amine group of the resulting chlorin derivative (Scheme 3.3), or 2) selective esterification of the acetic
acid side chain (152 ester) of chlorin e6 (1) followed by coupling with two equivalents of an amino acid to
afford the 131,173-di(amino acid) derivative (Scheme 3.4).
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Scheme 3.3: Proposed route to obtain 131,173-di(amino acid) derivative
In the first method, pheophorbide a (8) can be obtained by selective hydrolysis of the phytyl
ester group of pheophytin a (7) using the Wasielewski and Svec procedure as mentioned in the previous
chapter.10 Then the amino acid can be coupled to the propionic side chain to obtain the pheophorbide
derivative 9. Then the isocyclic ring can be cleaved using ethylene diamine as accomplished in the
previous chapter.11 That will provide a free amine group to couple the second amino acid to the 13 1
position to obtained 131,152 derivative 10.

Scheme 3.4: Synthesis of 131,173-diaspartyl chlorin e6 methyl ester (13)
The key step in the second method is the selective protection of the acetic acid side chain of
chlorin e6 (1) in the presence of the formic and propionic carboxylic side chains. From the previous work,
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it was found that the acetic acid group of chlorin e6 can be activated selectively by forming a cyclic
anhydride. Chlorin e6 was activated using one equivalent of DCC and DMAP to form the anhydride
intermediate (2).9 Formation of cyclic anhydride 2 can be confirmed by using UV-Vis spectroscopy. Then
freshly prepared 0.5 M sodium methoxide was added until the color of the reaction mixture change
from brown-purple to dark green. Mass spectroscopy confirmed the formation of desired product 11.
Purification of di-acid 11 was challenging due to its high polarity. After work-up it was possible to obtain
a 1H NMR spectrum of the crude product and it was clear enough to identify the unique peak for the 15 2
methyl ester, and sufficiently pure for the next step. Appearance of a new peak at 3.7 ppm for 3 protons
provided evidence that esterification took place at the acetic acid side chain. Then tert-butyl-protected
aspartic acid was coupled with crude 152-chlorin e6 monomethyl ester. The optimal yield was obtained
with HOBt and TBTU as coupling reagents at room temperature for 48 hours.12 This reaction was
monitored by TLC. The product was purified via silica gel column chromatography and the first moving
band with 5% methanol/DCM was collected. The structure of product 12 was confirmed by mass and 1H
NMR spectroscopy. Purified tert-butyl protected diaspartyl chlorin e6 12 was treated with TFA/CH2Cl2
mixture for six hours at room temperature to deprotect all four carboxylic acid groups. Pure compound
13 was obtained after removal of TFA. The final product, 131,173-diaspartyl chlorin e6 13, was obtained
in 28% yield over four steps.
3.2.3 Synthesis of 131,152-di(amino acid) chlorin e6 derivatives
Previous studies revealed that the formic and acetic acid derivatives of chlorin e6 have more
photosensitizing ability compared to propionic acid conjugates.8 So it was assumed that the 131,152
di(amino acid) derivatives may show more potent photosensitizing ability in this diamino acid series
compared to the two other regioisomers. Therefore two different amino acid conjugates of 13 1,152
regioisomer were synthesized.
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The main challenge was to protect the propionic side chain in the presence of other two
carboxyl groups. There is no known chemical method to selectively methylate the propionic side chain
of chlorin e6 without methylating the acetic side chain. Esterification with methanol under acidic
conditions will form the 152,173-chlorin e6 dimethyl ester.13 Diazomethane will methylate all three
carboxylic group to form chlorin e6 trimethyl ester.14 But in the recent literature there is reported a
chemoselective aminolysis of the β-keto ester of methyl pheophorbide a.15-17 This opens up a new route
to synthesize 131,152 chlorin e6 derivative from methyl pheophorbide a.
Previously, Shinoda and coworkers reported a facile transesterification of the β-keto ester of
methyl pheophorbide a.18 These authors were able to introduce various alcohols and steroid groups in
the presence of 2-chloro-1-methylpyridinium iodide (CMPI) and of 4-(N,N-dimethylamino)pyridine
(DMAP) to the 132 position of pheophorbide. Recently Haavikko and coworkers also reported a selective
aminolysis of β-keto ester of the methyl pheophorbide a.15 They used various primary, secondary and
aromatic amines for the aminolysis of the β-keto ester. t is known that aminolysis of the β-keto ester is
usually facile compared to unactivated esters.19,20 In the previous literature the formation of βenaminoesters by reaction between secondary amines and β-ketoesters under low temperatures is
described.21 It was noticed that at higher temperatures they tend to form substantial amounts of the
corresponding β-ketoamide along with the expected enaminoester.
We have observed the same behavior with pheophorbide a. In the previous work, it was
possible to open the isocyclic ring of pheophorbide a (by cleaving the β-keto ester) using ethylene
diamine at room temperature. This time it was noticed at higher temperatures (90 oC in toluene) that
reaction with ethylene diamine tended to form two major products (two new very close spots in TLC).
Both products were isolated using preparative TLC and characterized by 1H NMR and mass spectroscopy.
One of the products still clearly shows the peak unique for the pheophorbide isocyclic ring: the proton
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appears as a sharp singlet at δ 6.26. The disappearance of the peak for the methyl group of the βketoester and new peaks for the ethylene diamine methylene groups confirmed the formation of βketoamide 24. The second product was identified as the expected chlorin e6 derivative 26. As reported
in the literature, temperature and the concentration of the amine play vital roles in deciding the major
product.15 A large excess of amine and mild heating always produced the classical ring-opened product
26, and a slight excess of amine in refluxing toluene yielded β-ketoamide 24 as the major product.
The exact mechanism for this reaction is still unclear. However Gravel and coworkers had
proposed two possible mechanisms to form β-ketoamide at high temperature (Scheme 3.5).21 Their first
possible path involves an internal amine transfer from hemiaminal intermediate 15 to the ester carbonyl
group through a four membered transition state. Another possible mechanism involves formation of a
four membered β-lactone 18 followed by cleavage of this lactone by amine to yield the β-ketoamide 19.
These two mechanisms are also consistent with the reported high diastereomeric excess of the R-isomer
of pheophorbide 24 (at C132).15 Indeed the R-isomer is more stable compared to the S-isomer due to
steric interaction between the 132 and 17 side chains of pheophorbide. However, if the reaction goes
through an enol intermediate, the C132 position can be epimerized and end up as a mixture of isomers.
At low temperature, the reaction follows a different mechanism, as shown in Scheme 3.5. The
first step is the same as in the previous mechanisms. Free amine will attack at the more nucleophilic
keto group of molecule 14 to form hemiaminal 20. Then the isocyclic ring will cleave between the C131C132 atoms and form the chlorin e6 derivative 21. The ease of opening of the isocyclic ring is due to the
release of the strain in the ring upon opening. It is clear that at higher temperatures reaction goes
through a high energy transition state and forms the keto amide 19, but at lower temperature it follows
the low energy path and forms more stable ring-opened product 22.
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Scheme 3.5: Suggested mechanism for aminolysis of the β-keto ester of methyl pheophorbide a at high
temperature (top), and the corresponding ring-opening reaction of methyl pheophorbide a at low
temperature (bottom).

The first attempt to introduce the ethylene diamine to both ester and keto groups of the
pheophorbide 23 to form 131 and 152 substituted chlorine e6 derivative 25 was unsuccessful (Scheme
3.6). Both β-keto ester aminolysis and ring-opening reactions were attempted in one pot. First
pheophorbide 23 and ethylene diamine were refluxed in toluene until disappearance of the starting
material 23, as monitored by TLC. Then excess amine was added and the mixture was stirred at 40 oC for
12 hours to complete the ring cleavage reaction. Unfortunately, this process resulted in a mixture of
compounds, including the desired product 25. Mass spectrometry revealed three major compounds in
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this mixture, as shown in Scheme 3.6. Purification of these compounds was challenging due to high
polarity of the free amine groups.

Scheme 3.6: Attempted synthesis of 131 and 152 ethylenediamine substituted chlorine e6 derivative 25
Then it was decided to use half protected ethylene diamine to simplify the purification process.
As indicated by TLC, aminolysis of the β-keto-ester of pheophorbide 23 with protected ethylene diamine
was completed after 12 hours. But the second step, ring-cleavage was unsuccessful with Boc protected
ethylene diamine, possibly due to steric bulkiness of the amine. Next it was decided to purify the
product 27 before going on to the ring cleavage reaction. As it was possible to achieve the isocyclic ring
cleavage using free ethylene diamine, unprotected ethylene diamine was used for the second step and
the diethylene diamine substituted product 28 was obtained. Product 28 was purified using a short silica
gel column and its identity was confirmed using mass and 1H NMR spectroscopy. Boc deprotection was
achieved using TFA to obtain the free amines for the coupling reaction. Subsequent coupling with
protected aspartic acid followed by deprotection produced the desired product 30, in 15% yield over 5
steps from pheophorbide a (23, Scheme 3.7).
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Scheme 3.7: Synthesis of 131,152-diethylenediaminylaspartylchlorin e6 30
Advantage was taken of a previous route to introduce two types of amino acids to the 13 1 and
152 positions. Protected β-alanine was used for the aminolysis reaction as it greatly reduces the
unwanted ring-opened product and creates a carboxylic end to couple aspartic acid through its amino
group. Subsequent aminolysis with protected β-alanine followed by deprotection of the tert-butyl ester
provided free acid 31. Its identity was confirmed by mass spectroscopy. Free acid 31 was activated and
coupled with protected aspartic acid to obtain pheophorbide derivative 32. This was purified and
characterized by 1H NMR and mass spectroscopy. A classical ring-opening reaction was performed with
excess ethylene diamine in toluene at 40 oC to provide the chlorine e6 derivative 33. The reaction was
monitored using UV-Vis spectroscopy, and the color changed from dark green to bright green during
isocyclic ring-opening. 1H NMR spectroscopy shows the new peaks for ethylene diamine and mass
spectroscopy confirmed the identity of the product. Then boc protected lysine was coupled with free
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amine group of chlorin e6 derivative 33 to produce the desired 131-ethylenediaminyllysinyl-152-βalanylaspartylchlorine e6 tert-butyl methyl ester. This product was purified using silica gel
chromatography. Finally, global deprotection with TFA in DCM produced the final product 34 in 9% yield
over six steps starting from pheophorbide a (Scheme 3.8).

Scheme 3.8: Synthesis of 131,152-di(amino acid) derivative 34
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3.3 Cell Culture Studies
3.3.1 Time-dependent Cellular Uptake
The results obtained for the time-dependent uptake of chlorin e6 and its derivatives at a
concentration of 10 μM in human HEp2 cells are shown in Figure 3.2. The 131 amino acid conjugates of
chlorin e6 34, 30 and 131-AspCe6DME were readily taken up by cells compared to unconjugated chlorin
e6 (1). However, the 152,173-di(Asp)Ce6 MME (6) and 131,173-di(Asp)Ce6 MME (13) showed the similar
uptake kinetics to unconjugated chlorin e6 (1). The 131-EDLys-152-β-AlaAspCe6 MME (34) which is a
zwitterion at physiological pH, showed the highest cell uptake compared to the other derivatives. In
comparison with unconjugated chlorin e6 (1), compounds 34 and 30 showed 5-fold and 4-fold cellular
uptake after 24 hours, respectively. This is probably due to the high amphiphilicity and the linear
extended conformation compared to other amino acid derivatives. The uptake of derivative 34 and 30
continues to increase over the 24 hour period investigated, therefore one can expect much higher
uptake for these derivative with time. However di-amino acid derivative 13 and 6 showed similar uptake
to unconjugated chlorin e6; this might be due to the conjugation at the propionic side chain resulting in
non-linear conformations for these molecules.8 Previous computational studies of mono-conjugated
chlorine e6 derivatives revealed that the 173-conjugated chlorin e6 derivatives assume a L-shape
conformation with the side chain positioned perpendicular to the macrocyclic plane.8 However in the
case of the 152- and 131-conjugated derivatives, the amino acid side chain extends away from the
macrocycle resulting in nearly linear conformations compared to 173-conjugated derivatives. A similar
conformational change can be expected in the di-conjugated series. Amino acid conjugation at propionic
side chain (compound 13 and 6) makes it difficult for them to pass through the cell membrane, resulting
the lower cellular uptake.
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Figure 3.2: Time-dependent uptake of chlorin e6 (1, green line) and its derivatives 152,173-di(Asp)Ce6
MME (6, blue line), 131,173-di(Asp)Ce6 MME (13, light pink line), 131,152-di(EDAsp)Ce6 MME (30, purple
line), 131-EDLys-152-β-AlaAspCe6 MME (34, black line), 131-AspCe6DME (red line), at 10 M by HEp2
cells.

3.3.2 Cytotoxicity
The dark cytotoxicity and phototoxicity of chlorin e6 and its amino acid conjugated derivatives
was evaluated in HEp2 cells exposed to increasing concentrations of each compound, up to 400 μM.
Toxicity of 131 AspCe6 DME, which showed the highest phototoxicity in the mono conjugated amino acid
series, was compared with the toxicity of di-conjugated chlorin e6 series. The 131 lysine isomer 131LysCe6 DME was also tested with the new series and the dark and phototoxicity results are shown in
Figures 3.3 and 3.4, respectively, and summarized in Table 3.1. Chlorin e6 (1), 152,173-di(Asp)Ce6 MME (6)
and 131,173-di(Asp)Ce6 MME (13) were found to be the least toxic in the dark and also in the presence of
light. But all other mono- and di-substituted derivatives showed significant toxicity, even in the absence
of light. After expose to light, all these derivatives were highly toxic to HEp2 cells. Mono substituted
derivatives 131-LysCe6 DME and 131-AspCe6 DME were found to be most toxic compared to the disubstituted derivatives. The estimated IC50 values of the most phototoxic 131-chlorin e6 derivatives 131139

AspCe6 DME and 131-LysCe6 DME, are 0.8 and 0.7 μM, respectively, and this is comparable to our
previous cytotoxicity results of mono-conjugated derivatives. Surprisingly, our results revealed that the
introduction of a second amino acid decreased the cytotoxicity of the compound. For example, the
131,152-di(EDAsp)Ce6 MME (30) and 131,173-di(Asp)Ce6 MME (13) were less phototoxic than its 131
mono substituted derivative 131-AspCe6 DME by approximately 10-fold and 27-fold, respectively. As was
expected, among the di-substituted series, the 131,173-di(Asp)Ce6 MME (13) and 152,173-di(Asp)Ce6
MME (6) showed the least cytotoxicity, probably due to conjugation at the propionic side chain (17 3
position). On the other hand the 131-EDLys -152-β-AlaAspCe6 MME (34) and 131,152-di(EDAsp) Ce6 MME
(30) showed the highest phototoxicity with IC50 of 5.1 and 7.6 μM, respectively, but still more than 5-fold
lower than the mono-conjugated derivatives 131-AspCe6 DME and 131-LysCe6 DME. These results show
that the conjugation at the propionic and/or acetic acid chains of 131 AspCe6 MME derivative greatly
reduces its cytotoxicity. Cell uptake results of di-conjugated compounds also complemented the
phototoxicity results. 131-EDLys-152-β-AlaAspCe6 MME (34) has the highest cell uptake and the highest
phototoxicity of the di-amino acid derivatives and 152,173-di(Asp)Ce6 MME (6) and 131,173-di(Asp)Ce6
MME (13) showed the lowest cell uptake and lowest phototoxicity in the di-amino acid conjugated
series.
Table 3.1: Cytotoxicity (HEp2 cells) for chlorin e6 and its derivatives using the MTT assay
Dark toxicity
(IC50, μM)
330

Phototoxicity
(IC50, μM)
10.6

Ratio

152,173-di(Asp)Ce6 MME (6)

>400

21

>19

131,173-di(Asp)Ce6 MME (13)

286

22

13

131,152-di(EDAsp)Ce6 MME (30)

76

7.6

10

131-EDLys-152-β-AlaAspCe6 MME (34)

58

5.1

11

131-AspCe6 DME

58

0.7
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Figure 3.3: Dark toxicity of chlorin e6 (1, green line) and its derivatives 152,173-di(Asp)Ce6 MME (6, blue
line), 131,173-di(Asp)Ce6 MME (13, light pink line), 131,152-di(EDAsp)Ce6 MME (30, purple line), 131EDLys-152-β-AlaAspCe6 MME (34, black line), 131-AspCe6 DME (red line), 131-LysCe6 DME (yellow line)
toward HEp2 cells using 1 J/cm2 light dose and the Cell Titer Blue assay.
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Figure 3.4: Phototoxicity of chlorin e6 (1, green line) and its derivatives 152,173-di(Asp)Ce6 MME (6, blue
line), 131,173-di(Asp)Ce6 MME (13, light pink line), 131,152-di(EDAsp)Ce6 MME (30, purple line), 131EDLys-152-β-AlaAspCe6 MME (34, black line), 131-AspCe6 DME (red line), 131-LysCe6 DME (yellow line)
toward HEp2 cells using 1 J/cm2 light dose and the Cell Titer Blue assay.
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3.4 Experimental
152,173-Diaspartylchlorin e6 tetra(tert)butyl methyl ester (5):

Chlorin e6 (1, 100 mg, 0.168 mmol) was dissolved in dry CH2Cl2 (7 ml) and DIEA (0.06 ml, 0.34 mmol) was
added. A mixture of DCC (105 mg, 0.51 mmol) and DMAP (163 mg, 0.51 mmol) in CH 2Cl2 (8 ml) was
added and the mixture was allowed to stir for 2 h. Then aspartic acid di(tert)butyl ester hydrochloride
(125 mg, 0.445 mmol) and DIEA (0.075 ml) were mixed in CH2Cl2 and added to the reaction mixture. The
solution was allowed to stir overnight at room temperature and after 12 h it was treated with ethereal
diazomethane. Then the mixture was diluted with CH2Cl2 and washed with 5% aqueous citric acid,
followed by a wash with brine and water. It was dried over anhydrous Na2SO4 and the solvent was
evaporated. The residue was dissolved in 5% methanol/CH2Cl2 and purified via silica gel column
chromatography with the same mobile phase to afford 152,173-diaspartylchlorin e6 tera(tert)butyl
methyl ester (5, C59H80N6O12, 54 mg, 0.051 mmol, 30%); UV-Vis (acetone): λmax (rel. inten.) 664 nm
(0.305), 608 (0.023), 528 (0.021), 500 (0.075), 400 (1.000); 1H NMR (acetone-d6, 400 MHz): δ 9.80 (s, 1H),
9.63 (s, 1H), 9.06 (s, 1H), 8.15 (dd, J = 17.9, 11.6 Hz, 1H), 7.37 (d, J = 7.9 Hz, 1H), 7.23 (d, J = 8.0 Hz, 1H),
6.37 (dd, J = 17.9, 1.5 Hz, 1H), 6.10 (dd, J = 11.6, 1.4 Hz, 1H), 5.37 (d, J = 12.0 Hz, 2H), 4.67 (s, 2H), 4.26 (s,
3H), 3.77 (d, J = 7.6 Hz, 2H), 3.57 (s, 3H), 3.48 (s, 4H), 3.25 (s, 3H), 2.83 – 2.63 (m, 3H), 2.52 – 2.28 (m,
2H), 2.14 (s, 2H), 1.89 – 1.79 (m, 2H), 1.78 (d, J = 7.1 Hz, 3H), 1.69 (t, J = 7.6 Hz, 3H), 1.43 (s, 9H), 1.35 (s,
9H), 1.26 (s, 9H), 1.16 (s, 9H), -1.36 (s, 1H), -1.57 (s, 1H); MS (MALDI-TOF) m/z 1065.591 [M+H]+, calcd.
for C59H81N6O12 1065.591.
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152,173-Diaspartylchlorin e6 methyl ester (6):

152,173-Diaspartylchlorin e6 tetra(tert)butyl methyl ester (5, 54 mg, 0.051 mmol) was dissolved in 2 ml of
dry CH2Cl2 and TFA (1 ml) was added in an ice bath under argon and the reaction mixture was allowed to
stir overnight. Solvent was rotavaporated several times with diethyl ether to remove TFA. The residue
was washed with CH2Cl2 several times. The final product was redissolved in a water/acetonitrile mixture
and freeze dried to afford 152,173-diaspartylchlorin e6 methyl ester (6, C43H48N6O12, 38 mg, 0.045 mmol,
88%); UV-Vis (MeOH): λmax (ε/M-1cm-1) 661 nm (71,600), 607 (11,000), 527 (9,300), 499 (22,400), 399
(172,300); 1H NMR (acetone-d6, 400 MHz): δ 9.88 (s, 1H), 9.66 (s, 1H), 9.21 (s, 1H), 8.11 (dd, J = 17.8,
11.6 Hz, 1H), 6.35 (d, J = 17.8 Hz, 1H), 6.14 (d, J = 11.6 Hz, 1H), 5.35 (t, J = 22.7 Hz, 2H), 4.81 (br. s, 1H),
4.65 (br. s, 1H), 4.63 (br. S, 1H), 4.25 (s, 3H), 3.70 (d, J = 7.9 Hz, 2H), 3.54 (s, 3H), 3.46 (s, 3H), 3.18 (s, 3H),
3.06 – 2.60 (m, 5H), 2.27 (s, 3H), 1.81 (d, J = 7.1 Hz, 3H), 1.55 (t, J = 7.4 Hz, 3H). 2.00 – 1.50 (m, 4H); 13C
NMR (acetone-d6, 100 MHz) δ 193.10, 192.75, 191.97, 191.93, 191.86, 191.81, 191.02, 188.70, 164.12,
160.40, 158.09, 157.49, 155.66, 155.24, 155.18, 151.90, 150.00, 149.02, 145.81, 142.62, 124.87, 121.05,
117.58, 115.99, 73.49, 73.03, 69.42, 69.24, 68.91, 68.68, 59.56, 55.70, 53.43, 52.59, 50.75, 45.56, 44.90,
42.86, 39.10, 36.79, 31.75, 31.58, 30.41. MS (MALDI-TOF) m/z 841 [M+H]+, calcd. for C43H49N6O12
841.340.
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152-Chlorin e6 monomethyl ester (11):

Chlorin e6 (1, 100 mg, 0.168 mmol) was dissolved in methanol (5 ml). DCC (35 mg, 0.17 mmol) and DMAP
(21 mg, 0.17 mmol) were added and the mixture was stirred until the anhydride intermediate was
observed in the TLC. After 1 h, freshly prepared sodium methoxide (0.34 mL of a 0.5 M solution) was
added into the reaction mixture dropwise until the color changed from brown to light green. The
reaction was followed by UV-Vis spectroscopy. The solution changes from brown to light green as the
anhydride ring opens. The mixture was diluted with ethyl acetate and then washed with 5% aqueous
citric acid, followed by a wash with brine and water. It was dried over anhydrous Na2SO4 to afford 152chlorin e6 monomethyl ester (11, C35H39N4O6, 101 mg, 0.165 mmol, 100 %). Purification was challenging
due to the two free acid groups. Thus, the crude product was subjected to the next reaction without
purification. 1H NMR spectrum of the crude product confirmed the methylated acetic side chain. MS
(MALDI-TOF) m/z 611 [M+H]+, calcd. for C35H39N4O6 611.287.
131,173-Diaspartylchlorin e6 tetra(tert)butyl methyl ester (12):

Chlorin e6 monomethyl ester (11, 101 mg, 0.165 mmol) was dissolved in dry DMF (5 ml). A mixture of
HOBt (46 mg, 0.34 mmol), TBTU (109 mg, 0.34 mmol) and DIEA (0.06 ml, 0.34 mmol) in DMF was added
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and the mixture was allowed to stir for 30 min at room temperature. Then aspartic acid di(tert)butyl
ester hydrochloride (125 mg, 0.445 mmol) and DIEA (0.08 ml, 0.445 mmol) were mixed in CH 2Cl2 (2 ml)
and added to the reaction mixture. The solution was allowed to stir for 48-72 h until formation of the
desired product was confirmed by TLC. Then the reaction mixture was washed with 5% aqueous citric
acid, followed by a wash with brine and water. It was dried over anhydrous Na2SO4 and solvent was
evaporated. The residue was dissolved in 5% methanol/ CH2Cl2 and purified via a short silica gel column
chromatography with the same mobile phase to afford 152-173-diaspartylchlorin e6 tera(tert)butyl
methyl ester (12, C59H81N6O12, 85 mg, 0.079 mmol, 48% of); UV-Vis (acetone): λmax (rel. inten.) 663 nm
(0.328), 607 (0.023), 528 (0.019), 500 (0.081), 399 (1.000); 1H NMR (acetone-d6, 400 MHz): δ 9.79 (d, J =
6.1 Hz, 1H), 9.65 (s, 1H), 9.10 (s, 1H), 8.42 (d, J = 7.9 Hz, 1H), 8.12 (dd, J = 17.8, 11.6 Hz, 1H), 7.29 (d, J =
8.2 Hz, 1H), 6.32 (d, J = 17.8 Hz, 1H), 6.06 (d, J = 11.4 Hz, 1H), 5.73 (d, J = 18.9 Hz, 1H), 5.50 – 5.21 (m,
2H), 4.76 – 4.61 (m, 2H), 4.61 – 4.48 (m, 1H), 3.76 (s, 3H), 3.74 – 3.68 (m, 1H), 3.65 (s, 3H), 3.47 (s, 3H),
3.42 (s, 1H), 3.22 (s, 3H), 3.20 – 3.11 (m, 2H), 2.66 (d, J = 5.2 Hz, 2H), 2.46 – 2.27 (m, 1H), 2.24 – 2.14 (m,
1H), 1.83 – 1.72 (m, 2H), 1.66 (s, 9H), 1.55 (s, 9H), 1.41 (s, 9H), 1.35 (s, 9H), 1.72-1.2 (m, 6H); MS (MALDITOF) m/z 1065 [M+H]+, calcd. for C59H81N6O12 1065.591.
131,173-Diaspartylchlorin e6 methyl ester (13):

152,173-Diaspartylchlorin e6 tetra(tert)butyl methyl ester (12, 50 mg, 0.047 mmol) was dissolved in 2 ml
of dry CH2Cl2 in an ice bath under argon. TFA (1 ml) was added and the reaction mixture was allowed to
stir overnight. The mixture was rotavaporated several times with diethyl ether to remove TFA. The
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residue was dissolved in water/acetonitrile mixture and freeze dried to obtain 131,173-diaspartylchlorin
e6 methyl ester (13, C43H48N6O12, 21 mg, 0.025 mmol, 53%). UV-Vis (MeOH): λmax (ε/M-1cm-1) 662 nm
(75,300), 607 (23,000), 529 (10,000), 500(8,300), 400 (165,200);

13

C NMR (methanol-d4, 100 MHz) δ

175.47, 175.04, 174.87, 174.17, 174.03, 173.97, 173.81, 169.50, 144.08, 143.10, 142.62, 140.72, 140.57,
138.37, 138.15, 136.27, 135.61, 134.11, 132.76, 131.44, 129.62, 124.84, 107.17, 100.27, 98.96, 97.91,
55.09, 53.20, 51.40, 50.70, 50.31, 47.32, 39.03, 37.01, 35.50, 34.82, 33.92, 31.99, 30.83, 26.82, 26.17,
24.34, 23.85, 20.15, 17.13, 12.36, 11.05, 9.26. MS (MALDI-TOF) m/z 841 [M+H]+, calcd. for C43H49N6O12
841.340.
Ethylenediaminyl(boc) pheophorbide a (27):

Methyl pheophorbide a (23, 100 mg, 0.165 mmol) was dissolved in dry toluene and the mixture was
heated to 100 oC under nitrogen. Then mono-boc protected ethylene diamine (32 mg, 0.20 mmol) was
added. The reaction mixture was allowed to stir overnight at 100 oC while monitoring by TLC. Then the
solvent was removed and the residue was dissolved in CH2Cl2 and washed with 5% aqueous citric acid,
followed by water and brine. It was dried over anhydrous Na2SO4 and the solvent was evaporated. The
residue was dissolved in 3% methanol/CH2Cl2 and purified via a silica gel column chromatography with
the same mobile phase to afford ethylenediaminyl(boc) pheophorbide a (27, C42H51N6O6, 80 mg, 0.109
mmol, 65%); UV-Vis (D M): λmax (rel. inten.) 667 nm (0.463), 609 (0.066), 535 (0.079), 505 (0.101), 413
(1.000); 1H NMR (acetone-d6, 400 MHz) δ 9.58 (s, 1H), 9.30 (s, 1H), 8.87 (s, 1H), 8.13 – 7.92 (m, 2H), 6.27
(dd, J = 17.9, 1.5 Hz, 1H), 6.18 (s, 1H), 6.12 (dd, J = 11.5, 1.4 Hz, 1H), 4.77 – 4.55 (m, 1H), 4.37 (dt, J = 9.3,
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2.5 Hz, 1H), 3.59 (s, 3H), 3.52 (s, 3H), 3.42 – 3.36 (m, 2H), 3.35 (d, J = 6.5 Hz, 3H), 3.08 (s, 3H), 2.74 – 2.57
(m, 2H), 2.46 – 2.33 (m, 1H), 2.31 – 2.19 (m, 1H), 1.84 (d, J = 7.3 Hz, 3H), 1.76 – 1.64 (m, 1H), 1.58 (t, J =
7.6 Hz, 3H), 1.35 (s, 9H), -1.77 – -2.11 (m, 2H); MS (MALDI-TOF) m/z 841 [M+H]+, calcd. for C42H51N6O6
735.387.
152-Ethylenediaminyl(boc)-131-ethylenediaminylchlorin e6 methyl ester (28):

Ethylenediaminyl(boc) pheophorbide-a (27, 80 mg, 0.109 mmol) was dissolved in toluene (10 ml) and
ethylene diamine (30 mg, 0.5 mmol) was added. The reaction mixture was heated at 40 oC overnight.
Progress was monitored by TLC and UV-Vis spectrometry. After the reaction was complete by TLC, the
solvent was removed and the residue was dissolved in CH2Cl2 and washed with 5% aqueous citric acid to
remove excess amine, followed by a wash with brine. It was dried over anhydrous Na2SO4 and the
solvent was evaporated. The residue was dissolved in 5% methanol/CH2Cl2 and eluted with the same
mobile phase. Then the methanol percentage of the mobile phase was gradually increased up to 20% to
elute the pure product from the column. The solvent was evaporated and the residue was re-dissolved
in 5% acetone/CH2Cl2 and filtered to remove silica from the sample. After evaporation of the solvent
pure 152-ethylenediaminyl(boc)-131-ethylenediaminylchlorin e6 methyl ester was obtained (28,
C44H58N8O6, 55 mg, 0.069 mmol, 64%); UV-Vis (acetone): λmax (rel. inten.) 663 nm (0.325), 607 (0.015),
528 (0.008), 500 (0.072), 399 (1.000); 1H NMR (acetone-d6, 400 MHz) δ 9.74 (s, 1H), 9.73 (s, 1H), 9.13 (s,
1H), 8.36 (br. s, 1H), 8.23 (dd, J = 17.8, 11.5 Hz, 1H), 7.46 (br. s, 1H), 6.64 (br. s, 1H), 6.40 (dd, J = 17.9,
1.5 Hz, 1H), 6.12 (dd, J = 11.7, 1.5 Hz, 1H), 5.55 (d, J = 18.0 Hz, 1H), 5.09 (d, J = 9.3 Hz, 1H), 4.76 – 4.51
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(m, 2H), 4.28 (s, 1H), 4.01 – 3.83 (m, 1H), 3.80 – 3.67 (m, 4H), 3.58 (s, 3H), 3.54 (s, 3H), 3.52 (s, 3H), 3.29
(s, 3H), 3.25 – 3.16 (m, 2H), 3.08 (dd, J = 9.1, 4.9 Hz, 1H), 2.78 – 2.64 (m, 1H), 2.43 – 2.21 (m, 2H), 2.00 (d,
J = 8.0 Hz, 1H), 1.76 (d, J = 7.1 Hz, 3H), 1.68 (t, J = 7.6 Hz, 3H), 1.20 (s, 9H), -1.66 (s, 1H), -2.02 (s, 1H); MS
(MALDI-TOF) m/z 841 [M+H]+, calcd. for C44H59N8O6 795.447.
131,152-Diethylenediaminylchlorin e6 methyl ester (29):

152-Ethylenediaminyl(boc)-131-ethylenediaminylchlorin e6 methyl ester (28, 55 mg, 0.069 mmol) was
dissolved in 3 ml of dry CH2Cl2 in an ice bath under argon and 1 ml of TFA was added. Then the reaction
mixture was allowed to stir overnight. The mixture was rotavaporated several times with diethyl ether
to remove TFA. The residue was dissolved in water/acetonitrile mixture and and freeze dried. Without
any further purification the crude product was taken to the next step. (29, C39H50N8O4, 42 mg, 0.06
mmol, 88%) MS (MALDI-TOF) m/z 695 [M+H]+,calcd. for C39H51N8O4 695.403.
131,152-Diethyleneaminylaspartylchlorin e6 di(tert)butyl di(boc) methyl ester:

(Boc)Asp(tBu)OH (70 mg, 0.24 mmol) was dissolved in dry DMF (5 ml). A mixture of HOBt (32 mg, 0.24
mmol), TBTU (77 mg, 0.24 mmol) and DIEA (0.05 ml, 0.29 mmol) in DMF (3 ml) was added and the
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mixture was allowed to stir for 1 h. 131,152-Diethylenediaminylchlorin e6 methyl ester (29, 42 mg, 0.060
mmol) was added to the reaction mixture and stirring was continued for 48 h. The mixture was diluted
with CH2Cl2 and then washed with 5% aqueous citric acid, followed by washes with brine and water. The
organic layer was dried over anhydrous Na2SO4 and the solvent was evaporated. The residue was
dissolved in 6% MeOH/CH2Cl2 and purified via silica gel column chromatography using the same mobile
phase to afford 131,152-diethyleneaminyl-diaspartylchlorin e6 di(tert)butyl di(boc) methyl ester
(C65H92N10O14, 30 mg, 0.024 mmol, 40%); UV-Vis (acetone): λmax (rel. inten.) 663 nm (0.319), 607 (0.014),
528 (0.011), 500 (0.070), 399 (1.000); 1H NMR (chloroform-d, 400 MHz) δ 9.68 (s, 1H), 9.61 (s, 1H), 8.79
(s, 1H), 8.07 (dd, J = 17.9, 11.5 Hz, 1H), 7.97 (d, J = 5.7 Hz, 1H), 7.74 (s, 1H), 6.34 (d, J = 17.8 Hz, 1H), 6.13
(d, J = 11.5 Hz, 1H), 5.81 (d, J = 8.3 Hz, 1H), 5.47 (d, J = 18.1 Hz, 1H), 5.28 – 4.88 (m, 2H), 4.67 – 4.30 (m,
3H), 4.10 – 3.68 (m, 6H), 3.54 (s, 3H), 3.48 (s, 3H), 3.31 (s, 3H), 2.93 – 2.69 (m, 2H), 2.67 – 2.53 (m, 1H),
2.23 (d, J = 9.3 Hz, 1H), 2.04 (s, 1H), 1.90 – 1.55 (m, 6H), 1.31 (d, J = 3.9 Hz, 18H), 1.14 (d, J = 8.0 Hz, 18H),
0.94 – 0.80 (m, 1H), -1.62 (s, 1H), -1.80 (s, 1H); MS (MALDI-TOF) m/z 1237.651 [M+H]+, calcd. for
C65H93N10O14 1237.687.
131,152-Diethyleneaminyl-diaspartylchlorin e6 methyl ester (30):

131,152-Diethyleneaminyl-diaspartylchlorin e6 di(tert)butyl di(boc) methyl ester (30 mg, 0.024 mmol)
was dissolved in 2 ml of dry CH2Cl2 in an ice bath under argon. TFA (1 ml) was added and the reaction
mixture was allowed to stir overnight. The reaction mixture was rotavaporated several times with
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diethyl ether to remove TFA. The residue was washed with CH2Cl2 several times. The final product was
dissolved in water and freeze dried to obtain 131-152-diethyleneaminyl-diaspartylchlorin e6 methyl ester
(30, C48H59N9O12, 16 mg, 0.016 mmol, 70%). UV-Vis (MeOH): λmax (ε/M-1cm-1) 661 nm (74,700), 606
(8,400), 527 (6200), 500 (20,500), 400 (190,200); 1H NMR (methanol-d4, 400 MHz) δ 10.18 (s, 1H), 10.03
(s, 1H), 9.47 (s, 1H), 8.20 (dd, J = 17.7, 11.6 Hz, 1H), 6.39 (d, J = 17.8 Hz, 1H), 6.29 (d, J = 11.5 Hz, 1H),
5.59 (d, J = 18.7 Hz, 1H), 5.42 (d, J = 18.7 Hz, 1H), 4.79 (d, J = 7.2 Hz, 1H), 4.54 (d, J = 10.8 Hz, 1H), 4.44
(ddd, J = 24.1, 8.5, 4.2 Hz, 1H), 4.25 – 4.05 (m, 1H), 4.03 – 3.83 (m, 4H), 3.74 (s, 3H), 3.67 (s, 3H), 3.56 (s,
3H), 3.49 (td, J = 10.6, 9.5, 4.6 Hz, 2H), 3.41 – 3.26 (m, 5H), 3.23 – 3.00 (m, 2H), 2.99 – 2.82 (m, 2H), 2.70
(dd, J = 17.9, 9.0 Hz, 1H), 2.59 – 2.47 (m, 1H), 2.46 – 2.31 (m, 1H), 1.83 (d, J = 7.1 Hz, 3H), 1.68 (t, J = 7.3
Hz, 3H);

13

C NMR (methanol-d4, 100 MHz) δ 174.40, 173.96, 173.73, 172.85, 171.54, 171.38, 169.04,

168.71, 168.03, 143.06, 142.09, 141.75, 139.02, 138.75, 137.66, 136.96, 135.22, 134.57, 132.80, 131.32,
130.48, 128.32, 123.53, 105.18, 99.19, 97.42, 97.05, 53.89, 51.07, 49.95, 49.13, 39.50, 39.30, 39.19,
39.12, 38.70, 34.67, 34.46, 30.47, 29.64, 29.30, 22.82, 22.37, 18.95, 15.79, 11.06, 10.88, 9.85; MS
(MALDI-TOF) m/z 947 [M+Na]+, calcd. for C48H59N9NaO12 947.438.
β-Alanylpheoporbide a (tert)butyl methyl ester:

Methyl pheophorbide a (23, 100 mg, 0.165 mmol) was dissolved in dry toluene (10 ml) and the mixture
was heated to 100

o

under nitrogen. Then β-alanine(tBu).HCl (45 mg, 0.25 mmol) and DIEA (0.06 ml,

0.33 mmol) were added. The reaction mixture was allowed to stir overnight at 100 oC in an oil bath and
was monitored by TLC. Then the solvent was removed and the residue was dissolved in CH2Cl2 and
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washed with 5% aqueous citric acid followed by water and with brine. The organic layer was dried over
anhydrous Na2SO4 and the solvent was evaporated. The residue was dissolved in 5% methanol/CH2Cl2
and purified via silica gel chromatography with the same mobile phase and to afford βalanylpheoporbide a (tert)butyl methyl ester (31, C42H49N5O6, 65 mg, 0.090 mmol, 54%); UV-Vis (DCM):
λmax (rel. inten.) 667 nm (0.420), 609 (0.060), 535 (0.071), 505 (0.098), 412 (1.000); 1H NMR (acetone-d6,
400 MHz) δ 9.33, 9.23* (s, 1H), 8.99, 9.93* (s, 1H), 8.79, 8.77* (s, 1H), 7.97*, 7.92 (t, J = 6.0 Hz, 1H), 7.80
(m, 1H), 6.16, 6.13* (s, 1H), 6.07 (d, J = 9.7 Hz, 1H), 5.99 (dd, J = 11.6, 1.5 Hz, 1H), 4.65*, 4.57 (qd, J = 7.4,
2.0 Hz, 1H), 4.38 (tt, J = 9.7, 2.2 Hz, 1H), 3.68 (qd, J = 6.6, 2.3 Hz, 1H), 3.61 (q, J=6.4, 1H) 3.59*, 3.53 (s,
3H), 3.49, 3.41* (s, 3H), 3.28*, 3.27 (s, 3H), 2.86*, 2.84 (s, 3H), 2.71 – 2.52 (m, 3H), 2.49 – 2.12 (m, 1H),
1.85 (d, J = 7.3 Hz, 2H), 1.64 (d, J = 7.3 Hz, 1H), 1.48*, 1.49 (s, 9H), -2.08 (d, J = 66.3 Hz, 1H).(* Minor 132
epimer); MS (MALDI-TOF) m/z 720 [M+H]+, calcd. for C42H50N5O6 720.368.
β-Alanylpheoporbide a methyl ester (31):

β-Alanylpheophorbide a (tert)butyl methyl ester (65 mg, 0.090 mmol) was dissolved in 2 ml of dry CH2Cl2
in an ice bath under argon. TFA (1 ml) was added and the reaction mixture was allowed to stir for 6 h.
The reaction mixture was diluted with CH2Cl2 and washed with water and then with saturated sodium
bicarbonate. This formed a precipitate while washing with sodium bicarbonate then citric acid solution
was added until the precipitate dissolved in the organic phase. Then the solution was washed with brine
and dried over anhydrous Na2SO4 to give β-alanylpheoporbide a methyl ester (31, C38H41N5O6, 60 mg,
0.09 mmol, 100%). MS (MALDI-TOF) m/z 686 [M+H]+, calcd. for C38H41N5NaO6 686.295.
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β-Alanylaspartylpheoporbide a di(tert)butyl methyl ester (32):

β-Alanylpheoporbide a methyl ester (31, 60 mg, 0.090 mmol) was dissolved in dry DMF (5 ml). A mixture
of HOBt (18 mg, 0.135 mmol), TBTU (43 mg, 0.135) and DIEA (0.03 ml, 0.18 mmol) in DMF (3 ml) was
added and the mixture was allowed to stir for 30 min. Then a mixture of aspartic acid di(tert)butyl ester
hydrochloride (101 mg, 0.36 mmol) and DIEA (0.06 ml, 0.36 mmol) in CH 2Cl2 (3 ml) was added to the
reaction mixture. The mixture was allowed to stir for 24 h. The mixture was diluted with CH2Cl2 and then
washed with 5% aqueous citric acid, followed by with water and brine. The organic layer was dried over
anhydrous Na2SO4 and the solvent was evaporated. The residue was dissolved in 5% methanol/CH2Cl2
and purified via silica column chromatography with the same mobile phase to afford β-alanyl aspartyl
pheophorbide a di(tert)butyl methyl ester (32, C50H62N6O9, 48 mg, 0.053 mmol, 59%); UV-Vis (D M): λmax
(rel. inten.) 667 nm (0.401), 609 (0.055), 535 (0.069), 505 (0.097), 413 (1.000); 1H NMR (acetone-d6, 400
MHz) δ 9.06, 8.98* (s, 1H), 8.70, 8.59* (s, 1H), 8.69 (s, 1H), 8.2* 8.06 (t, J = 5.9 Hz, 1H), 7.70 – 7.45 (m,
2H), 6.17, 6.08* (s, 1H), 5.93 (dt, J = 17.7, 2.3 Hz, 1H), 5.85 (dd, J = 11.5, 1.4 Hz, 1H), 4.82*, 4.76 (dt, J =
8.3, 5.8 Hz, 1H), 4.64*, 4.55 (tt, J = 9.0, 4.5 Hz, 1H), 4.42*, 4.35 (dt, J = 9.7, 2.5 Hz, 1H), 3.77 (q, J = 6.5 Hz,
2H), 3.63*, 3.59 (s, 3H), 3.42, 3.31* (s, 3H), 3.14 (s, 3H), 3.05 (h, J = 6.8, 6.3 Hz, 3H), 2.78 (dd, J = 5.9, 4.7
Hz, 2H), 2.74 – 2.66 (m, 4H), 2.63 (s, 3H), 2.49 – 2.37 (m, 1H), 2.20 (td, J = 9.0, 3.3 Hz, 1H), 1.85, 1.65* (d,
J = 7.3 Hz, 3H), 1.45 (s, 9H), 1.42 (s, 9H), 1.35 (t, J = 7.5 Hz, 2H), -2.17*, -2.33 (s, 2H). ).(* Minor 132
epimer); MS (MALDI-TOF) m/z 891 [M+H]+, calcd. for C50H63N6O9 891.465.
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131-Ethylenediaminyl-152-β-alanylaspartylchlorin e6 di(tert)butyl methyl ester (33):

β-Alanylaspartylpeoporbide a di(tert)butyl methyl ester (32, 48 mg, 0.053 mmol) was dissolved in
toluene and ethylenediamine (15 mg, 0.26 mmol) was added. The reaction mixture was heated at 40 oC
for 24-36 h. It was monitored by TLC and UV-Vis spectroscopy. After reaction was complete as
monitored by TLC, the solvent was removed and the residue was dissolved in CH2Cl2 and washed with
5% aqueous citric acid to remove excess amine, followed by a wash with brine. It was dried over
anhydrous Na2SO4 and the solvent was evaporated. The residue was dissolved in 5% methanol/CH2Cl2
and chromatographed on a silica gel column with the same mobile phase. Then the methanol
percentage of the mobile phase was gradually increased up to 20% to elute the pure product from the
column. The solvent was evaporated and re-dissolved in 5% acetone/CH2Cl2 and filtered to remove silica
from the sample. After evaporation of solvent 131-ethylenediaminyl-152-β-alanyl aspartylchlorin e6
di(tert)butyl methyl ester was obtained (33, C52H70N8O9, 30 mg, 0.031 mmol, 58 %). UV-Vis (acetone):
λmax (rel. inten.) 664 nm (0.322), 607 (0.015), 528 (0.012), 500 (0.070), 400 (1.000); It was not possible to
obtain the 1H NMR spectrum and so the crude product was subjected to next step. MS (MALDI-TOF) m/z
951 [M+H]+, calcd. for C52H71N8O9 951.534.
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132-Ethylenediaminyllysinyl-152-β-alanylaspartylchlorin e6 di(tert)butyl di(boc) methyl ester:

Boc-Lys(Boc)OH.DCHA (61 mg, 0.116 mmol) was dissolved in dry DMF (5 ml). A mixture of HOBt (16 mg,
0.116 mmol), TBTU (37 mg, 0.116 mmol) and DIEA (0.024 ml, 0.14 mmol) in DMF (3 ml) was added and
the mixture was stirred for 30 min. 131-Ethylenediaminyl-152-β-alanylaspartylchlorin e6 di(tert)butyl
methyl ester (33, 30 mg, 0.031 mmol) was added to the reaction mixture and it was stirred for 72 h.
After the reaction was deemed complete by TLC, the mixture was diluted with CH2Cl2 and then washed
with 10% sodium bicarbonate, 5% aqueous citric acid, then followed by washing with brine. The organic
phase was dried over anhydrous Na2SO4 and the solvent was evaporated. The residue was dissolved in
10% MeOH/CH2Cl2 and purified via silica gel column chromatography using the same mobile phase to
afford 131-ethylenediaminyllysinyl-152-β-alanylaspartylchlorin e6 di(tert)butyl di(tert)butyl carbamates
methyl ester (C68H98N10O14, 24 mg, 0.018 mmol, 61%); UV-Vis (acetone): λmax (rel. inten.) 663 nm (0.320),
607 (0.021), 528 (0.019), 500 (0.075), 400 (1.000); 1H NMR (acetone-d6, 400 MHz) δ 9.67 (s, 1H), 9.65 (s,
1H), 9.10 (s, 1H), 8.71 (s, 1H), 8.26 (d, J = 5.5 Hz, 1H), 8.17 (dd, J = 17.8, 11.5 Hz, 1H), 7.05 (s, 2H), 6.34 (d,
J = 17.8 Hz, 1H), 6.23 (d, J = 8.0 Hz, 1H), 6.07 (d, J = 11.5 Hz, 1H), 5.95 (s, 1H), 5.56 (d, J = 18.9 Hz, 1H),
5.22 (d, J = 19.2 Hz, 1H), 4.68 (q, J = 7.1 Hz, 1H), 4.54 (d, J = 9.6 Hz, 1H), 4.29 (q, J = 3.6 Hz, 1H), 3.98 –
3.62 (m, 9H), 3.57 (s, 3H), 3.48 (s, 6H), 3.25 (s, 3H), 3.02 (d, J = 6.0 Hz, 2H), 2.56 – 2.40 (m, 2H), 2.40 –
2.26 (m, 2H), 2.26 – 2.17 (m, 1H), 1.91 (dt, J = 23.0, 8.6 Hz, 2H), 1.74 (d, J = 7.1 Hz, 3H), 1.66 (t, J = 7.2 Hz,
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3H), 1.57 – 1.44 (m, 4H), 1.37 (s, 18H), 1.34 (s, 18H), -1.65 (s, 1H), -1.94 (s, 1H); MS (MALDI-TOF) m/z
1279.775 [M+H]+, calcd. for C68H99N10O14 1279.734.
131-Ethylenediaminyllysinyl-152-β-alanylaspartylchlorin e6 methyl ester (34):

131-Ethylenediaminyllysinyl-152-β-alanylaspartylchlorin e6 di(tert)butyl di(boc) methyl ester (24 mg,
0.018 mmol) was dissolved in 2 ml of dry CH2Cl2 in an ice bath under argon. TFA (1 ml) was added and
the reaction mixture was allowed to stir overnight. The mixture was rotavaporated several times with
diethyl ether to remove TFA and the residue was washed with CH2Cl2 several times. The final product
was dissolved in water and then freeze dried to obtain 131-ethylenediaminyllysinyl-152-βalanylaspartylchlorin e6 methyl ester (34, C50H66N10O10, 14 mg, 0.014 mmol; 79%). UV-Vis (MeOH): λmax
(ε/M-1cm-1) 658 nm (18,900), 635 (67,800), 594 (14,000), 511 (10,000), 411 (150,800);

13

C NMR

(methanol-d4, 100 MHz) δ 174.29, 173.52, 173.43, 173.36, 172.48, 172.40, 172.37, 171.98, 169.48,
169.39, 169.22, 143.32, 143.11, 141.31, 141.27, 138.82, 138.71, 138.37, 138.20, 136.41, 134.92, 134.80,
134.48, 132.41, 130.82, 130.22, 130.20, 128.61, 128.35, 128.12, 125.99, 125.06, 123.04, 121.12, 118.95,
118.21, 115.29, 112.38, 109.04, 104.87, 104.84, 99.37, 96.89, 96.86, 53.87, 53.19, 51.06, 49.15, 48.72,
39.85, 39.27, 39.14, 38.98, 37.50, 36.18, 35.26, 34.82, 30.76, 30.52, 29.82, 26.79, 22.43, 21.66, 18.72,
15.78, 11.06, 10.83, 9.62..MS (MALDI-TOF) m/z 967.602 [M+H]+, calcd. for C50H67N10O10 967.50
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3.5 Supporting information
1

H NMR spectrum of 152,173-di(Asp)Ce6 (tBu)4 MME 5 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 152,173-di(Asp)Ce6 MME 6 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131,173-di(Asp)Ce6 (tBu)4 MME 12 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131-ED 152-ED(boc)Ce6 MME 28 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 131,152-ED-AspCe6 (tBu)2 (boc)2 MME in chloroform-d at 400 MHz
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1

H NMR spectrum of 131,152-ED-AspCe6 MME 30 in methanol-d4 at 400 MHz
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1

H NM spectrum of β-Ala-pheoporbide a tBu MME in acetone-d6 at 400 MHz
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1

H NM spectrum of β-Ala-Asp-pheoporbide a (tBu)2 MME 32 in acetone-d6 at 400 MHz
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1

H NMR spectrum of 132-EDLys -152-β-AlaAspCe6 (tBu)2 (boc)2 MME in acetone-d6 at 400 MHz
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13

C NMR spectrum of 152,173-di(Asp)Ce6 MME 6 in methanol-d4 at 100 MHz
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13

C NMR spectrum of 131,152-ED-AspCe6 MME 30 in methanol-d4 at 400 MHz
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13

C NMR spectrum of 132-EDLys -152-β-AlaAspCe6 MME 34 in methanol-d4 at 100 MHz
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CHAPTER 4: SYNTHESIS OF ELECTRON DEFICIENT PORPHYRINS FOR A SYNTHETIC CYTOCHROME
4.1 Introduction
A large number of enzymes contain redox centers, which comprise metal-associated
tetrapyrrolic precursors that are important for their function. These cofactors accomplish electron
transportation in biological systems. They display a wide range of reduction midpoint potentials. The
magnitude of the redox potential of cofactors needs to be tuned depending on their function. These
different values of redox potential are dictated by the oxidation state of metal ion, protein environment,
axial ligation to the metal ion and the nature of the substituents on the porphyrin ring.1-3
Cytochromes, which contain one or several heme groups in their active sites, are an important
subgroup of electron transfer proteins. They are primarily responsible for ATP production via electron
transfer processes where the heme centers serve as one-electron carriers. The iron in the cytochrome
cycles between Fe2+ (reduced) and Fe3+(oxidized). The protein environment mainly determines the redox
potential of the ion in the cytochrome and provides the direction of electron flow in the electron
transfer chain. In the past, cytochromes were classified into cytochrome a, b and c depending on their
lowest energy absorption band in the reduced state.4 But now they are labeled using the wavelength (in
nm) of an absorption band in the reduced state, for example, cytochrome c559.5 The reduced form of
cytochromes show three peaks in their UV-Vis spectra. Peaks are named α, β, and ϒ (the last of which is
also known as the Soret band) and these bands are positioned around 570 nm (α band), around 530 nm
(β band) and around 400 nm (Soret Band).
In the past few years numerous studies have reported the preparation of model systems that
mimic characteristics of the cytochromes.6-8 De novo design of such hemoproteins is now possible using
modern peptide synthesis and assembly techniques.9,10 The binding of heme to an antiparallel four-αhelix bundle (as in native cytochrome b, Figure 4.1) was investigated in detail and structural properties,7
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electronic properties10 and redox potentials11 of heme cofactors in a synthetic cytochrome were
examined experimentally and computationally by our collaborators.2

a)

b)

Figure 4.1: The side view of the artificial cytochrome-b (a) is the same as the view of the native
cytochrome-b (b). [Adapted with permission from reference 1. Copyright (2010) American Chemical
Society.]
The importance of the construction of artificial hemoproteins is to understand the relationship
between the structure and the redox chemistry, the minimal requirements for function and the
mechanism and the factors on which the electron transfer processes depend in the proteins.12 These
investigations may be useful in bioelectronic13 and biocatalytic14,15 applications by constructing artificial
proteins that are smaller, cheaper to produce, more efficient than natural counterparts, and more stable
under hostile environments compared to the natural protein.1,5
Previous studies on synthetic cytochrome-b revealed that there are significant differences in
redox potentials of hemes in synthetic cytochromes compared with natural cytochromes. As has been
reported, the redox potentials of two heme groups in synthetic cytochrome-b are -106 and -170 meV
compared to the heme in the native cytochrome-b subunit +93 meV and -34 meV.8 Even though both
artificial and native cytochromes contain the same cofactor and same axial ligation by histidine, the
native protein showed more positive values than did the synthetic protein.8 Later studies showed that
incorporation of electron donating and electron-withdrawing porphyrin substituents can alter the redox
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potential by as much as 200 mV within a single four-α-helix bundle. Then the incorporation of strong
electron-withdrawing groups resulted in a dramatic increase of the redox potential.3,11 This may be due
to decrease in donor ability of the lone pair of nitrogen in the porphyrin (equatorial ligands) upon
addition of electron withdrawing substituents to the macrocycle. This not only affects the equatorial
ligands but also changes the donor power of axial ligands through a cis-effect. Therefore, introducing
electron withdrawing substituents to a synthetic heme group will help to increase the reduction
potential of synthetic cytochromes to move the value closer to natural cytochromes redox potentials.
The main goal of this research is to synthesize a series of electron deficient porphyrins in order
to investigate the effect of their iron complexes (heme cofactors) in a synthetic cytochrome. It is
necessary to maintain the unnatural C2 symmetry of the heme group to minimize the number of isomers
that can form while binding with a synthetic four-α-helix bundle. The propionic acid side chains of heme
groups are vital in their coordination with protein as they can make salt bridges with arginine residues
the in synthetic protein.1 By considering these factors, a symmetric porphyrin 1 (Figure 4.2) was
designed which holds two strong electron-withdrawing groups at the β-position of one end, and
propionic acid chains at the other end, closely resembling the native heme group.

Figure 4.2: Comparison of porphyrin in native heme group and proposed porphyrin for a synthetic
cytochrome.
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In this research, the synthesis of a series of porphyrins, bearing electronegative nitrile groups,
nitro groups, and halogens was attempted, starting from simple building blocks. After completing the
syntheses of these electron deficient porphyrins, the magnitude of redox activity in synthetic proteins
induced by the factors of heme peripheral substitution will be investigated by our collaborators.
4.1.1 Synthesis of Porphyrins
There are numerous methods available for synthesis of porphyrins, but the most suitable route
depends on the structure of porphyrin, and most importantly the symmetry and the nature of the
substituents in the target porphyrin.16 For example, fully symmetric porphyrins can be synthesized
conveniently from polymerization of monopyrrole units (Scheme 4.1).

Scheme 4.1: Condensation of pyrrole and benzaldehyde to form TAPs
The most widely used methods for porphyrin synthesis are 1) cyclotetramerization of pyrroles;
2) condensation of two dipyrrolic intermidiates using 2+2 MacDonald cyclization; 3) the Fischer
porphyrin synthesis via dipyrromethenes; 4) condensation of tripyrrolic intermediates with a
monopyrrole unit (“3+1” methodology); and 5) cyclization of open chain tetrapyrroles such as b-bilenes
and a,c biladienes. Apart from these methods porphinoid compounds can be synthesized by
modification of readily accessible naturally occurring tetrapyrroles such as chlorophyll and heme.
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4.1.1.1 Cyclotetramerization of Monopyrroles
Cyclotetramerization of monopyrroles is the most convenient approach to prepare porphyrins
and has been used numerous times in the synthesis of simple symmetric porphyrins.17 But the usage of
this method is limited to symmetric porphyrins. β-Substituents of the pyrrole must be identical,
otherwise the approch leads to a mixture of structural isomers. This method is most commonly used in
synthesis of symmetric meso-substituted porphyrin.18 It involves the formation of porphyrinogen 4 from
the condensation between an aldehyde 3 and pyrrole 2 in the presence of a catalytic amount of acid,
and subsequent oxidation affords the desired porphyrin (Scheme 4.1). Asymmetrically meso-substituted
porphyrins can also be synthesized using mixed aldehyde condensation, but this results in a mixture of
compounds. By varying the stoichiometry of the reactants the yield of the desired product can be
maximized.
4.1.1.2 Fischer Porphyrin Synthesis via Dipyrromethenes
This 2+2 condensation method was first developed by Fisher in 1934.19 It involves the
condensation of two dipyrromethene units in an organic melt at very high temperature (Scheme 4.2).
High temperature is probably needed to convert dipyrromethene 6 in to its enamine counterpart 7
before condensation.

The major limitation of this method is that only a few substituted

dipyrromethenes are able to withstand the severe reaction conditions. In the 1960s MacDonald and
coworkers developed a method to synthesize porphyrins using dipyrromethanes under milder
conditions.20

Scheme 4.2: 2+2 Condensation of dipyrromethenes – Fischer method
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4.1.1.3 Condensation of Two Dipyrrolic Intermediates Using 2+2 MacDonald Cyclization
This is the most widely used method for the synthesis of porphyrins. But the principal limitation
to this method is the necessity to use at least one dipyrromethane which has a symmetric β substitution
pattern to avoid formation of constitutional isomers (Scheme 4.3). In situ decarboxylation of
dipyrromethane dicarboxylic acid 10 will form an α free dipyrromethane, which acts as a nucleophile in
the condensation reaction.20

ondensation of α free dipyrromethane with diformyldipyrromethane 9 is

catalyzed by acid. Then the intermediate porphodimethane 11a is oxidized by air to afford the desired
porphyrin 11b.

Scheme 4.3: 2+2 Condensation of Dipyrromethane – MacDonald Method
4.1.1.4 Condensation of Tripyrrolic Intermediates with a Monopyrrole Unit
To overcome limitations in the 2+2 cyclization, the 3+1 synthetic route was developed. This
involves condensation of an α free tripyrrole with a diformylpyrrole, followed by oxidation to obtain the
desired porphyrin (Scheme 4.4). To avoid constitutional isomers, one of the two units, tripyrrane or
diformylpyrrole should be symmetrical. Molecules such as 17 can be easily obtained using the 3+1
method, where 2+2 method condensation needs a significantly large number of steps. New
developments in the direct synthesis of tripyrranes such as compound 15 by condensation of two
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equivalents of an acetoxymethylpyrrole 12 with one equivalent of a diunsubstituted pyrrole 13 vastly
reduce the number of steps needed for synthesis of the desired pyrrole 17.21

Scheme 4.4: 3+1 Condensation of Tripyrrane with Diformylpyrrole
4.1.1.5 Cyclization of Open Chain Tetrapyrroles such as b-Bilenes and a,c-Biladienes
This strategy is very useful in the synthesis of a porphyrin which is asymmetric and has a variety
of substituents at the β positions. Linear tertrapyrroles can be cyclized using transition metals by
oxidative cyclization to obtain the desired porphyrin. The most widely used tetrapyrroles are 1,19dicarboxylic-b-bilenes (18) and 1,19-dimethy-a,c-biladienes (19, Scheme 4.5).

Scheme 4.5: Synthesis of porphyrin by cyclization of tetrapyrroles
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Condensation of 1,19-dicarboxylic-b-bilenes (18) requires orthoformate, which provides the
methylene bridge carbon. b-Bilenes 18 are in a lower oxidation state compared to a,c-biladiene 19. This
results in lower yield in the synthesis of porphyrin using b-bilene compared to a,c-biladiene. However
both these cyclizations suffer from side reactions, such as poor yields, and sometimes, lack of
reproducibility.22 Cyclization of 1,19-dimethy-a,c-biladienes (19) involves the formation of a so-called
“valley” substituted intermediate (24) and subsequent loss of a carbon function to afford the desired
porphyrin (Scheme 4.6).23,24 Cyclization usually takes place in DMF or ethanol under reflux conditions in
the presence of a copper salt. The resulting copper porphyrin is treated with strong acid to obtain the
free porphyrin. As shown in the mechanism in the first step, the fairly acidic methylene proton of the
a,c-biladiene 21 is lost to produced more conjugated bilatriene 22. Then the bilatriene 22 is oxidized to
an enamine intermediate 23, which is cyclized by attack of the enamine at the electrophilic carbon of
the terminal pyrrole ring, forms the macrocycle 24 bearing a methyl group at the α position of the
pyrrole. This will undergo oxidation to give macrocycle 25 followed by nucleophilic displacement of the
“valley” methyl group which results in the porphyrin 26.

Scheme 4.6: Mechanism of a,c biladiene oxidative cyclization
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4.2 Synthesis
4.2.1 Retrosynthetic Analysis of Porphyrin 1
In our retrosynthesis (Scheme 4.7), the first disconnections were made at meso positions of the
porphyrin in order to get symmetric dipyrromethanes 27 and 28. These dipyrromethanes can be cyclized
using the 2+2 MacDonald cyclization.20 Then these symmetric dipyrromethanes can be synthesized from
the analogous pyrroles using self-condensation. Self-condensation of β substituted pyrrole 32 will form
β substituted dipyrromethane 27. β-Substituted pyrrole 32 can be obtained from acetylpyrrole 33. The
β position of acetylpyrrole 33 can be functionalized through formation of β-free pyrrole. The Knorr
pyrrole synthesis can be used, which is widely used in the synthesis of substituted pyrroles, to obtain
acetylpyrrole 33.25 In the same way the lower lobe of the targeted molecule can be synthesized.
Dipyrromethane 28 can be synthesized by self-condensation of pyrrole 29, which can be synthesized by
the Knorr pyrrole route, namely by condensation between diketone 31 with oximinoacetate 30.

Scheme 4.7: Retrosynthesis of porphyrin 1
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4.2.2 Synthesis of the Lower Lobe 28
Synthesis of dipyrromethane 28 was previously reported and gave a good yield (Scheme 4.8).26
Treatment of benzyl acetoacetate (35) with aqueous sodium nitrite in acetic acid formed benzyl
oximinoacetate 30 which was condensed with diketone 31 in acetic acid under Johnson conditions in the
presence of Zn dust to obtain the benzyl pyrrole carboxylate 29.27 After precipitation and
recrystallization, it was possible to obtain the pure product 29 in 43% yield. Prior to condensation, the αmethyl group of the pyrrole 29 required activation. The most widely used activation methods are 1)
bromination of an α-methyl group followed by condensation;28 or 2) oxidation of an α-methyl group
with lead tetra-acetate.26 The lead tetra-acetate oxidation was followed first. The pyrrole 29 was treated
with lead tetraacetate to afford acetoxymethylpyrrole 36. The product was purified via recrystallization
in methanol. This purified product 36 was heated in methanol under acidic conditions to form the
desired dipyrromethane 28, which was characterized by 1H NMR and mass spectroscopy.

Scheme 4.8: Synthesis of benzyl dipyrromethane 28
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4.2.3 Synthesis of the Upper Lobe 27
The other precursor pyrrole 33 for the synthesis of the β-substituted dipyrromethane 27 was
prepared using the same Johnson conditions (Scheme 4.9).27,29 Oximinoacetate 30 was synthesized from
the reaction between benzyl acetoacetate (35) with sodium nitrite in acetic acid and then condensed
with pentanedione 34 in the presence of Zn dust to obtain acetylpyrrole carboxylate 33.

Scheme 4.9: Synthesis of acetylpyrrole 33
The next step was to oxidize the α-methyl group of the acetylpyrrole 33 in order to facilitate the selfcondensation to obtain the desired dipyrromethane 39. But the oxidation of acetylpyrrole 33 with lead
tetra-acetate failed. Only the starting material was recovered after 20 hours. Different reaction
conditions were employed but it was impossible to obtain the desired product 37. Then it was decided
to try the α-bromination route in order to obtain α-bromomethylpyrrole 38, which can be selfcondensed to give the dipyrromethane 39. After the bromination, the crude product was subjected to
the self-condensation reaction. But again it was not possible to obtain the desired dipyrromethane 39.
The mass spectrum of the crude material, obtained after the bromination step, showed a peak for
mono-brominated compound. But bromination could in theory happen on either the α-methyl group on
the pyrrole or at the α-methyl group on acetyl group. Purification of brominated product was
unsuccessful due to its low yield (Scheme 4.10).
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Scheme 4.10: Attempted synthesis of acetyldipyrromethane 39
It was then decided to replace the acetyl group with a formyl group to eliminate the competition
in the bromination step (Scheme 4.11). To obtain formylpyrrole 33, first it was required to synthesize
the β-free pyrrole 40. In the literature a versatile high yielding method for deacylation of pyrrole is
reported.30 The authors were able to deacylate pyrroles with ethylene glycol and p-toluenesulfonic acid
under reflux in benzene. When this procedure was followed a 95% yield of β-free pyrrole 40 was
obtained. Reaction progress was monitored through TLC. After completion of the reaction, solvent was
removed to obtain the pure crystalline product. 1H NMR and mass spectroscopy confirmed the identity
of the product 40.

Scheme 4.11: Deacylation of the acetylpyrrole 33
As the authors discussed in the paper, the mechanism involves initial ketal formation (41) in a
classical carbonyl protection reaction (Scheme 4.12). Then electrophilic substitution (protonation) at the
ketal substituted carbon followed by elimination of the bulky protected acetyl group will help to regain
the aromaticity of pyrrole 42.
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Scheme 4.12: Mechanism of deacylation
The next step required formylation of the free β-position of pyrrole 40. Formylation can be
accomplished either using triethyl orthoformate31 or under Vilsmeier-Haack conditions.32 Triethyl
orthoformate worked best in the formylation of this pyrrole. β-Free pyrrole 40 was treated with a slight
excess of triethyl orthoformate in TFA to obtain formylpyrrole 41 in 70% yield (Scheme 4.13). A very
short silica gel column was used to purify the product, which was characterized by 1H NMR and mass
spectrometry. Some difficulty was encountered in the formylation under Vilsmeier-Haack conditions,
and the yield was always lower than the yield of the triethyl orthoformate reaction.

Scheme 4.13: Formylation of β-free pyrrole 40
Self-condensation of formylpyrrole 41 was attempted by initial bromination followed by
condensation in methanol under acidic conditions (Scheme 4.14). After two hours of reflux a white color
precipitate was formed in the reaction mixture. This precipitate refused to dissolve in common solvents
tested. It seems under reflux, the pyrrole 41 tends to polymerize to give this white precipitate. Oxidation
of the α-methyl group of formylpyrrole 41 with lead tetra-acetate (LTA) was also unsuccessful, as with
its acetyl precursor 43.
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Scheme 4.14: Attempted synthesis of formyldipyrromethane 42
Then it was decided to perform chlorination of the α-methyl group instead of bromination in
order to prevent the polymerization during the condensation reaction. Formylpyrrole 41 was treated
with sulfuryl chloride to obtain the chloromethylpyrrole 44. Mass spectrometry showed a peak for mono
chlorinated product but purification was unsuccessful. Then the crude product was used for the
condensation reaction in methanol. But again it was not possible to obtain the desired dipyrromethane
42. Our next approach was to convert chloromethylpyrrole 44 to acetoxymethylpyrrole 45 using a SN2
type

reaction.

Previous

literature

has

reported

conversion

of

chloromethylpyrrole

into

acetoxymethylpyrrole using sodium acetate.33 But with acetylpyrrole 44 only a trace amount of product
45 was isolated. The yield of this reaction was very low and it was not possible to prepare enough
material for the next condensation reaction (Scheme 4.15).

Scheme 4.15: Atempted synthesis of acetyldipyyromethane 42 by chlorination
Both acetyl and formyl groups can significantly lower the electron density in the pyrrole by
removing electrons from the system by resonance. Lower electron density in the pyrrole makes it
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unreactive towards electrophilic substitution reactions. To overcome electron deficiency in the pyrrole,
the next approach employed was to synthesize β-free dipyrromethane 46 and then functionalize it with
electron withdrawing substituents (Scheme 4.16). Removal of formyl and acetyl substituents from the
pyrrole can increase the electron density in the pyrrole. Hence, it will increase the reactivity of α-methyl
group of the pyrrole 40.

Scheme 4.16: Retrosynthesis of dipyrromethane 47
The synthesis was started with the previously synthesized β-free pyrrole 40. The first attempt to
synthesize acetoxymethylpyrrole with lead tetraacetate failed to achieve the desired product (Scheme
4.17). 1H NMR and mass spectrometry showed the addition of an extra acetoxymethyl group to the
product. Absence of the peak for β-hydrogen confirmed the additional substitution of hydrogen with an
acetoxy group had taken place at β-position. Excess lead tetraacetate was reacted with both β-position
and α-methyl group of pyrrole 40. It was not possible to obtain the desired dipyrromethane 47 even by
changing the number of equivalents of LTA or by changing the reaction conditions. Then it was decided
to do the condensation reaction with acetoxypyrrole 48 to obtain dipyrromethane 49, which can be
converted into the desired dipyrromethane. But this acetoxypyrrole 48 was easily polymerized in
methanol under acidic conditions. Bromination followed by condensation of pyrrole 40 also provided no
success. As expected, bromination leads to di-brominated pyrrole 50. The crude mixture was refluxed in
methanol under acidic conditions to obtain di-bromodipyrromethane 51, but only polymerized product
was observed.
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Scheme 4.17: Attempted self-condensation of β free pyrrole 40
It was not possible to synthesize the starting material for the MacDonald cyclization. The
retrosynthesis (Scheme 4.7) involved synthesis of two symmetric dipyrromethanes followed by a 2+2
MacDonald tetramerization to give the macrocycle 1. Synthesis of dipyrromethane 28 has previously
been reported and gave a good yield (Scheme 4.8). However using various synthetic paths, synthesis of
the upper lobe of the molecule 27 that bears either electron-withdrawing groups or hydrogens at the βpositions failed. The electron-withdrawing groups at the β-positions of pyrrole 32 significantly reduced
the reactivity of the α-methyl group. For the condensation of two pyrroles, one needs an activated
acetoxymethylpyrrole or bromomethylpyrrole.27 But in the presence of an electron-withdrawing group
at the β-position, it was not possible to synthesize the desired acetoxymethylpyrole 37 or
bromomethylpyrrole 38 from acetylpyrrole 33 or from formylpyrrole 41. Another possible route, selfcondensation of β-free pyrrole 40, provided a polymerized product rather than the desired
dipyrromethane 46. This led to the design of a different retrosynthetic path.
4.2.4 Revised Retrosynthesis
The designed alternate strategy is shown in Scheme 4.18; it involves an a,c-biladiene 53
synthesis, followed by cyclization to construct the β-free porphyrin 52. Functionalization of the βpositions of porphyrin 52 will be done to get the target molecules 1. a,c-Biladiene 53 can be synthesized
from two different starting materials. Either reacting the dipyrromethane dicarboxylate 54a with
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formylpyrrole 55a or the diformyldipyrromethane 54b can be react with pyrrole carboxylate 55b to
obtain a,c-biladiene 53. Both formylpyrrole 55a and pyrrole carboxylic acid 55b can be synthesized from
previously synthesized benzyl pyrrole carboxylate 40. Likewise diformyldipyrromethane 54b and
dipyrromethane dicarboxylic acid 54a can be synthesized from benzyl dipyrromethane dicarboxylate 28
which was already synthesized in good yield.

Scheme 4.18: Revised retrosynthesis of porphyrin 1
4.2.5 Synthesis of a,c Biladiene
As was mentioned earlier, a,c biladienes 53 can be synthesized using two different starting
materials. The best overall yield is obtained by reaction between a formylpyrrole 55a and a
dipyrromethane di-carboxylic acid 54a. As shown in Scheme 4.19, first pyrrole carboxylic acid 57 was
obtained from benzyl deprotection of benzyl pyrrole 40. Then formypyrrole 59 was obtained by
decarboxylation followed by formylation of pyrrole 57. Pyrrole carboxylate 57 was stirred in TFA in an
ice bath to accomplish the decarboxylation and then treated with excess triethyl orthoformate to
selectively formylate the α-position of the α,β-unsubstituted pyrrole 58. Pyrrole undergoes electrophilic
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aromatic substitution predominantly at the α-positions. Once formylated at the α-position, this will
prevent the addition of a second formyl group to the β-position by deactivating the pyrrole ring through
resonance. The desired formylpyrrole 59 was purified via a short silica gel column and characterized by
1

H NMR and mass spectrometry.

Scheme 4.19: Synthesis of β-free formylpyrrole 59
Dipyrromethane dicarboxylic acid 60 was synthesized by benzyl deprotection of the previously
synthesized dipyrromethane 28. After de-benzylation by hydrogenolysis, the first attempt at formylation
with triethyl orthoformate was unsuccessful, but formylation using the modified Vilsmeier-Haack
procedure gave the diformyldipyrromethane 61 in a relatively good yield (Scheme 4.20). The modified
Vilsmeier-Haack reaction uses benzoyl chloride (63) and dimethylformamide (62), which forms the
reactive chloromethyleneiminium 64 salt that will react at the α-position of pyrrole by electrophilic
substitution followed by hydrolysis of the imine to produce the formyl group.

Scheme 4.20: Formylation of dipyrrolmethane using modified Vilsmeier-Haack reaction
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Condensation of formylpyrrole 59 with dipyrromethane dicarboxylic acid 60 in trifluoroacetic
acid afforded the corresponding a,c-biladiene salt 53 (Scheme 3.21). This involves in situ generation of
α-free dipyrromethane by decarboxylation of the dipyrromethane dicarboxylic acid 60 in TFA. Then the
a,c-biladiene was converted into the hydrochloride salt by bubbling HCl gas through the reaction
mixture and there was a noticeable color change from orange to dark red. The reaction was monitored
by UV-Vis throughout (Figure 4.3). Once the reaction was complete, the absorption spectrum showed
two characteristic absorption bands at around 440 and 507 nm as shown in Figure 4.3. a,c-Biladiene 53
was purified via precipitation, i.e. adding petroleum ether into a concentrated solution of a,c-biladiene
53 in MeOH, and Figure 4.4 shows its proton NMR spectrum in CDCl3. As an alternate method,
condensation of diformyldipyrromethane 54b with pyrrole carboxylic acid 55b was carried out but the
overall yield was always lower than the previous method.

Scheme 4.21: Syntheis of a,c-biladiene
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Figure 4.3: UV-Vis spectroscopic progression of the a,c-biladiene synthesis in CH2Cl2 and UV-Vis
spectrum of pure a,c biladiene dihydrochloride 53 (pink) in CH2Cl2.

Figure 4.4: 1H NMR spectrum of a,c-biladiene dihydrochloride 53 in CDCl3
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4.2.6 Synthesis of β-Free Porphyrin 52
The literature reports two main methods for cyclization of a,c-biladiene salts to give the
corresponding porphyrin. 1) Metal catalyzed oxidative cyclization;23 and 2) electrochemical cyclization.34
Various metals [Cu(II), Cr(III), Ru(III) and Rh(III)] have been used in the metal catalyzed oxidative
cyclizations.35 According to the literature, the cyclization of a,c-biladiene salts catalyzed by copper ions
has proved to be one of the most successful syntheses of porphyrins.35 The reactions were generally
carried out in DMF and the resulting products are the corresponding copper porphyrinates. If acid-labile
substituents are present on the macrocycles, the removal of the metal ion can be quite difficult, as it
requires a strong acid to remove copper from the copper porphyrinates; also, unpredictable yields of
porphyrins have sometimes been reported. Cyclization using Cr(III), Ru(III) and Rh(III) provide the
porphyrin free base and eliminate the harsh acidic conditions necessary for removal of copper. But the
cyclization yields were significantly lower than those using the copper mediated oxidative cyclization. 35
After considering all these facts it was decided to use Cu(II) for the oxidative cyclization step.
Oxidative cyclization of a,c biladiene dihydrochloride 53 was carried out in DMF using Cu(OAc)2
and the reaction was monitored by UV-Vis spectroscopy (Scheme 4.22). The reaction mixture was
heated at 100 oC until reaction was completed as indicated by UV-Vis spectrometry. Once reaction was
completed, the UV-Vis spectrum showed the Soret band (400 nm) that is characteristic of porphyrins
(Figure 4.5). After workup, the crude product was taken to the next step. Crude copper porphyrin 65
was demetalated in the presence of ice cold H2SO4/ TFA for six hours. The final product was purified
using a silica gel column and the porphyrin was characterized by X-ray crystallography (Figure 4.6), 1H
NMR (Figure 4.7) and mass spectrometry. Unfortunately, the yield of these two steps was highly variable
as reported in the literature and the maximum yield obtained was 13%.
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Scheme 4.22: Synthesis of β-free porphyrin 52 by oxidative cyclization of a,c-biladiene 53.

Figure 4.5: UV-Vis spectrum of β-free porphyrin 52 in CH2Cl2

Figure 4.6: X-ray crystal structure of β-free porphyrin 52
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Figure 4.7: 1H NMR spectrum of β-free porphyrin 52 in CDCl3
As proposed in the revised retrosynthesis, the last step is to functionalize the β-position of the
porphyrin 52. The plan is to functionalize it with electron withdrawing groups such as nitriles, halides,
formyl and nitro groups. As shown in Scheme 4.23, several reactions to introduce electron-withdrawing
substituents to the porphyrin 52 were attempted. Formylation with triethyl orthoformate, the Vilsmeier
complex, or with the modified Vilsmeier-Haack reaction were unsuccessful and the starting material was
recovered. Nitration of the β-position using PPh3/Br2/AgNO3, as reported in the literature,36 was also
attempted. But it was not possible to obtain the desired product 67. Bromination was unsuccessful with
Br2 in ether but the peak for the desired di-bromoporphyrin 68 was visible in the mass spectrum when
NBS was used for bromination. However, the amount of product was not sufficient to characterize by 1H
NMR.
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Scheme 4.23: Attempted β functionalization of β free porphyrin 52
As can be seen from the literature, under acidic conditions the basic inner nitrogens of
porphyrins can be easily protonated, and this deactivates the ring towards electrophilic substitution
reactions. Therefore, formylation of free base porphyrins is not possible under acidic conditions. But
protonation of the inner nitrogens can be prevented by inserting a metal ion into the porphyrin core.
The best choice is to use copper complex porphyrin 65 as it forms during the synthesis as an
intermediate. Then formylation of copper porphyrin 65 was done under Vilsmeier conditions (Scheme
4.24). Mass spectrometry confirmed the formation of monoformylated product. But increasing the
reaction time, temperature or number of equivalents of Vilsmeier complex did not show any sign of
formation of the diformyl derivative 69. Reaction with triethyl orthoformate was also unsuccessful in
giving the diformyl derivative 69.

Scheme 4.24: Attempted diformylation of copper porphyrin 69
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To test each one of these functionalization reactions, the cyclization of a,c-biladiene 53 was the
starting point. The yield of the cyclization step of a,c biladiene 53 was very low and highly variable. Also,
selective functionalization of the β-position of the meso unsubstituted porphyrin is extremely
challenging due to high reactivity of the meso positions compared to the β-positions. However, the
functionalization of β-positions of porphyrin may require preparation of β-activated porphyrins over
meso position prior to functionalization. This led to the conclusion that addition of electron withdrawing
groups to the β-free pyrrole 40 should be done before the cyclization step. The next approach therefore
was to synthesize a pyrrole 71 bearing an electron-withdrawing group such as nitrile and halides at the
β-position. This can be synthesized from the previously synthesized β-free pyrrole 40. Then a,c biladiene
synthesis followed by oxidative cyclization should result in the final product 1 (Scheme 4.25).

Scheme 4.25: New approach to synthesize porphyrin 1 from electron deficient pyrrole 71
4.2.7 Synthesis of Electron Deficient Pyrrole
Synthesis was started from formylpyrrole 41, which was synthesized by deacylation of
acetylpyrrole 33 followed by formylation with triethyl orthoformate. The next step was to convert the
formyl group into a nitrile group. Recently, Veisi reported an efficient procedure for the one-pot
conversion of various alcohols, aldehydes and primary amines into the corresponding nitriles in
excellent yields using trichloroisocyanuric acid (TCCA) and aqueous ammonia.37 But this oxidative
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conversion was unsuccessful in conversion of formylpyrrole 41 to its nitrile counterpart 72 (Scheme
4.26).

Scheme 4.26: Attempted synthesis of 3-cyanopyrrole 72
The next approach was to convert the formyl group into an oxime followed by dehydration to
give the desired cyanopyrrole 72. Before that, models studies were performed using ethyl formylpyrrole
carboxylate 73 which was readily available in the laboratory (Scheme 4.27). Formylpyrrole 73 was
reacted with hydroxylamine hydrochloride to afford aldoxime 74 in high yield.38 For the dehydration of
aldoxime 74, first a traditional dehydrating agent chlorosulfonic acid was used.39 After dehydration, the
product was purified via a silica gel column to afford 31% yield, along with large number of by products
(in the TLC).

Scheme 4.27: Conversion of formylpyrrole 73 to cyanopyrrole 75
Previous literature has reported a two-step method to convert a variety of ketones and
aldehydes into amide and nitriles, respectively, under mild conditions.40 In this method, the first step
involves formation of the corresponding oxime and then a rearrangement to nitrile using cyanuric
chloride (trichlorotriazine, TCT) in DMF. As shown in Scheme 4.28, TCT and DMF forms a VilsmeierHaack type active complex 76 and then the hydroxyl group of the oxime 77 will add to the complex in a
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type of Mannich addition. A subsequent Beckman rearrangement to the intermediate 78 will afford the
final product; cyanopyrrole 75. The TCT/DMF complex was prepared by dissolving one equivalent of TCT
in DMF at room temperature. During the reaction the complex precipitated as a white solid. After
confirming complete disappearance of free TCT by TLC, one equivalent of aldoxime 77 in DMF was
added and the reaction was monitored by TLC. After completion of the reaction, the product was
purified via column chromatography. It was possible to isolate the desired cyanopyrrole 75 in 78% yield
and X-ray crystallograpy (Figure 4.7), 1H NMR, and mass spectrometry confirmed the identity of the
product 75.

Scheme 4.28: Mechanism of dehydration by TCT

Figure 4.7: X-ray crystal structure of cyanopyrrole 75
As the targeted conversion of formyl to nitrile in good yield by using model compound 73 had
been achieved, the same conversion was carried out with benzyl formylpyrrole carboxylate 41. The
formyl group of the benzyl pyrrole 41 was transformed into nitrile by oximation followed by dehydration
with TCT in good yield. Next it was necessary to formylate the cyanopyrrole 73 in order to do the
condensation with a dipyrromethane dicarboxilic acid 60. Hydrogenolysis of cyanopyrrole 73 afforded
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pyrrole carboxylic acid 81 in quantitative yield. Formylation was attempted with triethyl orthoformate in
TFA but it was not possible to obtain the formypyrrole 82. Formylation with the Vilsmeier complex also
provided no success (Scheme 4.29).

Scheme 4.29: Synthesis of 3-cyano-1-formylpyrrole 82
The next approach was to synthesize α-free β-cyanopyrrole 86 which can condense with
diformyldipyrromethane 61 directly. β-Formylpyrrole 84 has been synthesized from ethyl formylpyrrole
carboxylate 73 by ester hydrolysis under basic conditions followed decarboxylation. Then it was
converted into the corresponding oxime 85 in good yield, but dehydration to nitrile 86 was unsuccessful
(Scheme 4.30).

Scheme 4.30: Attempted synthesis cyanopyrrole 86
As the synthesis of both formylpyrrole 82 and α-free cyanopyrrole 86 were unsuccessful, it was
decided to condense pyrrole carboxylic acid 81 with diformyldipyrromethane 61 to obtain the a,cbiladiene 87 (Scheme 4.31). The reaction was monitored by UV-Vis spectroscopy over three hours,
which showed no a,c-biladiene absorption peak. After treatment with HCl gas, petroleum ether was
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added. If a,c-biladiene salt was present it should precipitate in the medium, but no precipitate was
obtained. Thus, the electron withdrawing ability of the cyano group may reduce the nucleophilicity at
the α-carbon of the pyrrole. That is most likely the reason for the failure of both formylation and
condensation reactions.

Scheme 4.31: Attempted synthesis of a,c biladiene 87 from cyanopyrrole 81
Then it was decided to introduce a less electron withdrawing substituent at the β-position to
determine its effect on the formylation. Iodo was selected as an ideal substituent as it can be used for
further coupling reactions to introduce various substituents at the β-position. Iodination of pyrrole 40
was archived by direct action of I2 in aqueous KI, which maintains a low concentration of free I2 in the
reaction medium by equilibration with triiodide ion ( I3- ). Sodium bicarbonate was used to neutralize the
starting material and prevent the formation of HI. Iodopyrrole 88 was afforded in high yield and was
characterized by 1H NMR and mass spectrometry (Scheme 4.32). Unfortunately, debenzylation of
iodobenzene 88 afforded a polymerized product.

Scheme 4.32: Attempted synthesis of iodopyrrole 89
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The next approach was to reduce the carboxylic acid group of the cyanopyrrole 81 to a formyl
group because its α-carbon no longer acts as a nucleophile in the condensation reaction. The resulting
formylpyrrole 82 can potentially be condensed with dipyrromethane dicarboxylic acid 60 to obtain a,cbiladiene 87. The main challenge is to reduce the carboxyl without reducing the nitrile group. Strong
reducing agents such as lithium aluminum hydride will reduce both functional groups. With this in mind
a mild and selective reducing agent to convert carboxyl group to formyl in good yield without
occurrence of overreduction was sought. Burns and coworkers reported a mild and selective method to
reduce carboxyl group to formyl in the presence of an electron withdrawing β-acetyl functional group.41
The reaction involves formation of an acid chloride in the presence of oxalyl chloride and a catalytic
amount of trimethylphosphine followed by reduction of the acid chloride to aldehyde with sodium
triacetoxyborohydride and trimethylphosphine (Scheme 4.33). Cyanopyrrole 81 was dissolved in CH2Cl2
as it refused to dissolve in benzene, and was then added to the freshly distilled oxalyl chloride in CH2Cl2
and a few drops of trimethylphosphine were added. After one day the temperature was lowered to 0 oC
and 1.2 equivalents of sodium triacetoxyborohyride were added and the mixture was stirred for another
one day. Mass spectrometry showed the peak for the desired formylpyrrole 82. Crude 1H NMR
spectroscopy confirmed the formation of the aldehyde. However the yield of purified product was less
than satisfactory. Unfortunately, the use of other solvents such as THF, CH3CN and CH2Cl2/THF or
different phosphine reagents, such as tributylphosphine, did not improve the yield.

Scheme 4.33: Reduction of cyanopyrrole carboxylic acid 81 to formylpyrrole 82
As was mentioned earlier, iodination followed by formylation of pyrrole was unsuccessful.
Attention then focused on doing the iodination on formylpyrrole 59. It was possible to obtain
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iodopyrrole 89 from β-free formylpyrrole 59 in good yield using N-iodosuccinimide in carbon
tetrachloride (Scheme 4.34). Then the condensation of iodopyrrole 89 with dipyrromethane dicarboxylic
acid was performed to afford a,c-biladiene 91. Mass spectroscopy confirmed the formation of a,cbiladiene 91. Oxidative cyclization with copper acetate followed by demetalation with sulfuric acid
afforded the desired iodoporphyrin 92 in only trace amount. The compound was characterized by highresolution mass spectrometry.

Scheme 4.34: Attempted cyclization of 2,18-diiodo-a,c-biladiene 91
4.2.8 Synthesis of Electron Rich Pyrrole
Since the difficulty encountered in the decarboxylation and formylation was probably due to
electron-withdrawing β-substituents, the same reaction sequence was attempted with a pyrrole bearing
a neutral or electron donating substituents at the β-position which can later be converted into electron
withdrawing substituents. As shown in Scheme 4.35, after cyclization of a,c-biladiene 94, hydroxymethyl
substituents can be converted into nitriles in one step.37 a,c-Biladiene 94 will be synthesized from
pyrrole carboxylic acid 95, condensed with diformyldipyrromethane 61. Hydroxymethylpyrrole
carboxylic acid 95 can be synthesized from reduction of formylpyrrole 83.
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Scheme 4.35: Retrosynthesis of porphyrin 93
Hydroxymethylpyrrole 96 was synthesized in high yield, by reduction of formylpyrrole 73 using
lithium borohydride (Scheme 4.36). The product was purified via silica gel column chromatography and
characterized by 1H NMR and mass spectrometry. Pyrrole carbocyclic acid 95 was obtained by
hydrogenolysis of hydroxymethylpyrrole 96 in quantitative yield. Then crude carboxylic acid 95 was
dissolved in TFA in an ice bath. Within a few minutes the reaction mixture turned red in color before
addition of diformyldipyrromethane 61. It seems in the presence of an acid that the hydroxyl group can
protonate and leave as a water molecule to afford a methylene pyrrole intermediate, which is no longer
a nucleophile in the condensation reaction. As an alternate method, decarboxylation was attempted
with a catalytic amount of p-TSA but the final result was the same. Next it was attempted to dissolve
both pyrrole carboxylic acid 95 and diformyldipyrromethane 61 in CH2Cl2/methanol and p-TSA in
methanol was added dropwise into the reaction mixture. By doing that, it was thought that the
decarboxylated pyrroles will readily react with diformyldipyrromethane 61 to afford a,c-biladiene 94
before dehydration. After thirty minutes there were no a,c-biladiene absorption peaks in the UV-Vis
spectrum.

Scheme 4.36: Attempted synthesis of β-hyroxymethylpyrrole 97
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It was also a struggle to make dipyrromethane using hydroxymethylpyrrole 96. Activation of the
α-methyl group of pyrrole 96 with lead tetraacetate formed an unexpected product 98 (Scheme 4.37).
After purification 1H NMR showed addition of two extra methyls to the pyrrole 96. The molecular weight
of this compound was equal to addition of two acetate groups to pyrrole 96. This product 98 was selfcondensed to afford dipyrromethane 99 but the product could not be characterized.

Scheme 4.37: Attempted synthesis of dipyrromethane 99

4.3 Future work
Recent literature has reported a total synthesis of protoporphyrin IX using a new alternate
method to the well-known MacDonald condensation (Scheme 4.38).42 The key step is the condensation
of diiododipyrromethane 100 with known diformyldipyrromethane 61 to obtain the desired porphyrin
101 in a single step in 76% yield. In the classical MacDonald condensation, diformyldipyrromethane
reacts with α-free dipyrromethane to give dihydroporphyrin as the product. Then it needs to oxidize to
get the desired porphyrin using either air43 or DDQ.44

Scheme 4.38: Reported synthesis of protoporphyrin IX
Our previous attempts to synthesize benzyl 5-acetoxymethyl-4-acetyl-3-methylpyrrole
carboxylate (37) were unsuccessful as mentioned earlier. But the authors reported a new one pot
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synthetic procedure to obtain molecule 37 in 45% yield from benzyl 4-acetyl-3,5-dimethylpyrrole
carboxylate (33, Scheme 4.39).

Scheme 4.39: Reported synthesis of acetoxymethylpyrrole 37
The new approach is to synthesize diiododipyrromethane 106 starting from formylpyrrole 33
(Scheme 4.39). First formylpyrrole 33 will be acetoxylated using the new synthetic procedure. Reaction
between pyrrole 33 and sulfuryl chloride will form the chloromethylpyrrole intermediate that will
readily react with acetate to form the desired acetoxymethylpyrrole 37. Self-condensation of
acetoxypyrrole 37 will lead to the desired dipyrromethane 42. But the formyl group at the β-position
may diminish the nucleophilicity of the α-carbon of the pyrrole by resonance. As alternate route,
deformylation of acetoxymethylpyrrole 37 can be achieved prior to the self-condensation reaction. That
will help to keep the α-carbon more nucleophilic in the condensation reaction. After the selfcondensation, formyl groups can be reinserted using formylation with triethyl orthoformate. As
mentioned earlier, formyl groups can be easily converted into nitriles using oximation followed
dehydration, to obtain dipyrromethane 104.

Scheme 4.40: Proposed synthesis of dicyanodipyrromethane 104
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Removal of benzyl protection via hydrogenolysis with Pd/C will form the diacid 105 which can be
converted into the desired diiododypyrromethane 106 using decarboxylation followed by iodination.
With the previously synthesized diformyldipyrromethane 61 and diiododiyromethane 106 in hand, the
condensation will be carried out in a mixture of acetic anhydride and trifluoromethyl sulfonic acid in
acetic acid under anhydrous conditions to obtain the desired porphyrin 1 (Scheme 4.41). But there is a
possibility for hydrolysis of nitrile group in the condensation step with strong acids.45 As an alternate
route, condensation can be done with diformyldipyrromethane to obtain diformylporphyrin which can
be converted into the desired product.

Scheme 4.41: Proposed synthesis of porphyrin 1

4.4 Experimental
Benzyl 4-(2-methoxycarbonylethyl)-3,5-dimethylpyrrole (29):

Benzyl acetoacetate (35, 33.5 g, 171 mmol) was dissolved in acetic acid (40 ml) and placed in an ice bath.
Then it was treated with solution of sodium nitrite (13 g, 188 mmol) in water and the temperature was
controlled around 10 oC throughout. Then the reaction mixture was stirred for another 3 h and stored in
a refrigerator overnight to complete the formation of benzyl oximinoacetate 30. This solution was added
to the solution of methyl 4-acetyl-5-oxohexanoate (31, 19 g, 102 mmol) in acetic acid (65 ml) during 2 h
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at 65 oC. Simultaneously, an intimate mixture of zinc dust (19 g, 287 mmol) and sodium acetate (19g,
231 mmol) was added while keeping zinc dust always excess in the reaction mixture. The resulting
mixture was stirred for 1 h at 65 oC. Then it was poured into chilled water (1.5 L) while stirring. The
resulting precipitate was filtered off and dissolved in CH2Cl2 and washed with water and brine. It was
dried over anhydrous Na2SO4 and the solvent was removed. Crude product was recrystallized from a
methanol/water mixture to afford

benzyl 4-(2-methoxycarbonylethyl)-3,5-dimethylpyrrole (29,

C18H21NO4, 14g, 44 mmol, 43%); m.p. 98-102 oC, Lit m.p. 99-101 oC.46 1H NMR (chloroform-d, 400 MHz): δ
8.56 (s, 1H), 7.53-7.23 (m, 5H), 5.29 (s, 2H), 3.66 (s, 3H), 2.71 (t, J = 8.6, 7.0 Hz, 2H), 2.43 (t, J = 8.7, 6.8
Hz, 2H), 2.29 (s, 3H), 2.21 (s, 3H). MS (ESI) m/z 136.15 [M+H]+, calcd. for C18H22NO4 136.14.
Benzyl 5-acetoxymethyl-4-(2-methoxycarbonylethyl)-3-methylpyrrole-2-carboxylate (36):

benzyl 4-(2-methoxycarbonylethyl)-3,5-dimethylpyrrole (29, 5.0 g, 15 mmol) was dissolved in acetic acid
(50 ml) and acetic anhydride (1.5 ml, 15 mmol) was added. Then lead tetraacetate (7.5 g, 17 mmol) was
added in small portions over a period of 1.5 h to the reaction mixture. It was stirred overnight at room
temperature under argon and the resulting solution was added dropwise to chilled water (200 ml) while
continuous stirring. The resulting precipitate was filtered off and dissolved in CH2Cl2 and washed with
water and brine. It was then dried over anhydrous Na2SO4 and the solvent was removed. The crude
product recrystallized from CH2Cl2/hexane mixture to afford benzyl 5-acetoxymethyl-4-(2methoxycarbonylethyl)-3-methylpyrrole-2-carboxylate (36, C20H23NO6, 5.5g, 14.7 mmol, 98%); m.p. 106109 oC, Lit m.p. 109.5-110.46 1H NMR (chloroform-d, 400 MHz): δ 9.05 (br. s, 1H), 7.51-7.29 (m, 3H), 5.31
(s, 2H), 5.06 (s, 2H), 3.67 (s, 3H), 2.79 (t, J = 7.7 Hz, 2H), 2.47 (t, J = 7.6 Hz, 2H), 2.29 (s, 3H), 2.07 (s, 3H).
MS (ESI) m/z 374.1603 [M+H]+, calcd. for C20H24NO6 374.1604.
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Dibenzyl 3,3'-di(2-methoxycarbonylethyl)-4,4'-dimethylpyrromethane-5,5'-dicarboxylate (28):

Method a
Benzyl 5-acetoxymethyl-4-(2-methoxycarbonylethyl)-3-methylpyrrole-2-carboxylate (36, 5.5 g, 14.7
mmol) was dissolved in methanol (30 ml) and HCl (2 ml). The reaction mixture was heated at 70 oC for 4
h or until a precipitate formed. Then the mixture was stirred at room temperature and placed in an ice
bath to complete the precipitation of the product. The titled product 28 was collected by filtration
(C35H38N2O8, 3.8 g, 6.2 mmol, 42%).
Method b
Benzyl 4-(2-methoxycarbonylethyl)-3,5-dimethylpyrrole (29, 5.2 g, 16.5 mmol) was dissolved in diethyl
ether (200 ml) by heating the mixture at 40 oC. Then bromine (1.1 ml, 21.4 mmol) was added dropwise
and the mixture was stirred for 1.5 h at room temperature. Then the solvent was evaporated and a pink
solid residue was dissolved in methanol (35 ml). Then concentrated hydrochloric acid (0.2 ml) was added
and the mixture was refluxed for 9 to 11 h. While cooling down to room temperature, the product
precipitated. The precipitated product was isolated by filtration and washed with cold methanol. Then it
was recrystallized from hot methanol to give the titled product 28 (C35H38N2O8, 3.17g, 5.2 mmol, 31%);
m.p. 103 oC, Lit m.p. 102-103 oC.47 1H NMR (chloroform-d, 400 MHz): δ 9.06 (s, 2H), 7.44-7.23 (m, 10H),
5.26 (s, 4H), 3.97 (s, 2H), 3.57 (s, 6H), 2.76 (t, J = 7.0 Hz, 4H), 2.52 (t, J = 7.0 Hz, 4H), 2.29 (s, 6H). MS (ESI)
m/z 615.6908 [M+H]+, calcd. for C35H39N2O8 615.6928.
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3,3'-Di(2-methoxycarbonylethyl)-4,4'-dimethylpyrromethane-5,5'-dicarboxylate (60):

Dibenzyl 3,3'-di(2-methoxycarbonylethyl)-4,4'-dimethylpyrromethane-5,5'-dicarboxylate (28, 2.5 g, 4.1
mmol) was dissolved in dry THF (20 ml) and degassed with argon for 10 min. Then 10% Pd/C (500 mg)
and 1-2 drops of TEA were added and the flask was sealed. Then the flask was evacuated of air by using
a syringe and filled with hydrogen gas using a hydrogen gas filled balloon. The reaction mixture was
stirred for 12 h. After completion of reaction (monitored by TLC), the solvent was evaporated and the
residue was dissolved in 2 M ammonium hydroxide and filtered through a Celite cake to remove the
catalyst. 2 M acetic acid solution was added dropwise to the filtrate while stirring until a precipitate was
fully formed. The product was collected by filteration, washed with water and dried in a desiccator to
obtain compound 60 (C21H26N2O8, 1.7 g, 3.9 mmol, 95% ); MS (ESI) m/z 457.1577 [M+Na]+, calcd. for
C21H26N2O8Na 457.1578.
Benzyl 4-acetyl-3,5-dimethylpyrrole carboxylate (33):

Benzyl acetoacetate (35, 33.5 g, 174 mmol) was dissolved in acetic acid (40 ml) and placed in an ice bath.
Then it was treated with a solution of sodium nitrite (13 g, 188 mmol) in water and the temperature was
controlled around 10 oC throughout. The mixture was stirred for another 3 h and stored in a refrigerator
overnight. This solution was added to a solution of 2,4-pentandione (34, 10.2 g, 102 mmol) in acetic acid
(65 ml) during 2 h at 65 oC. Simultaneously, an intimate mixture of zinc dust (19 g, 287 mmol) and
sodium acetate (19g, 231 mmol) was added while keeping zinc dust always excess in the reaction
mixture. The resulting mixture was stirred for 1 h at 65 oC. Then it was poured into chilled water (1.5 L)
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while stirring. The resulting precipitate was filtered off and dissolved in CH2Cl2 and washed with water
and brine. It was then dried over anhydrous Na2SO4 and the solvent was evaporated. The crude product
was recrystallized from a methanol/water mixture to afford benzyl 4-(2-methoxycarbonylethyl)-3,5dimethylpyrrole (33, C16H17NO3, 15 g, 55 mmol, 53 % of); m.p. 134-136 oC, Lit m.p. 134.5 oC.48 1H NMR
(chloroform-d, 400 MHz): δ 9.06 (s, 1H), 7.73-7.22 (m, 5H), 5.33 (s, 2H), 2.62 (s, 3H), 2.51 (s, 3H), 2.45 (s,
3H); MS (ESI) m/z 272.1266 [M+H]+, calcd. for C16H18NO3 272.1287.
Benzyl 3,5-dimethylpyrrole carboxylate (40):

Benzyl 4-acetyl-3,5-dimethylpyrrole carboxylate (33, 1.0 g, 3.7 mmol) in dry benzene was treated with ptoluenesulfonic acid (0.02 g, 0.12 mmol). Then dry ethylene glycol (4 ml) was added and the mixture was
refluxed under argon for 15 h until reaction completion was confirmed by TLC. After the reaction was
completed, water (16 ml) was added the mixture was washed with CH2Cl2, which was then washed with
saturated NaHCO3, water and brine. The organic layer was dried over anhydrous Na2SO4. The product
was purified via a silica gel column chromatography to obtain benzyl 3,5-dimethylpyrrole carboxylate
(40, C14H15NO2, 0.8 g, 3.5 mmol, 95% ); m.p. 100-102 oC, Lit m.p. 99 oC.49 1H NMR (chloroform-d, 400
MHz): δ 8.57 (br. s, 1H), 7.63-7.29 (m, 5H), 5.82 (s, 1H), 5.30 (s, 2H), 2.33 (s, 3H), 2.25 (s, 3H); MS (ESI)
m/z 230.1179 [M+H]+, calcd. for C14H16NO2 230.1181.
Benzyl 4-formyl-3,5-dimethylpyrrole carboxylate (41):

Benzyl 3,5-dimethylpyrrole carboxylate (40, 1.0 g, 4.3 mmol) was dissolved in TFA under argon in an ice
bath. Then triethyl orthoformate was added slowly and the reaction mixture was allowed to stir an
additional 3 h while it reached room temperature. The reaction mixture was diluted with CH2Cl2 and
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extracted with several portions of water to remove the TFA. Then the organic layer was neutralized with
saturated NaHCO3, washed with brine and dried over anhydrous Na2SO4. After removal of the solvent,
the resulting crude product was dissolved in a minimum amount of CH2Cl2 and eluted through a silica gel
column. The first fraction was collected and shown to be the title compound 41 (C15H15NO3, 0.85 g, 3.0
mmol, 70%); m.p. 151-153 oC, Lit m.p. 151 oC.49 1H NMR (chloroform-d, 400 MHz): δ 10.00 (s, 1H), 9.37
(br. s, 1H), 7.64-7.29 (m, 5H), 5.34 (s, 2H), 2.59 (s, 3H), 2.53 (s, 3H); MS (ESI) m/z 258.1115 [M+H] +, calcd.
for C15H16NO3 258.1130.
3,5-dimethylpyrrole carboxylic acid (57):

Benzyl 3,5-dimethylpyrrole-2-carboxylate (40, 2.2 g, 9.6 mmol) was dissolved in dry THF (10 ml) and
degassed with argon. Then 10% Pd/C was added and the flask was sealed. Then the flask was evacuated
of air and filled with hydrogen gas using a balloon filled with hydrogen. The reaction mixture was stirred
overnight. Then the catalyst was filtered off using a Celite cake and the solvent was evaporated. This
product 57 (1.3 g, 9.3 mmol, 97%) was not purified or characterized, and was directly subjected to the
next step.
2-Formyl-3,5-dimethylpyrrole (59):

3,5-Dimethylpyrrole carboxylic acid (57, 1.3 g, 9.3 mmol) was treated with TFA (10 ml) in an ice bath and
stirred for 15 min. in a open flask to complete the decarboxylation to form pyrrole 58. Then triethyl
orthoformate (5 ml) was added slowly into the reaction mixture and it was stirred for an additional 3 h
under argon. Once at room temperature, the solution was partitioned between CH2Cl2 and water. The
organic layer washed with saturated NaHCO3 to neutralize TFA. The resulting organic layer was washed
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with brine and dried over anhydrous Na2SO4 and then evaporated to give a dark brown product. Crude
product was purified via a silica gel column to afford 3,5-dimethyl-2-formylpyrrole (59, C7H9NO, 0.55 g,
4.5 mmol, 48%); m.p. 87-89 oC, Lit m.p. 91 oC.50 1H NMR (chloroform-d, 400 MHz): δ 9.45 (s, 1H), 9.37
(br. s, 1H), 5.86 (s, 1H), 2.32 (s, 3H), 2.29 (s, 3H); MS (ESI) m/z 122.0500 [M-H]-, calcd. for C7H8NO
122.0606.
3,3'-Di(2-methoxycarbonylethyl)-4,4'-dimethyl-5,5'-diformylpyrromethane (61):

3,3'-Di(2-methoxycarbonylethyl)-4,4'-dimethylpyrromethane-5,5'-dicarboxylic acid (60, 0.6 g, 1.38
mmol) was dissolved in CH2Cl2 (10 ml) and p-toluenesulfonic acid (0.1 g) was added. The reaction
mixture was stirred for 1 h while monitoring by TLC. After completion of the decarboxylation, a
saturated solution of NaHCO3 was added to neutralize the acid, and the mixture was washed with water,
brine and dried over anhydrous Na2SO4. Without any purification, the crude product was dissolved in
dimethylformamide (2 ml) and placed in an ice bath. Then Vilsmeier complex 64 was prepared by adding
benzoyl chloride (1.2 ml, 10 mmol) dropwise to dry dimethylformamide (1.6 ml, 20 mmol) at 0 oC over
30 min. The Vilsmeier complex was added dropwise into the solution of decarboxylated dipyrromethane
in dimethylformamide and stirred for 15 min in an ice bath and another 1 h at room temperature. Then
benzene (10 ml) was added to the reaction mixture to precipitate the iminium salt. The resulting
precipitate was collected by filtration and redissolved in a saturated solution of NaOAc in methanol (12
ml) and water (12 ml). The mixture was heated at 60 oC for 8 h until it formed a precipitate. The reaction
mixture was extracted with CH2Cl2 and dried over anhydrous Na2SO4. Then the resulting brown solid,
after removal of the solvent, was purified via a silica gel column eluting with 2.5% methanol/CH 2Cl2 to
afford the titled compound 61(C21H26N2O6, 0.12g, 3.1 mmol, 24%); m.p. 179-182 oC, Lit m.p. 184-185 oC.51
210

1

H NMR (chloroform-d, 400 MHz): δ 10.46 (d, J = 23.5 Hz, 2H), 9.44 (s, 2H), 4.05 (s, 2H), 3.70 (s, 6H), 2.79

(t, J = 7.4 Hz, 4H), 2.51 (t, J = 8.9, 4H), 2.29 (s, 6H). MS (ESI) m/z 403.1888 [M+H]+, calcd. for C21H27N2O6
403.1896.
a,c-Biladiene dihydrochloride (53):

Method a:
Dipyrromethane dicarboxylic acid (60, 0.17 g, 0.4 mmol) was treated with TFA (8 ml) in an ice bath and
stirred under argon for 15 min to complete the decarboxylation. Then formylpyrrole (59, 0.10 g, 0.81
mmol) in methanol (5 ml) was added to the mixture of decarboxylated dipyrromethane. During the
addition of formylpyrrole, the color of the reaction mixture changed from yellow to red. The reaction
was monitored by UV-Vis spectrometry and the appearance of absorption bands around 440 and 507
nm confirmed the formation of the a,c-biladiene 53. After 2 h, freshly prepared HCl gas was bubbled
through the reaction mixture for 5 min and the color of the reaction mixture changed from red to dark
red. Then chilled ether was added to the mixture until the a,c-biladiene salt precipitated. Then the flask
was sealed and kept in the refrigerator overnight. The precipitate was collected by filtration to afford
a,c-biladiene 53 (C33H42Cl2N4O4, 0.096 g, 0.15 mmol, 38%).
Method b:
3,5-dimethylpyrrole carboxylic acid (57, 0.17 g, 1.2 mmol) was dissolved in TFA and kept in an ice bath
for 10 min under argon. Then diformyldipyrromethane (61, 0.24 g, 0.6 mmol) in methanol was added to
the decarboxylated pyrrole. A color change from yellow to red was observed over time and reaction was
monitored by UV-Vis spectrometry. After completion of the reaction, freshly prepared HCl gas was
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bubbled through the reaction mixture for 5 min. Then chilled ether was added to the mixture until a
precipitate of the a,c-biladiene dihydrochloride salt 53 was observed. Then the flask was sealed and kept
in the refrigerator overnight. The precipitate was collected by filtration to afford a,c-biladiene 53
(C33H42Cl2N4O4, 0.11g, 1.9 mmol, 32%); UV-Vis (MeOH): λmax (rel. inten.) 507 nm (1.00), 440 (0.92); 1H
NMR (acetone-d6, 400 MHz): δ 14.16 (s, 2H), 13.92 (s, 2H), 7.15 (s, 2H), 6.24 (s, 2H), 5.07 (s, 2H), 3.43 (s,
6H), 2.84 (t, J = 9.3 Hz, 4H), 2.68 (s, 6H), 2.39 (s, 6H), 2.27 (s, 6H), 2.05 (t, J=7.98, 4H).
Copper(II) Porphyrin (65):

The a,c-biladiene dihydrochloride salt (53, 96 mg, 0.15 mmol ) was dissolved in dimethylformamide and
treated with excess copper acetate in dimethylformamide. The reaction mixture was heated at 100 oC
while monitoring with UV-Vis spectrometry. Appearance of a sharp absorption band at 399 nm (Soret
band) in the UV-Vis spectrum confirmed the formation of porphyrin. After 40 min the mixture was
partitioned between water and CH2Cl2. The organic layer was washed with Na2CO3 and brine. It was
dried over anhydrous Na2SO4 to afford crude titled product (C32H32CuN4O4); MS (MALDI-TOF) m/z
600.182 [M+H]+, calcd. for C32H33CuN4O4 600.180, which was immediately demetalated.
Demetalation of Copper(II) Porphyrin (52):
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The crude copper(II) porphyrin 65 was demetalated using ice cold sulfuric acid/TFA (1:4) mixture. The
mixture was stirred in an ice bath for 6 h. Then CH2Cl2 was added to the reaction mixture and it was
washed with water 2 times to remove the acid. Then it was washed with 10% NaOH to neutralize any
acids remaining and then again with water and brine. After drying over anhydrous Na2SO4, the solvent
was evaporated and the resulting residue was redissolved in CH2Cl2 and treated with ethereal
diazomethane gas for 5 min. The solvent was evaporated and the crude product was placed on a silica
gel column and eluted with 1% methanol/CH2Cl2. The first band (red color) was collected and crystallized
to afford the title compound 52 (C33H34N4O4, 11 mg, 0.02 mmol, 13%); UV-Vis (DCM): λmax (rel. inten.)
564 nm (0.054), 529 (0.064), 496 (0.083), 468 (0.030), 397 (1.000); m.p. >260 oC, Lit m.p. 224-225 oC.52 1H
NMR (chloroform-d, 400 MHz): δ 10.05 (s, 3H), 9.92 (s, 1H), 9.04 (s, 2H), 4.40 (t, J = 7.8 Hz, 4H), 3.72 (s,
6H), 3.67 (s, 6H), 3.62 (s, 6H), 3.29 (t, J = 7.6 Hz, 4H), -3.97 (s, 2H). MS (MALDI-TOF) m/z 539.287 [M+H]+,
calcd. for C32H35N4O4 539.266.
Ethyl 4-(hydroxyimino)methyl-3,5-dimethylpyrrole carboxylate (74):

Ethyl 4-formyl-3,5-dimethylpyrrole carboxylate (73, 0.61 g, 3.14 mmol) was dissolved in dry methanol
(10 mL). Sodium acetate (0.31 g, 3.77 mmol) and hydroxylamine hydrochloride (0.26 g, 3.77 mmol) were
added and mixture was refluxed for 2 h. Then the mixture was allowed to cool to room temperature and
diluted with ethyl acetate (20 mL). 2M NaOH (2.14 mL) was added and the solvent was removed. The
crude product was dissolved in ethyl acetate and washed with water several times and then with brine
(50 mL). It was dried over anhydrous Na2SO4 and filtration through cotton, followed by concentration in
vacuo furnished an off-white solid shown to be titled compound 74 (C10H14N2O3, 0.64 g, 3.04 mmol,
97%); 1H NMR (chloroform-d, 400 MHz): δ 8.81 (br. s, 1H), 8.17 (s, 1H), 4.33 (q, J = 7.6 Hz, 2H), 2.43 (s,
3H), 2.39 (s, 3H), 1.37 (t, J = 7.7 Hz, 3H). MS (ESI) m/z 211.1084 [M+H]+, calcd. for C10H15N2O3 211.1083
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Ethyl 4-cyano-3,5-dimethylpyrrole carboxylate (75):

Method a
Ethyl 4-(hydroxyimino)methyl-3,5-dimethylpyrrole carboxylate (74,0.30 mg, 1.5 mmol) was placed in a
two neck round-bottomed flask with a condenser attached, and toluene (2 ml) was added. Then the
mixtue was heated to 90 oC while stirring. Once it reached 90 oC, chlorosulfonic acid (0.05 ml, 0.75
mmol) was added dropwise through the other mouth of the round-bottomed flask. The reaction mixture
was further stirred for 30 min at 90 oC. The reaction mixture cooled to room temperature, sodium
hydroxide (2M, 1.5 mmol) was added to neutralize the acid. Toluene (15 ml) was added to dissolve the
product. Then it was washed with water and brine and dried over anhydrous Na2SO4. The crude product
was purified via a silica gel column eluted with a 7% acetone/CH2Cl2 solvent system to obtain ethyl 4cyano-3,5-dimethylpyrrole carboxylate (75, C10H12N2O2, 0.090 g, 0.046 mmol, 31%)
Method b
2,4,6-Trichloro-[1,3,5]-triazine (74, 0.22 g, 1.2 mmol) was added to DMF (2 mL) and stirred at room
temperature for 1 h. During the reaction a white precipitate (Vilsmeier-Haack-type complex) was formed
and the reaction was monitored by TLC until complete disappearance of 2,4,6-trichloro-[1,3,5]-triazine.
Then ethyl 4-(hydroxyimino)methyl-3,5-dimethylpyrrole (0.21 g, 1.0 mmol) in DMF (5 ml) was added and
the reaction mixture was stirred at room temperature until complete disappearance of ethyl 4(hydroxyimino)methyl-3,5-dimethylpyrrole in the TLC. The mixture was diluted with water and extracted
with CH2Cl2. Then the organic phase was washed with saturated Na2HCO3 followed by 1M hydrochloric
acid and brine. Then it was dried over anhydrous Na2SO4 and the solvent was evaporated. The crude
product was purified using a short silica gel column and eluted with 8% acetone/CH2Cl2 to afford ethyl
4-cyano-3,5-dimethylpyrrole carboxylate (75, C10H12N2O2, 0.15 g, 0.78 mmol, 78%); m.p. 170-172 oC. 1H
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NMR (chloroform-d, 400 MHz): δ 9.36 (br. s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 2.43 (s, 3H), 2.40 (s, 3H) 1.38 (t,
J=7.1 Hz, 3H). MS (ESI) m/z 193.2183 [M+H]+, calcd. for C10H13N2O2 193.2145
Benzyl 4-(hydroxyimino)methyl-3,5-dimethylpyrrole carboxylate (80):

Benzyl 4-formyl-3,5-dimethylpyrrole carboxylate (33, 0.57 g, 2.21 mmol) was dissolved in dry methanol
(10 mL). Sodium acetate (0.22 mg, 2.7 mmol) and hydroxylamine hydrochloride (0.20 g, 2.8 mmol) were
added and mixture was refluxed for 2 h. Then the reaction mixture was allowed to cool to room
temperature and it was diluted with ethyl acetate (20 mL). Then 2M NaOH (1 mL) was added and the
solvent was removed. The crude product was dissolved in ethyl acetate and washed with water several
times and then with brine (50 mL). It was then dried over anhydrous Na2SO4 and filtration through
cotton, followed by concentration in vacuo furnished the titled product 80 (C15H16N2O3, 0.58 g, 2.13
mmol, 96% yield); m.p. 195-198 oC, Lit m.p. 199-200 oC.53 1H NMR (acetone-d6, 400 MHz): δ 10.71 (br. s,
1H), 9.72 (s, 1H), 8.11 (s, 1H), 7.55-7.25 (m, 5H), 5.27 (s, 2H), 2.42 (s, 3H), 2.36 (s, 3H). MS (ESI) m/z
173.2140 [M+H]+, calcd. for C15H17N2O3 173.2139
Benzyl 4-cyano-3,5-dimethylpyrrole carboxylate (73):

2,4,6-Trichloro-[1,3,5]-triazine (0.18 g, 1.0 mmol) was added to DMF (2 mL) and it was stirred at room
temperature for 1 h. During the reaction a white precipitate (Vilsmeier-Haack-type complex) was formed
and the reaction was monitored by TLC until complete disappearance of 2,4,6-trichloro-[1,3,5]-triazine.
Then benzyl 4-(hydroxyimino)methyl-3,5-dimethylpyrrole (80, 0.25 g, 0.91 mmol) in DMF was added and
the reaction mixture was stirred at room temperature until complete disappearance of ethyl 4-
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(hydroxyimino)methyl-3,5-dimethylpyrrole in the TLC. The mixture was diluted with water and extracted
with CH2Cl2. Then the organic phase was washed with saturated Na2HCO3 followed by 1M hydrochloric
acid and brine. Then it was dried over anhydrous Na2SO4 and the solvent was evaporated. The crude
product was purified using a short silica gel column and eluted with 8% acetone/CH2Cl2 to afford benzyl
4-cyano-3,5-dimethylpyrrole carboxylate (73, C15H14N2O2, 0.18 g, 0.71 mmol, 78%); m.p. 173-175 oC. 1H
NMR (chloroform-d, 400 MHz): δ 9.16 (s, 1H), 7.57 – 7.22 (m, 5H), 5.32 (s, 2H), 2.41 (s, 6H). MS (ESI) m/z
255.1127 [M+H]+, calcd. for C15H15N2O2 255.1134.
4-Formyl-3,5-dimethylpyrrole (64):

Ethyl 4-formyl-3,5-dimethylpyrrole carboxylate (73, 0.30 g, 1.5 mmol) and NaOH (0.48 g, 1.2 mmol) were
added to ethylene glycol (10 ml) and heated at 100 oC for 30 min until it dissolved completely. Then the
temperature was increase to 195 oC for the decarboxylation reaction. After half an hour the reaction
mixture was allowed to cool to room temperature. Then the product was extracted with CH2Cl2 and
purified via a silica gel column to afford 4-formyl-3,5-dimethylpyrrole (64, C7H9NO, 0.12 g, 0.97 mmol,
65%); m.p. 124-126 oC, Lit m.p. 126 oC.54 1H NMR (chloroform-d, 400 MHz): δ 9.89 (s, 1H), 9.68 (br. s,
1H), 6.40 (s, 1H), 2.50 (s, 3H), 2.28 (s, 3H). MS (ESI) m/z 124.1604 [M+H]+, calcd. for C7H10NO 124.0684.
4-(Hydroxyimino)methyl-3,5-dimethylpyrrole (85):

4-Formyl-3,5-dimethylpyrrole (84, 0.10 g, 0.81 mmol) was dissolved in dry methanol (10 mL). Sodium
acetate (0.77 g, 94 mmol) and hydroxylamine hydrochloride (0.066 g, 0.94 mmol) were added and the
mixture was refluxed for 2 h. Then the reaction mixture was allowed to cool to room temperature and
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diluted with ethyl acetate (20 mL). 2M NaOH (1 mL) was added and the solvent was removed. The crude
product was dissolved in ethyl acetate and washed with water several times and then with brine. Then
it was dried over anhydrous Na2SO4 and filtration through cotton, followed by concentration in vacuo
provided 4-(hydroxyimino)methyl-3,5-dimethylpyrrole 85 (C7H10N2O, 0.08 g, 0.58 mmol, 72%); 1H NMR
(chloroform-d, 400 MHz): δ 8.18 (s, 1H), 7.82 (br. s, 1H), 6.41 (s, 1H), 2.33 (s, 3H), 2.18 (s, 3H). MS (ESI)
m/z 139.0869 [M+H]+, calcd. for C7H11N2O 139.0871
Benzyl 4-iodo-3,5-dimethylpyrrole carboxylate (88):

Benzyl 3,5-dimethylpyrrole carboxylate (40, 1.0 g, 4.35 mmol) was dissolved in dichloroethane (20 ml)
and saturated Na2HCO3 (10 ml) was added. The mixture was heated at 50 oC for 15 min. Then a
saturated solution of KI/I2 in water (20 ml) was added and heating was continued at 70 oC for 1 h. Then
saturated solution of sodium thiosulfate (20 ml) was added to quench the excess iodine. The reaction
mixture was diluted with CH2Cl2 and the organic phase was washed with water followed by 1M
hydrochloric acid and brine. After removal of the solvent, the crude product was chromatographed on a
silica gel column and eluted with 1% methanol/CH2Cl2 to afford benzyl 4-iodo-3,5-dimethylpyrrole
carboxylate (88, C14H14INO2, 1.35 g, 3.8 mmol, 87%); 1H NMR (chloroform-d, 400 MHz): δ 9.04 (s, 1H),
7.55 – 7.16 (m, 5H), 5.31 (s, 2H), 2.31 (s, 3H), 2.28 (s, 3H). MS (ESI) m/z 356.1787 [M+H]+, calcd. for
C14H15INO2 356.1789.
4-Iodo-3,5-dimethyl-1-formylpyrrole (89):

To a solution of benzyl 3,5-dimethylformylpyrrole carboxylate (59, 0.25 mg, 2.03 mmol) in carbon
tetrachloride (15 ml), was added N-iodosuccinimide (0.68 mg, 3.0 mmol), which was recrystallized from
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a mixture of 1,4-dioxane/CCl4 before use. Then mixture was stirred at room temperature for 2 h. After
confirming the formation of 4-iodo-3,5-dimethyl-1-formylpyrrole by mass spectrometry, the mixture
was diluted with CH2Cl2 and washed with 1M NaOH and brine. The crude product was chromatograph
on a silica gel column and eluted with 1% methanol/CH2Cl2 to give 4-iodo-3,5-dimethyl-1-formylpyrrole
(89, C7H8INO, 0.42 mg, 1.7 mmol, 83%) ; m.p. 166-167 oC, Lit m.p. 167-170 oC.55 1H NMR (chloroform-d,
400 MHz): δ 10.53 (s, 1H), 9.49 (s, 1H), 2.36 (s, 3H), 2.28 (s, 3H). MS (ESI) m/z 249.9721 [M+H]+, calcd. for
C7H9INO 249.9729.
4-Cyano-3,5-dimethyl-1-formylpyrrole (82):

Benzyl 4-cyano-3,5-dimethylpyrrole carboxylate (72, 350 mg, 1.37 mmol) was dissolved in dry THF and
10% Pd/C (70 mg) was added. The reaction flask was sealed, evacuated of air and filled with hydrogen
gas using a hydrogen filled balloon. The reaction mixture was stirred overnight at room temperature.
After confirming the completion of the reaction by TLC, the catalyst was removed by filtration and the
solvent was evaporated. Then the crude carboxylic acid 81 was dissolved in benzene (7 ml) and a
solution of oxalyl chloride (0.35 ml, 4.11 mmol) in CH2Cl2 (7 ml) was added. A few drops of 1M
trimethylphosphine in toluene were added as a catalyst and the reaction mixture was allowed to stir at
room temperature for 24 h under argon. The solvent was evaporated and the crude acid chloride 90 was
redissolved in a THF/CH2Cl2 1:1 mixture (15 ml) in an ice bath. A solution of trimethylphosphine in
toluene (1.4 ml, 1.4 mmol) was added and the mixture was stirred for 1 h. Then sodium
triacetoxyborohydride (0.46 g, 2.17 mmol) was added and strring was continued at 0 oC for 18 h. 5%
NaHCO3 solution was added to quench the reaction and was stired for another 2 h at room temperature.
Then the reaction mixture was extracted with CH2Cl2 and the organic layer was washed with water, brine
and dried over anhydrous Na2SO4. The solvent was removed and the residue was chromatographed on a
218

silica gel column to afford titled product 82 (C8H8N2O); m.p. 218-221 oC. 1H NMR (chloroform-d, 400
MHz): δ 10.53 (s, 1H), 9.51 (s, 1H), 2.40 (s, 3H), 2.36 (s, 3H). MS (ESI) m/z 149.0710 [M+H]+, calcd. for
C8H9N2O 249.0715.
3,7-Diiodoporphyrin-13,17-dipropionic methylester (92):

Dipyrromethane dicarboxylic acid 60 (355 mg) was treated with TFA (25 ml) in an ice bath and stirred
under argon for 15 min to complete the decarboxylation. Then 4-iodo-3,5-dimethyl-1-formylpyrrole (89,
400 mg) in methanol was added to the mixture of decarboxylated dipyrromethane. During the addition
of formylpyrrole 89, the color of the reaction mixture changed from yellow to red. After 2 h, freshly
prepared HCl gas was bubbled through the reaction mixture for 5 min and the color of the reaction
mixture changed from red to dark red. Chilled ether was added to the mixture until the a,c-biladiene salt
91 precipitated. The flask was sealed and kept in the refrigerator overnight. The precipitate was
collected by filtration to afford 2,18-diiodo-a,c-biladiene dihydrochloride (91, C33H40Cl2I2N4O4) m.p. >260
o

C. The crude a,c-biladiene dihydrochloride salt 91 was dissolved in dimethylformamide and treated with

excess copper acetate. The reaction mixture was heated at 100 oC while monitoring with UV-Vis
spectrometry. Appearance of a sharp absorption band at 400 nm (Soret band) in the UV-Vis spectrum
confirmed the formation of porphyrin. After 40 min the mixture was partitioned between water and
CH2Cl2. The organic layer was washed with Na2CO3 and brine. It was dried over anhydrous Na2SO4 to
afford the copper(II) porphyrin which was demetalated using ice cold sulfuric acid/TFA (2:8) (10 ml)
mixture. The mixture was stirred in an ice bath for 5 h. Then CH2Cl2 was added to the reaction mixture
and it was washed with water 2 times to remove the acid. Next it was washed with 10% NaOH to
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neutralize any acids remaining and then again with water and brine. After drying over anhydrous
Na2SO4, the solvent was evaporated and the resulting residue was redissolved in CH2Cl2 and treated with
ethereal diazomethane gas for 5 min. The solvent was evaporated and the crude product was placed on
a silica gel column and eluted with 1% methanol/CH2Cl2. The titled product 92 was characterized by
mass spectrometry. Unfortunately, the amount was not enough to characterize by

1

H NMR.

(C32H32I2N4O4); MS (MALDI-TOF) m/z 791.051 [M+H]+, calcd. for C32H33I2N4O4 791.051.
Ethy 4-hydroxymethyl-3,5-dimethylpyrrole carboxylate (96):

Ethyl 4-formyl-3,5-dimethylpyrrole (83, 0.10 g, 0.52 mmol) was dissolved in dry CH2Cl2 (5 ml) in an ice
bath under argon. Then a solution of sodium borohydride in THF (1.00 ml, 2.50 mmol) was added
dropwise. After 15 min the reaction was completed as indicated by TLC. An aqueous solution of
ammonium chloride was added slowly to quench the excess sodium borohydride. The product was
extracted with CH2Cl2 and washed with water and brine. It was then dried over anhydrous Na2SO4. The
crude product was chromatographed on a silica gel column and eluted with 2.5% methanol/CH2Cl2 to
afford the titled product 96 (C10H16NO3, 0.098 g, 0.50 mmol, 96%); m.p. 125 oC. 1H NMR (chloroform-d,
400 MHz): δ 8.78 (br. s, 1H), 4.50 (s, 2H), 4.31 (q, J = 7.1 Hz, 2H), 2.36 (s, 3H), 2.30 (s, 3H), 1.36 (t, J = 7.1
Hz, 3H). MS (ESI) m/z 198.1126 [M+H]+, calcd. for C10H17NO3 198.1130.
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4.5 Supporting Information
1

H NMR spectrum of benzyl pyrrole carboxylate 29 in chloroform-d at 400
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1

H NMR spectrum of acetoxymethylpyrrole carboxylate 36 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl dimethylpyrromethane dicarboxylate 28 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl acetylpyrrole carboxylate 33 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl 3,5-dimethylpyrrole carboxylate 40 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl formylpyrrole carboxylate 41 in chloroform-d at 400 MHz

226

1

H NMR spectrum of formylpyrrole 59 in chloroform-d at 400 MHz
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1

H NMR spectrum of diformylpyrromethane 61 in chloroform-d at 400 MHz
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1

H NMR spectrum of a,c-biladiene dihydrochloride 53 in acetone-d6 at 400 MHz
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1

H NMR spectrum of porphyrin 52 in chloroform-d at 400 MHz
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1

H NMR spectrum of ethyl cyanopyrrole carboxylate 75 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl hydroxyiminopyrrole carboxylate 80 in acetone-d6 at 400 MHz
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1

H NMR spectrum of benzyl cyanopyrrole carboxylate 73 in chloroform-d at 400 MHz
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1

H NMR spectrum of 4-formylpyrrole 64 in Chloroform-d at 400 MHz
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1

H NMR spectrum of 4-(hydroxyimino)methylpyrrole 85 in chloroform-d at 400 MHz
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1

H NMR spectrum of benzyl 4-iodopyrrole carboxylate 88 in chloroform-d, 400 MHz
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1

H NMR spectrum of 4-iodo-formylpyrrole 89 in chloroform-d at 400 MHz
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1

H NMR spectrum of ethylhydroxymethylpyrrole carboxylate 96 in chloroform-d at 400 MHz
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